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ABSTRACT 
VASOPRESSIN ANATOMY OF THE MOUSE BRAIN 
FEBRUARY 2010 
BENJAMIN D. ROOD, B.S., BATES COLLEGE 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Geert J. de Vries 
 The nine amino acid peptide vasopressin acts as a neurohormone in the periphery 
and a neurotransmitter / neuromodulator in the central nervous system.  Historically, 
research on vasopressin neurons and their projections to the pituitary has helped lay the 
groundwork for our understanding of peptidergic neurotransmission.  Currently, our 
research on central vasopressin projections is driving a revolution in our understanding of 
social behavior.  Vasopressin affects a number of social behaviors from social memory to 
aggression to affiliative behavior, such as pair-bonding.  Further, with the addition of 
more and more transgenic mouse models of disease states, anxiety and depression related 
disorders, and social behavior dysfunction, it is important now more than ever to have a 
clear knowledge of the mouse vasopressin system, which derives from a number of 
distinct nuclei within the brain.  Here, I map out vasopressin immunoreactivity in the 
mouse brain, and delineate the subset of brain regions with gonadal steroid hormone-
dependent vasopressin immunoreactivity.  Such projections are thought to derive from 
the bed nuclei of the stria terminalis and medial amygdala in the telencephalon.  Finally, 
based on data from mice with lesions of the suprachiasmatic nucleus, I outline the subset 
of regions that likely receive vasopressin from this source. Our research on the anatomy 
of the vasopressin system of mice and our attempts to delineate the site of origin of the 
many vasopressin fibers found throughout the brain suggest that a significant amount of 
the vasopressin innervation deriving from cells in the bed nuclei of the stria terminalis 
and medial amygdala project to areas in the midbrain involved in serotonin and dopamine 
transmission, such as the dorsal raphe and ventral tegmental area.  These transmitter 
systems play a crucial role in the control of anxiety and depression levels as well as 
motivated behavior and emotional regulation.  Our results strongly suggest that a direct 
link exists between these systems, and future plans include an examination of this 
possibility.  It is our hope that this work will further our understanding of the role of 
vasopressin and other transmitter systems in the regulation of social behaviors. 
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CHAPTER 1 
THE VASOPRESSIN SYSTEM 
 
1.1  Introduction  
 A number of prominent disorders (e.g., autism, schizophrenia, obsessive-
compulsive disorder, anxiety, depression etc.) are characterized by disruptions of social, 
emotional, or cognitive behavior.  Behaviors altered in these disorders are controlled or 
regulated by many areas of the brain.  Understanding the connections between brain areas 
implicated in behavior and the neurochemical properties of those areas is crucial to the 
ability to treat psychological disorders.  Research, especially in the last two decades, has 
identified vasopressin as an important factor in the control of social behavior.  To 
understand how vasopressin controls social behavior under natural conditions it is 
important to first understand the anatomy of the vasopressin system. 
1.2  Vasopressin is a peptide 
 Vasopressin is a nine amino acid peptide (Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-
Gly) produced in a number of nuclei in the brain.  The functional properties of 
vasopressin were first described in the late 1800's (Oliver and Schafer, 1895), the peptide 
was first isolated in 1951 (Turner et al., 1951), and the gene was sequenced in 1982 
(Land et al., 1982).  The vasopressin gene located on chromosome 20 in humans and 
chromosome 2 in mice codes for a pre-propeptide made up of vasopressin, neurophysin 
II, and vasopressin-associated glycopeptide (Land et al., 1982).  Vasopressin is cleaved 
from the pre-propeptide and has functional signaling activity following extracellular 
release.   Neurophysin II and vasopressin-associated glycopeptide are packaged with 
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vasopressin and co-released, but have no known signaling activity (Gainer et al., 1977; 
Russell et al., 1981).   
1.3  Vasopressin acts as a neurotransmitter 
 There are three primary requirements for a substance to be classified as a 
neurotransmitter.  The substance must be present in pre-synaptic neurons, particularly in 
the synaptic terminals; it must be released from those terminals in a calcium dependent 
manner; and it must bind to a post-synaptic receptor thereby affecting the function of that 
post-synaptic cell.  The first evidence for neurosecretory neurons projecting centrally 
came in the 1950's and 1960's when researchers observed Gomori stained cells within the 
central nervous system (Scharrer, 1951; Barry, 1961).  In the 1970's, the development and 
refinement of immunocytochemistry allowed the first visualization of neurophysin 
containing neurons and fibers (Swaab and Pool, 1975; Vandesande and Dierickx, 1975; 
Swanson, 1977).  More specific antibodies and staining procedures allowed researchers 
to further distinguish between vasopressin and oxytocin staining. 
 Some of the first analyses of the distribution of vasopressin-containing cells and 
fibers in the brain were done in 1978 using brain sections from male Wistar rats and 
"home-made" antisera to vasopressin neurophysin (Buijs, 1978; Buijs et al., 1978).  
Neurophysin containing cell bodies were found in the paraventricular, supraoptic, and 
suprachiasmatic nuclei of the hypothalamus (Buijs et al., 1978).  In addition, vasopressin-
immunoreactive (-ir) fibers were observed in numerous central nervous system regions 
from the forebrain to the spinal cord (Buijs, 1978; Sofroniew and Weindl, 1978a; 
Sofroniew and Weindl, 1978b).  The fibers observed were postulated to derive from the 
three nuclei observed.  We now know that other vasopressin-producing regions also 
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contribute to the diverse projections sites.  Nevertheless, these early reports demonstrated 
that vasopressin was indeed present in neurons and neuronal processes throughout the 
central nervous system.   
 Shortly after the description of the neuronal vasopressin projections, electron 
microscopic evidence demonstrated that vasopressin immunoreactivity was found in 
synapses within areas populated by vasopressin-ir fibers.  More specifically, vasopressin 
immunoreactivity was observed in synapses, identified by the increased density at the 
synaptic cleft, of the lateral septum, lateral habenula, and medial amygdala (Buijs and 
Swaab, 1979).  Synaptic release was demonstrated subsequently, in 1982 (Buijs and Van 
Heerikhuize, 1982).  Briefly, tissue was collected from the lateral septum and the nucleus 
of the solitary tract, areas that display vasopressin-ir terminals, and the lateral 
hypothalamus, where vasopressin fibers travel from the paraventricular nucleus to the 
median eminence but do not form terminals.  When tissue from the lateral septum or 
nucleus of the solitary tract was incubated in a solution containing both calcium and high 
levels of potassium, vasopressin levels four times greater than detection limits could be 
measured by radioimmunoassay.  Basal vasopressin, in the absence of potassium, was 
below the detection limits of the assay.  When calcium was removed from the medium, 
vasopressin could not be detected.  The tissue from the lateral hypothalamus, which does 
not have terminals, did not result in measurable release of vasopressin.  These results 
demonstrated calcium dependent release of vasopressin from nerve terminals in the brain. 
 The introduction of tritiated vasopressin allowed scientists to accurately measure 
the binding characteristics of vasopressin without disrupting the function of binding sites 
(Dorsa et al., 1983).  Radiolabeled-vasopressin was found to bind to areas throughout the 
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rat brain including the nucleus of the solitary tract, lateral septum, nucleus accumbens, 
diagonal band, and stria terminalis (Baskin et al., 1983; Dorsa et al., 1983).  The specific 
binding of vasopressin to the brain suggested the existence of vasopressin receptors.  
Since the first demonstration of vasopressin binding sites, three types of vasopressin 
receptors have been identified and cloned: V1a, V1b, and V2 (Lolait et al., 1992; Morel 
et al., 1992; Saito et al., 1995).  Further, the V1a receptor was found to be most 
prominent in the central nervous system, and its distribution has been mapped for 
multiple species using both in situ hybridization and receptor autoradiography (Ostrowski 
et al., 1992; Ostrowski et al., 1993; Insel et al., 1994; Ostrowski et al., 1994; Wang et al., 
1997).  
1.4  Location of vasopressin production 
 In nearly every mammalian species studied to date, three regions of the brain 
consistently produce vasopressin: the paraventricular, supraoptic, and suprachiasmatic 
nuclei of the hypothalamus (De Vries and Panzica, 2006).  While these cell groups are 
the most prominent and consistent across species, they rarely if ever are the only sources 
of vasopressin.  Two other brain regions, the bed nucleus of the stria terminalis (BNST) 
and medial amygdala, express vasopressin in most species, although exceptions do exist 
(Miller et al., 1999; Rosen et al., 2007).  Aside from these five brain regions, vasopressin 
cells have been observed in various other nuclei of the forebrain, hypothalamus, 
midbrain, brainstem, and spinal cord in various species. 
 In mice, vasopressin-producing cells have been described in three other regions of 
the brain: the anterior commissural nucleus, the periventricular nucleus, and the "mouse" 
accessory nucleus (Castel and Morris, 1988).  Cells in each of these regions are described 
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as magnocellular similar to neurons found in the paraventicular and supraoptic nuclei.  
Cells of the suprachiasmatic nucleus, BNST, and medial amygdala are smaller and 
described as parvocellular (Castel and Morris, 1988).  Islets of cells similar to those seen 
in the mouse have been observed in other species such as the guinea pig, cat, and 
macaque (Caverson et al., 1987; Caffe et al., 1989; Dubois-Dauphin et al., 1989).  Some 
islets, particularly the nucleus circularis, appear to be associated with a blood vessel 
passing through the hypothalamus (Caverson et al., 1987; Dubois-Dauphin et al., 1989).   
1.5  Regulation of vasopressin gene expression 
 One of the hallmarks of vasopressin expression is the diverse manner by which 
the vasopressin gene is regulated.  The regulation of vasopressin gene expression seems 
therefore coupled to the function of the brain region that synthesizes it. 
 In the supraoptic nucleus of the rat, for example, osmotic stimuli result in an 
increase in gene expression (Murphy and Carter, 1990).  The supraoptic nucleus sends 
most of its efferent projections to the neural lobe of the pituitary (Caverson et al., 1987).  
Vasopressin release from the posterior pituitary alters blood pressure by binding to 
receptors in blood vessels throughout the body and increases water retention by the 
kidneys by binding to receptors located in the renal tubules (Turner and Pallone, 1997). 
 Cells in the suprachiasmatic nucleus, which are important for the expression of 
circadian and seasonal rhythms, rhythmically express multiple genes due to a negative 
feedback system (Jin et al., 1999).  Briefly, the proteins CLOCK and BMAL1 
heterodimerize, bind to an E-box transcription site (i.e., a region of DNA with the 
nucleotide sequence CACGTG), and initiate the transcription of (m)Per genes.  The 
mPER protein binds to CLOCK and disrupts CLOCK's heterodimerization with BMAL1, 
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thereby preventing its own transcription.  As levels of mPER decline, CLOCK and 
BMAL1 once again result in the production of new mPER.  Several genes, including 
vasopressin, contain the E-box regulatory sequence and can be regulated by CLOCK, 
BMAL1, and mPER (Jin et al., 1999).  Vasopressin expression in the suprachiasmatic 
nucleus has a diurnal rhythm with a peak in expression during the dark phase.  Disruption 
of the Clock gene results in a loss of the circadian rhythm and a constitutively low 
daytime level expression of vasopressin (Jin et al., 1999). 
 The first suggestion that vasopressin might be hormonally regulated came in 
1981, when a sex difference in vasopressin-ir fiber density was observed in the lateral 
septum (de Vries et al., 1981).  Subsequent studies showed that castration eliminated 
vasopressin peptide immunoreactivity in the lateral septum and multiple other brain areas 
and eliminated vasopressin mRNA expression in the BNST (de Vries et al., 1984; 
DeVries et al., 1985; Mayes et al., 1988; Miller et al., 1992).  The sex difference in 
vasopressin-ir fiber density, which depends on conversion of testosterone to estradiol in 
the male brain (De Vries et al., 1994), persists when testosterone levels are clamped at 
similar levels in male and female rats and mice, suggesting a developmental or 
organizational process (De Vries et al., 1994; Rood et al., 2008); although gonadal steroid 
hormones are required for the expression of vasopressin in adulthood and other sex 
differences not examined in these studies could be due to activational effects of steroid 
hormones (de Vries et al., 1984).  Further, neonatal castration of male rats lowers, and 
injection of testosterone during the first week of life in female rats increases, the 
vasopressin-ir fiber density observed in the presence of steroid hormones in adulthood, 
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reducing or eliminating the sex difference in both cases (Wang et al., 1993; Han and De 
Vries, 2003). 
 The differences in the regulation of vasopressin expression present a unique 
opportunity for researchers to explore the regulation of gene transcription and 
mechanisms of cellular differentiation that lead to differential gene transcription.  For the 
purposes of this manuscript, the hormonal regulation of gene expression will be used as a 
tool.  Vasopressin expression in the BNST and medial amygdala can be eliminated by 
removing gonadal hormones.  This provides an efficient technique, namely gonadectomy, 
for studying the projections of these nuclei within the nervous system. 
1.6  Location of vasopressin-containing fibers 
 The location of vasopressin-ir fibers, axons, and terminal boutons has been 
examined in at least 20 mammalian species (De Vries and Panzica, 2006).  Below, I will 
highlight some of the similarities and differences that are found across species.  Because 
the rat vasopressin system is the most well studied, and the mouse vasopressin system is 
the focus of this proposal, I will pay special attention to those species in the narrative. 
 Vasopressin-ir fibers, or immunoreactivity of the vasopressin-associated peptides 
neurophysin II or vasopressin-related glycopeptide, have been observed in every level of 
the central nervous system (i.e., telencephalon, diencephalon, mesencephalon, 
metencephalon, myelencephalon, and spinal cord) in multiple species.  Hypothalamic 
regions have areas of dense fibers in addition to the multiple magnocellular and 
parvocellular vasopressin-producing cell groups.  The lateral hypothalamus contains thick 
fibers descending from the paraventricular nucleus toward the supraoptic nucleus and 
eventually to the neurohypophysis (DeVries et al., 1985; Caverson et al., 1987; Castel 
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and Morris, 1988).  In rats, small fibers and terminals are found throughout the 
hypothalamus especially in the lateral hypothalamus, preoptic area, arcuate nucleus, 
periventricular nucleus, and dorsomedial hypothamalamic nucleus (DeVries et al., 1985).  
The ventromedial hypothalamus has almost no fibers in the rat (DeVries et al., 1985).  
This observation is noteworthy in that it is one of the few observations where fibers are 
explicitly reported to be absent.  Much of the data regarding the location of vasopressin 
fibers are incomplete.  Thus, when an author does not report on the fibers it could mean 
that there were no fibers located in a brain region, the researchers did not look at that 
region, or the authors just did not mention the presence of fibers in their report.  For 
example, although Castel and Morris (1988) give a detailed description of neurophysin 
II-ir cells and fibers in the forebrain, they reported neurophysin II-ir fibers in the "rostral 
to caudal extent of the amygdala" without identifying individual nuclei, and they did not 
report on midbrain or hindbrain fibers. 
 In addition to the hypothalamus, vasopressin is present throughout many ventral 
forebrain structures associated with the limbic system, such as the lateral septum, ventral 
pallidum, diagonal band of Broca, and the medial septum (DeVries et al., 1985).  
Vasopressin-ir fibers are observed in many of these same regions in the mouse (Castel 
and Morris, 1988; Rood et al., 2008), and fibers have been reported in some of these 
areas for other mammalian species (Caffe et al., 1989; Dubois-Dauphin et al., 1989; 
Crenshaw et al., 1992).  Vasopressin innervation of the cortex is sparse at best in most 
species studied.  In the rat scarce fibers are found in the cingulate, prefrontal, entorhinal, 
and endopiriform cortices (DeVries et al., 1985).  Castel and Morris (1988) report the 
 
 
8
presence of neurophysin II-ir fibers in the cortex, but do not describe the specific location 
of fibers. 
 Vasopressin is found in the thalamus of rats and mice, primarily in midline nuclei, 
and the epithalmaus (DeVries et al., 1985; Castel and Morris, 1988; Rood et al., 2008) 
and in various nuclei throughout the midbrain and brain stem (DeVries et al., 1985; Caffe 
et al., 1989; Dubois-Dauphin et al., 1989).  Vasopressin-ir fibers have not yet been 
described in the midbrain or brainstem of the mouse. 
 Many areas of the brain connected with the limbic system, which control 
emotional and memory processes, contain vasopressin-producing cell bodies (i.e., BNST 
and medial amygdala) and vasopressin-ir fibers (e.g., lateral septum, amygdala, 
hippocampus, cingulate cortex, mediodorsal thalamus, ventral pallidum, etc.).  In 
addition, vasopressin immunoreactivity in many of these areas is hormone dependent 
(i.e., gonadectomy leads to a loss of fiber immunoreactivity; (DeVries et al., 1985)) and 
sexually dimorphic (i.e., males exhibit more vasopressin immunoreactivity than females; 
(de Vries et al., 1981; Mayes et al., 1988; De Vries and al-Shamma, 1990; Rood et al., 
2008).  
 As discussed above, vasopressin is produced in at least five distinct nuclei in most 
species examined: the paraventricular nucleus, supraoptic nucleus, suprachiasmatic 
nucleus, BNST, and the medial amygdala.  Given the different locations and functions of 
these nuclei, it stands to reason that the vasopressin within each area would be involved 
in unique functions.  I have already discussed how vasopressin expression within 
different nuclei is under different transcriptional regulation, and it is reasonable to 
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assume that each nucleus would also have a unique pattern of afferent projections suited 
to its individual function. 
1.7  Site of origin of vasopressin-containing fibers 
 A few studies have attempted to discern the various projections sites of 
vasopressin neurons by assuming the identity of projections based on the appearance of 
vasopressin-ir fibers.  Castel and Morris (1988) suggested that the thin punctate nature of 
fibers observed in the diagonal band of Broca and the lateral septum had the appearance 
of those derived from the suprachiasmatic nucleus.  However the authors acknowledged 
work by De Vries et al. (1983) suggesting that these fibers derived from the BNST, in the 
rat.  Abrahamson and Moore (2001) also examined vasopressin innervation of the 
forebrain and suggested that similar areas, the lateral septum and lateral habenula, likely 
received vasopressin innervation from the suprachiasmatic nucleus given the nature of 
the fibers and the direction of fiber pathways leaving the suprachiasmatic nucleus.  Both 
of these groups noted "thick" and "thin" fibers throughout brain (see Figure 2.7).  The 
thin fibers were posited to come from the suprachiasmatic nucleus, whereas as thick 
fibers were suggested to arise from the magnocellular neurons of the paraventricular and 
supraoptic nucei.  In their description of the guinea pig vasopressin system, Dubois-
Dauphin et al. (1989) further delineated the morphology of axons as being "thick and 
varicose", "thin and moderately stained varicose", or "very thin".  However, these authors 
did not hypothesize the site of origin of the various fibers.  One other difference between 
these three studies is the peptide examined: vasopressin (Abrahamson and Moore, 2001), 
neurophysin II (Castel and Morris, 1988), or vasopressin-associated glycopeptide 
(Dubois-Dauphin et al., 1989).  Finally, one common conclusion from both Castel and 
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Morris (1988) and Abrahamson and Moore (2001) was that the sometimes dense 
vasopressin innervation by different size fibers and the inability to follow thin varicose 
fibers any distance through sections made interpreting the site of origin difficult at best. 
 A few empirical studies have more accurately located the site of origin of 
vasopressin fibers from the BNST and paraventricular nucleus (De Vries and Buijs, 
1983), the suprachiasmatic nucleus (Hoorneman and Buijs, 1982; Watts and Swanson, 
1987; Delville et al., 1998), and the medial amygdala (Caffe et al., 1987).  Following 
SCN lesions vasopressin-ir fibers remained in the lateral septum, lateral habenula, 
amygdala, diagonal band of Broca, nucleus of the solitary tract, interpeduncular nucleus, 
and dorsal raphe nucleus, but disappeared in the vascular organ of the lamina terminalis, 
dorsomedial hypothalmaus, and paraventricular nucleus of the thalamus (Hoorneman and 
Buijs, 1982).  The authors of this study concluded that the remaining brain regions must 
receive their vasopressin innervation from the paraventricular or supraoptic nuclei.  
However, vasopressin neurons were discovered to exist in the BNST in 1983 (van 
Leeuwen and Caffe, 1983).  Subsequently, retrograde tracing of the lateral septum using 
horseradish peroxidase resulted in labeled cells in the BNST, but not the paraventricular, 
supraoptic, or suprachiasmatic nuclei (De Vries and Buijs, 1983).  In addition, lesions to 
the BNST, but not the paraventricular nucleus, resulted in a decrease in vasopressin 
immunoreactivity in the lateral septum, lateral habenula, diagonal band of Broca, 
amygdala, periventricular gray, and locus coeruleus.  In contrast, lesions of the PVN 
resulted in the loss of fibers in the nucleus of the solitary tract and the nucleus ambiguus, 
suggesting that the paraventricular nucleus does have centrally projecting vasopressin 
cells in addition to neurosecretory cells projecting to the neurohypophysis (De Vries and 
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Buijs, 1983).  Finally, lesions of the medial amygdala resulted in a noticeable decline of 
vasopressin-ir fibers in the lateral septum and a complete loss of fibers in the ventral 
subiculum and other ventral hippocampal structures (Caffe et al., 1987).  After amygdala 
lesions, decreases in vasopressin immunoreactivity were not observed in the lateral 
habenula, mediodorsal thalamus, ventral tegmental area, central gray, dorsal raphe, or 
locus coeruleus; however, only qualitative observations were made.  In addition, 
retrograde tracer injections into the lateral septum and the ventral hippocampus each 
resulted in cells co-labeled for vasopressin immunofluorescence in the medial amygdala.  
Injections into the lateral septum also resulted in co-labeled cells in the BNST, and no 
other nuclei that produce vasopressin had any retrograde-labeled cells following these 
tracer injections (Caffe et al., 1987).  Evidence suggests that each group of vasopressin 
cells has a subset of nuclei to which it projects that does not necessarily overlap with 
projections from other vasopressin producing nuclei.  However, for most brain regions 
evidence for the site of origin of projections is neither conclusive, nor complete. 
1.8  Vasopressin receptors 
 Thus far three different vasopressin receptors have been identified:  V1a, V1b, 
and V2 (Lolait et al., 1992; Morel et al., 1992; Saito et al., 1995; Ventura et al., 1999).  
The V2 receptor is found primarily in the kidney (Ostrowski et al., 1992), and the V1b is 
known for its activity in the pituitary gland to potentiate adrenocorticotropin hormone 
release (Yates et al., 1971).  The V1a receptor on the other hand is found in the brain as 
well as in peripheral sites, such as the liver and in blood vessels (Ostrowski et al., 1992; 
Ostrowski et al., 1993; Ostrowski et al., 1994).  Importantly, at least in the rat, V1a 
mRNA is found in many of the same brain regions where vasopressin fibers are located 
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(Ostrowski et al., 1994).  All three vasopressin receptors are G-protein coupled receptors.  
The V1a, in particular, interacts with Gq stimulating phospholipase C, thereby increasing 
inositol phospholipid metabolism and ultimately increasing intracellular calcium 
(Stephens and Logan, 1986; Shewey and Dorsa, 1988).  
 The increase in intracellular calcium can mean a number of things for cell 
function.  Neurons in the facial nucleus of peripubertal rats, the solitary nucleus of adult 
rats, and the dorsal cochlear nucleus of guinea pigs all respond to vasopressin with an 
increase in intracellular firing (Charpak et al., 1989; Raggenbass et al., 1989; Raggenbass 
et al., 1991).  In the hippocampus, vasopressin potentiates cAMP turnover induced by 
norepinephrine  (Brinton and McEwen, 1989).  In the lateral septum, one of the most 
studied projection sites, vasopressin is thought to directly excite a population of 
GABAergic intereurons, which then causes a general inhibition of the projection neurons 
of the lateral septum (Allaman-Exertier et al., 2007). 
1.9  Functions carried out by vasopressin 
 The general effects of vasopressin have been studied since long before the 
anatomy of the vasopressin system was conceived, even prior to the isolation of the 
peptide itself.  The first observations of vasopressin activity were in the increase in blood 
pressure after injection of pituitary extracts (Oliver and Schafer, 1895).  In the early 
1900's, pituitary extracts were observed to have anti-diuretic properties as well (Farini, 
1913).  In the intervening century, vasopressin was isolated, the gene structure was 
determined, the localization of vasopressin in the brain was determined, the activity of 
vasopressin was ascribed to three receptor types, and a host of vasopressin-modulated 
physiological and behavioral functions were identified (reviewed by (Caldwell et al., 
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2008).  In short, vasopressin appears to be important for blood pressure, water balance, 
thermoregulation, affiliative social behaviors, aggression, and social memory (Ferris et 
al., 1984; Naylor et al., 1985; Pittman and Franklin, 1985; Demotes-Mainard et al., 1986; 
Dantzer et al., 1987; Young et al., 1999; Lim and Young, 2004; Beiderbeck et al., 2007).   
 Many of the early studies examining the function of vasopressin on the nervous 
system involved injections of vasopressin receptor agonists or antagonists peripherally or 
into the lateral ventricles.  In 1965, De Wied and colleagues determined that the posterior 
pituitary appeared to be important for a conditioned avoidance task.  Removal of the 
neurohypophysis led to rapid extinction of the avoidance response; animals could not be 
conditioned.  They found that peripheral injections of pituitary extracts or vasopressin 
alone following the conditioning trials could inhibit extinction and restore the 
conditioned response (De Wied, 1965; De Wied, 1971).  These studies were among the 
first to observe a behavioral effect of vasopressin.  Since these initial observations, many 
studies have focused on the behavioral actions of vasopressin.  For example, injections of 
vasopressin into the medial preoptic area / anterior hypothalamus facilitate flank-
marking, a territorial behavior, in Syrian Hamsters (Ferris et al., 1984); injections of 
vasopressin agonist increase and antagonist decrease paternal behavior in prairie voles 
(Wang et al., 1994); and injections of vasopressin receptor antisense into the lateral 
septum, which decreases vasopressin function in the septum, inhibit social recognition 
memory in rats (Landgraf et al., 1995).  Although many of the best studied effects of 
vasopressin on behavior have focused on the hypothalamus or lateral septum, analyses of 
vasopressin projections suggest that vasopressin has effects on many regions throughout 
the central nervous system.   
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1.10  Summary 
 Vasopressin, a nine-amino acid peptide produced in the hypothalamus and 
extended amygdala, acts as a neurotransmitter and binds to various receptors of which the 
V1a is most prominent in the brain.  Vasopressin fiber immunoreactivity has been 
examined in a number of species, but a thorough accounting for the mouse is still lacking.  
Recent research suggests a role for vasopressin in social behaviors many of which are 
altered in common psychiatric disorders such as anxiety, depression, schizophrenia, and 
autism.  In this manuscript, I present research which moves our understanding of the 
anatomy of vasopressin projections forward.  It is my hope that this work will lead to 
critical hypotheses regarding the function and mechanism of action of vasopressin in 
social behavior. 
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CHAPTER 2 
VASOPRESSIN ANATOMY IN INTACT MALES 
 
2.1  Introduction 
 Vasopressin has become a key player in our attempt to understand the complex 
neurobiology of social behavior.  Studies over the last three decades have suggested roles 
for vasopressin in regulating or controlling social behaviors such as social memory, pair-
bonding, partner preference, aggression, and communication (Ferris et al., 1984; Dantzer 
et al., 1987; Dantzer et al., 1988; Dubois-Dauphin et al., 1989; Compaan et al., 1993; 
Insel et al., 1994; Lim et al., 2004; Lim and Young, 2004; Thompson et al., 2006), in 
addition to the physiological roles that vasopressin plays in regulating water balance, 
blood pressure, thermoregulation, and stress (Oliver and Schafer, 1895; Farini, 1913; 
Yates et al., 1971; Banet and Wieland, 1985; Naylor et al., 1985; Pittman and Franklin, 
1985; Demotes-Mainard et al., 1986).  Anatomical and pharmacological examination of 
the vasopressin system has resulted in several hypotheses regarding the influences of 
specific brain regions on behavior.  Examples with more specific neural correlates 
include flank marking, thermoregulation during fever, and social memory. 
  Flank marking is a territorial behavior displayed by male and female hamsters 
that involves a stereotyped pattern of grooming and rubbing of the flanks on objects.  
Injections of vasopressin into the medial preoptic area, but not into the lateral ventricles 
or other hypothalamic brain regions (e.g., ventromedial hypothalamus), initiate this 
pattern of behavior (Ferris et al., 1984; Ferris et al., 1996).  In addition, lesions of the 
preoptic area / anterior hypothalamic area eliminate flank-marking (Ferris et al., 1986; 
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Ferris et al., 1993).  A second area, the ventral septal region, is implicated in 
thermoregulation.  In rats and rabbits with interleukin-1 induced fever, injection of 
vasopressin into the ventral septal area, but not the ventral lateral septum (Bernardini et 
al., 1983), reduces core body temperature (Naylor et al., 1985; Cooper et al., 1987), even 
though vasopressin does not reduce body temperature under normal conditions (Banet 
and Wieland, 1985).  A third region of much interest is the lateral septum, which has 
been studied for its role in memory, especially in the rat.  Rats have a tendency to 
investigate a familiar animal less than an unfamiliar animal; they are thought to 
"remember" the familiar animal.  This "social memory" lasts for less than 2 hours in 
males and 3 hours in females (Bluthe and Dantzer, 1990).  Injections of vasopressin into 
the lateral septum extend the duration of this memory in both sexes (Dantzer et al., 1987; 
Dantzer et al., 1988; Bluthe and Dantzer, 1990).  However, V1a receptor antagonists 
blocks recognition in males, but not females (Dantzer et al., 1987; Dantzer et al., 1988; 
Bluthe and Dantzer, 1990; Everts and Koolhaas, 1997).  In addition, V1a mRNA anti-
sense injections decrease social recognition and overexpression of the V1a receptor, 
using an adenoviral vector, facilitates social recognition when injected into the lateral 
septum (Landgraf et al., 1995; Landgraf et al., 2003).  Finally, and most convincingly, 
viral-vector mediated expression of the V1a receptor in the lateral septum rescues social 
recognition in V1a knockout mice, which normally have impaired social memory 
(Bielsky et al., 2005). 
 These three examples illustrate a direct functional link between a behavior and 
vasopressin.  However, the functional link is not always as clear.  For example, several 
attempts have been made to correlate aggression with vasopressin levels in the brain.  
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Long-attack latency (i.e., low aggression) mice have more vasopressin immunoreactivity 
in the lateral septum than short-attack latency mice (i.e., high aggression; (Compaan et 
al., 1993), and more aggressive rats have less vasopressin in the lateral septum (Everts et 
al., 1997).  In contrast, highly aggressive California mice have higher levels of 
vasopressin in the lateral septum than much less aggressive white-footed mice (Bester-
Meredith, 1999).  The opposing patterns in vasopressin fibers warn against simple 
correlations between vasopressin fiber density and vasopressin effects on behavior.  
Furthermore, extracellular vasopressin levels in the septum appear to drop, suggesting a 
reduction in release, during an aggressive encounter in low-anxiety rats, which are highly 
aggressive.  However, vasopressin agonists are unable to alter behavior in these rats 
(Beiderbeck et al., 2007).  In humans, vasopressin administration by intranasal spray 
leads to changes in emotive facial movements in response to pictures of faces and 
increased anxiety, responses not generally linked to the lateral septum (Thompson et al., 
2006).  In order to understand how vasopressin might influence aggression and other 
complex social behavior, one must take into account the entirety of the vasopressin 
system.  The lateral septum, ventral septal area, and medial preoptic area are just the tip 
of the iceberg.    
 Although the anatomy of the vasopressin system has been studied in more than 
twenty different mammalian species (De Vries and Panzica, 2006), a thorough 
accounting has only been made for a few including the rat and guinea pig.  In most 
descriptions, authors focus on forebrain areas, but ignore the midbrain and hind brain 
regions.  In the case of the mouse, two studies have been published in which a brief 
description of neurophysin II or vasopressin in the telencephalon and diencephalon is 
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given (Castel and Morris, 1988; Abrahamson and Moore, 2001).  Given the current 
importance of the mouse in transgenic approaches to anatomy, physiology, and behavior, 
it is crucial to have a thorough knowledge of the location of vasopressin projections 
throughout the mouse brain.  In addition, a complete accounting of fiber projections 
allows for greater accuracy in making comparisons with other species and in designing 
functional hypotheses.   
 In the following sections, I describe the locations of vasopressin-immunoreactive 
fibers and cell bodies throughout the brains of male C57BL6 mice with an emphasis on 
describing distinct characteristics of fibers (i.e., small versus medium  fibers) and 
defining discrete regions of innervation within larger regions (e.g., the posterodorsal 
medial amygdal within the amygdala).  In addition, I compare the vasopressin innervation 
of the mouse brain to previous research in mice and other species.  Finally, by defining 
the vasopressin innervation throughout the mouse brain, I set the stage for future 
discussions on the origins of the various fibers described. 
2.2  Methods 
2.2.1  Animals 
 C57BL6 mice were studied in this experiment.  Animals were derived from a 
breeding colony at the University of Massachusetts.  Following weaning, animals were 
group-housed (5 or less per cage) with same-sex siblings under a 14:10 light cycle with 
lights on at 6:00 am.  Animals had ad libitum access to food and water.  All procedures 
conformed to NIH guidelines and were in accordance with a protocol approved by the 
University of Massachusetts IACUC. 
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 Brains from three gonadally intact male mice were used for the ensuing 
descriptions.  The brains of 12 gonadally intact male mice from a separate study 
(presented in CHAPTER 3) were used to corroborate the observations made in this study. 
2.2.2  Tissue collection and processing 
 The three male C57BL6 mice were sacrificed at approximately 90 days of age by 
CO2 asphyxiation followed by rapid decapitation.  Brains were removed rapidly and 
placed in 5% acrolein in 0.1 M phosphate buffer.  Fixation lasted for four hours at which 
time brains were transferred to 30% sucrose in 0.1M phosphate buffer and stored at 4° C 
until sectioning.  Each brain was sectioned at 30 m in one of three planes: coronal, 
sagittal, or horizontal.  For each brain, every other section was collected for vasopressin 
immunohistochemistry.  All brain sections reserved for immunohistochemistry were 
stored in cryoprotectant at -20° C until staining.  Alternate sections were briefly stored in 
0.05M Tris-buffered saline until being mounted on slides and Nissl stained.  Tissue from 
animals used to corroborate results of this study were collected and processed in a similar 
manner, except only every third coronal section (30 m sections) was collected. 
2.2.3  Nissl staining 
 Brain sections were mounted onto gel coated slides and allowed to dry at least 
overnight.  Sections were rinsed 2x2 min in distilled water and then 2x2 min in 70% 
ethanol followed by a 5 min incubation in thionin.  Following thionin staining, sections 
were rinsed in distilled water and then then placed in 70% ethananol plus 0.1% glacial 
acetic acid for 10 min to remove non-specific staining.  Subsequently, tissue was 
dehydrated in 95% ethanol (1 min) and 100% ethanol (2x1 min) and finally rinsed in 
Hemo-De (Scientific Safety Solvents, Kellar, TX) for 4 min prior to coverslipping. 
 
 
20
2.2.4  Immunohistochemistry 
 Immunohistochemistry was carried out in mesh-bottomed cups and all 
incubations and rinses were done at room temperature except where noted.  Sections were 
incubated in the following solutions: 3x5 min in Tris-buffered saline (TBS; 0.05 M Tris, 
0.9% NaCl, pH 7.6); 0.05 M sodium citrate in TBS for 30 min; 3x5 min in TBS; 0.1 M 
glycine in TBS for 30 min; 3x5 min in TBS.  Finally, sections were incubated in blocking 
solution (20% normal goat serum (NGS), 0.3% Triton-X (Labchem, Inc., Pittsburgh, PA) 
and 1% H2O2 in TBS) for 30 min before being transferred to 2 ml Eppendorf tubes 
containing primary antibody (2% NGS, 1% BSA, 0.3% Triton-X, and 1:12,000 guinea-
pig anti-vasopressin antiserum (T-5048, Peninsula Laboratories, San Carlos, CA, USA)).  
After incubating overnight (~18 h), sections were returned to wells and rinsed with 37° C 
TBS containing 1% NGS and 0.02% Triton-X for 3x10 min.  Next, sections were 
incubated in secondary antiserum (1:250 biotinylated goat anti-guinea-pig IgG (Vector 
Laboratories, Burlingame, CA, USA) in TBS with 2% NGS and 0.32% Triton-X) for 1 h 
followed by 3x10 min rinses in TBS containing 0.2% Triton-X.  Sections were then 
incubated for 1 h in avidin–biotin complex in TBS (ABC elite kit, Vector Laboratories) 
followed by 3x10 min rinses in TBS.  Finally, sections were incubated in DAB with 
nickel enhancer (DAB peroxidase substrate kit, Vector Laboratories) for 2.5 min 
followed by 4x5 min rinses in TBS.  Sections were mounted on gel coated slides and 
allowed to dry at least overnight.  Sections were subsequently rinsed 3x30 sec with 
distilled water and allowed to dry before being coverslipped using Permount 
(ThermoFisher) 
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 Multiple controls for immunohistochemical staining were carried out on sections 
from animals used in CHAPTER 3 and CHAPTER 5.  Procedures were the same as 
described above except for the following alterations to the primary antibody for 
individual controls: 1)  no primary antibody was added to incubation buffer, 2) antibody 
was pre-adsorbed to 50 M vasopressin (Sigma Aldrich, St. Louis, MO), anti-body was 
pre-adsorbed to 50 M oxytocin (Sigma Aldrich, St. Louis, MO), or 4) several crystals of 
thyroglobbulin (Sigma Aldrich, St. Louis, MO) were added to primary antibody buffer. 
2.2.5  Analyses and image acquisition 
 Oberservations were made using a bright field microscope (Nikon Eclipse E600).  
Nissl stained section were occasionally used for reference.  Photomicrographs presented 
throughout were taken with a MicroFire camera (Optronics, Goleta, CA) and 
PictureFrame software.  Anatomical distinctions made throughout are derived from 
nomenclature and regional delineation presented by Franklin and Paxinos in The Mouse 
Brain in Stereotaxic Coordinates (2008). 
2.3  Results 
 Before describing immunoreactivity throughout the brain, it is important to first 
discuss staining controls (Saper and Sawchenko, 2003).  Immunoreactivity observed 
throughout the brain resembled immunoreactivity described by numerous other authors in 
both the characteristics of fibers (Buijs, 1978; Buijs et al., 1978; Castel and Morris, 1988; 
Abrahamson and Moore, 2001) and in the location of fibers (DeVries et al., 1985; Castel 
and Morris, 1988).  No staining was observed in the absence of primary antibody.  Pre-
adsorption with 50 M vasopressin eliminated staining except for a very faint haze in the 
PVN, where vasopressin production is quite high.  Pre-adsorption with 50 M oxytocin 
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caused a decrease in the intensity of staining, but did not eliminate staining of fibers.  
These results suggest that the antibody was reasonably specific.    
 One particular staining concern was a peculiar "specific" background artifact 
observed in cell bodies in distinct nuclei.  This staining (best observed in Figure 2.19F in 
the trochlear nucleus) was particular to regions such as the red nucleus (n.), trochlear n., 
occulomotor n., substantia nigra pars reticulata, and other regions with motor system 
function or large cholinergic or noradrenergic neurons such as those in the vertical 
diagonal band and locus coeruleus.  The staining in these cells appeared to be of cell 
body substructure, and no fiber staining was present around these cells.  In contrast, 
vasopressin producing neurons such as those in the paraventicular hypothalamus, 
suprachiasmatic nucleus, or BNST stain uniformly except for a nuclear void and have 
fibers projecting out from the cells.  One possible explanation for this background artifact 
comes from the fact that the polyclonal vasopressin antibody used was produced by 
injecting vasopressin conjugated to the protein thyroglobbulin.  This may have created 
some antibodies with different target affinities.  In imunohistochemical controls, the 
addition of thyroglobbulin to the primary anti-serum led to a large decrease in this artifact 
staining in the vertical diagonal band, cortex, and other regions without affecting staining 
of vasopressin cells and fibers.  We are confident that the rather specific staining artifact 
does not affect any of the data presented throughout.  On the contrary, the presence of 
this artifact enabled us to clearly visualize numerous nuclei throughout the brain thereby 
increasing our ability to determine the location of vasopressin-ir fibers and greatly 
increasing our anatomical precision.    
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2.3.1  Cell bodies in the diencephalon 
2.3.1.1  Paraventricular nucleus 
 In mice, the paraventricular nucleus (PVN) begins rostrally as the fornix bends 
ventrally and drops caudally below the upper edge of the third ventricle.  At first only a 
few large darkly staining neurons are observed bilaterally just below the top of the third 
ventricle in the anterior parvicellular PVN (PaAP; Figure 2.1A).  Caudally the number of 
neurons increases drastically along the upper half of the ventral third ventricle in the 
ventral and medial magnocellular PVN (PaV and PaMM; Figure 2.1B).  Subsequently a 
group of vasopressin-ir neurons appears laterally in the lateral magnocellular PVN 
(PaLM) at the top of the third ventricle, the PaV cell group ends, and a less dense group 
of immunoreactive cells is seen in the medial parvocellular PVN (PaMP; Figure 2.1C).  
After this point, the labeling in the PaLM cell group continues to be dense, but fewer 
labeled cells are observed adjacent to the third ventricle in the PaMP (Figure 2.1D).  As 
the fornix nears the dorsal-ventral midline of the third ventricle, the PVN ends with just a 
few scattered vasopressin-ir cells near the top of the ventricle.   
2.3.1.2  Supraoptic nucleus 
 The distribution of vasopressin-ir cells in the supraoptic nucleus (SON) is rather 
extensive.  Large darkly staining neurons first begin to appear hugging the ventral surface 
of the brain just above and lateral to the optic chiasm in the episupraoptic nucleus (Figure 
2.2A).  As the optic tract begins to curve up into the brain, large, darkly staining neurons 
are so densely packed atop the optic tract that they often cannot be distinguished (Figure 
2.2B).  While most vasopressin-ir neurons in the SON are seen in a distinct cluster just 
dorsal and lateral to the optic tract, a string of large neurons spreads medially atop the 
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optic tract stopping in the retrochiasmatic region below the anterior hypothalamus 
(rostrally) and ventromedial hypothalamus (caudally; Figure 2.2C).  As the optic tracts 
take a sharp turn dorsally to meet the cerebral peduncles, the large vasopressin-ir neurons 
of the SON disappear (Figure 2.2D).   
2.3.1.3  Suprachiasmatic nucleus 
 The suprachiasmatic nucleus (SCN) contains a very dense cluster of small darkly 
staining cells, which at times are difficult to tell apart due to an extremely dense halo of 
fibers and terminals surrounding the nucleus.  Vasopressin-ir cells in the SCN form a 
shell around an empty (i.e., no vasopressin-ir cells) core (Figure 2.3B).  Densely packed 
cells are found in the rostral (Figure 2.3A) and caudal poles (Figure 2.3C).  In the middle 
of the SCN, vasopressin-ir cells form a shell dorsal, lateral, and medial to a central core.  
The ventral part contains fewer cells (Figure 2.3B). 
2.3.1.4  Accessory nuclei 
 In addition to the vasopressin-ir neurons of the above mentioned nuclei, there are 
numerous other scattered vasopressin immunoreactive cells throughout the 
hypothalamus.  Because many of these cells appear similar in size and shape to 
magnocellular neurons of the PVN and SON and lie along fiber pathways from these 
nuclei, these neurons are often referred to as "accessory nuclei."  The accessory cells are 
most consistently found in the periventricular region (see figure 2.14E), anterior 
hypothalamus (Figure 2.4A), perifornical region (Figure 2.4B), and peduncular lateral 
hypothalamus (Figure 2.4C).  In general, these areas only have sparse labeling as no more 
than a dozen vasopressin-ir cells are generally seen in any single cross section.  The 
emergence of the anterior hypothalamus caudal to the medial preoptic area is generally 
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announced by the presence several large vasopressin-ir neurons halfway between the 
PVN and SON.  These cells are close to projections of the PVN, and fibers from these 
cells can be seen following a similar path to that of other fibers passing through the area 
possibly from the PVN.  A similar pattern is observed in vasopressin cells in the 
perifornical region and peduncular lateral hypothalamus.  In addition, within the anterior 
hypothalamus, a densely packed cluster of neurons is observed, the nucleus circularis 
(Figure 2.4D). 
2.3.1.5  Other hypothalamic nuclei 
 There are three other conspicuous clusters of vasopressin-ir cells in the 
hypothalamus.  One cell group is located rostral to the PVN just below the fornix in the 
striohypothalamic region (Figure 2.5A).  This nucleus contains a loosely packed cluster 
of immunoreactive neurons.  A second conspicuous cell group is observed in more caudal 
reaches of the hypothalamus.  Just caudal to the last SON neurons, a distinct cluster of 
darkly staining neurons is observed along the ventral surface of the brain in the 
retrochiasmatic supraoptic nucleus (Figure 2.5B).  These neurons are often difficult to see 
as they are buried in a dense tangle of medium to large vasopressin-ir fibers passing 
through the tuberal part of the hypothalamus.  Finally, vasopressin-ir neurons are found 
in the ventral lateral preoptic area and are usually large, darkly staining, and tightly 
clustered along the ventral brain surface (Figure 2.5C).   
2.3.2  Cell bodies in the telencephalon 
2.3.2.1  Bed nuclei of the stria terminalis 
 Outside of the hypothalamus vasopressin cells are found in the bed nuclei of the 
stria terminalis (BNST) and medial amygdala (MeA).  In the BNST, most of the cells 
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observed are small (i.e., parvocellular) and very lightly staining and are found primarily 
in two subdivisions of the BNST.  The first group of cells is located in the medial 
posteromedial BNST (STMPM) just lateral to the fornix.  These cells sit just medial to 
fibers entering from the stria terminalis (Figure 2.6A and B).  A second loose cluster of 
cells is observed caudally in the lateral posteromedial BNST (STLPM).  This cell group 
spreads out in a dorsolateral to ventromedial orientation starting just under the stria 
terminalis (Figure 2.6C and D).  Aside from these two locations a few lightly staining 
small cells are scattered throughout the posterior BNST, and a few isolated cells are 
observed in the anteromedial BNST.  Finally, occasional single large, darkly staining 
neurons are observed in the STMPM and STMPL. 
2.3.2.2  Medial Amygdala 
 A smaller and more loosely organized collection of vasopressin-ir cells is found in 
the medial amygdala.  These cells, like the BNST, are small and stain very lightly.  They 
typically appear from rostral to caudal levels of the posterodorsal medial amaygdala and 
tend to concentrate on the very lateral edge of the nucleus (Figure 2.6E to H). 
2.3.3  Small versus medium  fibers 
 Throughout the description of vasopressin fibers below, I refer to small, medium, 
and occasionally large fibers.  In addition, I frequently refer to terminal fields.  In 
general, the characteristics of fibers provide a unique insight into various fiber pathways.  
In rats medium fibers are typical of PVN or other hypothalamic pathways, except the 
SCN, whereas small fibers are typical of projections from the BNST, MeA, and SCN 
(Buijs et al., 1978; De Vries and Buijs, 1983).  Small fibers typically have very small 
faint processes with small varicosities as seen in the lateral septum (Figure 2.7A; also see 
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Figure 2.10F).  Small fibers are often associated with punctate staining, which are 
referred to as terminal fields.  In contrast, medium fibers are larger, have larger 
varicosities, and often stain more darkly.  In addition these fibers are rarely associated 
with the small punctate staining typical of small fiber terminal fields.  Instead, these 
fibers often have very visible protrusions, which could be boutons of passage, that branch 
off the fiber as it passes through an area as in the ventral periaqueductal gray (Figure 
2.7B).  Large fibers are only seen in a few places such as the medioventral BNST and the 
periventricular area (see Figure 2.4A). 
2.3.4  Fibers in the telencephalon 
2.3.4.1  Cortex 
 Most of the cortex is devoid of vasopressin-ir fibers; however, a few regions 
consistently contain fibers.  In the frontal lobe, medium fibers are observed in the midline 
cortical nuclei such as the medial orbital, frontal, infralimbic, prelimbic (Figure 2.8A), 
and dorsal peduncular cortex.  The insular cortex just dorsal to the rhinal fissure contains 
sparse fibers at points along its rostral to caudal length (Figure 2.8B).  The rostral 
cingulate cortex also contains a very sparse innervation, often only a single fiber (Figure 
2.8C).  The densest innervation of the cortex occurs caudally as the hippocampus reaches 
ventrally.  Here, there are vasopressin-ir fibers in areas such as the endopiriform, 
entorhinal, intermediate endopiriform claustrum, and dorsolateral ectorhinal cortex 
(Figure 2.8D).   
2.3.4.2  Hippocampus 
 Dorsally the hippocampus is devoid of vasopressin fibers.  Only a rare fiber is 
observed in the fimbria.  As the hippocampus reaches ventrally at the level of the caudal 
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amygdala scattered small fibers are observed in the oriens layer of the hippocampus and 
along the border between the hippocampal formation and the amygdala-hippocampal 
transition zone (Figure 2.8E and F) and further caudally in the ventral subiculum.  Sparse 
small fibers are also observed in the molecular layer of CA1.  In addition to the small 
fibers seen in CA1, medium to large fibers are observed in the caudal molecular layer of 
CA1 (LMol)  as the sulcus between the hippocampal and dentate gyri stretches ventrally 
(Figure 2.8G and H).   
2.3.4.3  Basal ganglia 
 The caudate, putamen, and globus pallidus do not contain vasopressin-ir fibers.  
The nucleus accumbens contains a small number of medium  fibers mostly in its core 
region (Figure 2.9A and B).  The ventral pallidum (VP), in contrast, contains mostly 
small fibers and terminals.  Rostrally, there are densely innervated patches of ventral 
pallidum between the shell of the nucleus accumbens and the olfactory tubercle, both of 
which do not contain labelled fibers (Figure 2.9A).  As the vertical limb of the diagonal 
band becomes prominent, the dense patches of fibers in the ventral pallidum seem to 
connect to a dense band of vasopressin immunoreactivity between the diagonal band and 
the accumbens shell.  As the horizontal limb of the diagonal band begins to spread 
laterally the VP contains a more moderate innervation of small fibers and terminals 
located primarily in the medial portion of the VP underneath the waning nucleus 
accumbens (Figure 2.9B).  The central region of the VP remains relatively free of fibers 
suggesting that the vasopressin innervation of the VP is region specific.  Caudally the 
innervation of the ventral pallidum becomes increasingly sparse. 
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 2.3.4.4  Septal Complex 
 The rostral septum contains sparse medium fibers in all three divisions (ventral, 
intermediate, and dorsal; Figure 2.10A).  Caudally, as the anterior commissure starts to 
pass under the lateral ventricle, a moderate innervation of small fibers and terminals 
reaches up around the diagonal band and invades the ventral lateral septum, intermediate 
lateral septum, and to a lesser extent the septohypothalamic nucleus (Figure 2.10B).  The 
fiber plexus in the ventral lateral septum and more caudal septal regions appears to be 
continuous with fibers in the ventral septal area, which is described below.  The plexus of 
small fibers and terminals becomes very dense in the ventral and intermediate lateral 
septum as the fibers of the fimbria become visible (Figure 2.10C).  At the caudal extent 
of the septal complex (Figure 2.10D), some small fibers make their way into the fringes 
of the septofimbrial region, although the main body of the fimbria is devoid of 
vasopressin fibers.  The dorsal lateral septum contains only a very few medium fibers 
along its length.  One additional feature of the small fibers in ventral and intermediate 
lateral septum is the formation of peri-cellular baskets, groups of terminals surrounding 
individual cells (Figure 2.10E ad F).   
 In sharp contrast to the dense innervation of the lateral septum, the medial septum 
does not contain vasopressin fibers (Figure 2.10A and B).  However, a few medium 
fibers rise up just lateral to the medial septum and occupy a region between the medial 
septum and the dense small fibers of the lateral septum (Figure 2.10B).  In addition, 
scattered medium fibers pass through the median preoptic area rostral to the anterior 
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commissure and ascend into the subfornical organ.  A few fibers even reach the triangular 
septal nucleus (Figure 2.10D). 
2.3.4.5  Ventral forebrain  
 Rostral to the appearance of the diagonal band, there are sparse to scattered 
vasopressin fibers along the midline in the navicular postolfactory nucleus.  These fibers 
extend up into the intermediate lateral septum avoiding the shell of the nucleus 
accumbens.  As the diagonal band emerges a dense band of fibers is observed stretching 
from the ventral surface up toward the septal region between the diagonal band and 
nucleus accumbens and around the islands of Calleja (Figure 2.9A).  Interestingly, the 
three regions just mentioned appear to be specifically avoided by vasopressin fibers.  The 
region that is innervated is unnamed in The Mouse Brain in Stereotaxic Coordinates 
(Franklin and Paxinos, 2008), but corresponds to the ventral septal area (not to be 
confused with the ventral lateral septum) described in the thermoregulation literature 
(Naylor et al., 1985).  Rostrally, pockets of vasopressin-ir fibers in the ventral pallidum 
are continuous with this fiber plexus (Figure 2.9A), and caudally fibers spread into the 
substantia innominata (Figure 2.9B).   
2.3.4.6  Bed nuclei of the stria terminalis 
 Each division of the bed nuclei of the stria terminalis (BNST) presents a unique 
pattern of vasopressin-ir fibers.  In the anterior BNST just caudal to the nucleus 
accumbens (Figure 2.11A), there are medium fibers both above and below the anterior 
commissure in the anteromedial (STMA) and medioventral (STMV) divisions.  The 
lateral nuclei above and below the anterior commissure contain only sparse medium 
fibers.  At this rostral level, the STMA alone contains a moderate terminal field and small 
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fibers.  As the anterior commissure decussates (Figure 2.11B), a moderate to dense 
innervation of medium fibers is observed in the STMV below the decussation. The 
STMA at this level has an increased density of small fibers.  The dorsal lateral nuclei still 
contain almost no fibers, but small fibers begin to appear in the lateroventral division. 
 In the posterior BNST, the medial part of the posteromedial nuclei (STMPM) 
contains a dense plexus of fibers and terminals just above the incoming fibers of the stria 
terminalis and a second less dense plexus closer to the dorsal edge of the nucleus adjacent 
to the dorsal third ventricle (Figure 2.11C).  The middle of the STMPM contains fewer 
fibers.  The intermediate (STMPI) and lateral (STMPL) parts of the nucleus on the other 
hand contain a larger scattered to moderate distribution of small vasopressin fibers and 
terminals (Figure 2.11D and E).  Most of the parvocellular BNST vasopressin cells are 
located in the STMPM and STMPL, and many fibers appear to travel dorsally into the 
stria terminalis and laterally into the extended amygdala, as labelled by Franklin and 
Paxinos (2008) and not to be confused with the larger concept of the extended amygdala 
(de Olmos and Heimer, 1999), from this region.  Finally, as the posterior BNST nuclei 
end caudally, moderate to dense fibers and terminals persist ventral to the stria medullaris 
and lateral to the fornix in the nucleus of the stria medullaris (Figure 2.11E). 
2.3.4.7  Amygdala 
 Numerous nuclei throughout the amygdala contain small  fibers and associated 
terminal fields.  Rostrally, the extended amygdala has a moderate innervation of small 
fibers that appear to extend into the anterior amygdaloid nucleus (Figure 2.12A and B).  
The anterior cortical amygdala also contains a light innervation at this level.  Fibers do 
not make their way into the piriform cortex, cortex-amygdala transition zone, basolateral 
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amygdala, lateral olfactory tract (Figure 2.12C and D), bed nucleus of the accessory 
olfactory tract, or magnocellular preoptic area, which borders the medial edge of the 
amygdala.  As the optic tract begins to ascend and separate the amygdala from midline 
brain structures, the medial amygdala emerges adjacent to the looping fibers of the SON.  
The anteromedial amygdala contains mostly small fibers, although occasional medium 
fibers possibly from the adjacent supraoptic nucleus wander into and anteroventral 
medial amygdala.  The basomedial amygdala also contains a moderate innervation at this 
level.  Some fibers appear to make their way laterally into the ventral endopiriform cortex 
and ventral basolateral amygdala.   
 Further caudal the SON is no longer present and the posterodorsal (MePD) and 
posteroventral medial amygdala replace the anterior medial nuclei along the optic tract 
and contain dense small fibers and terminals.  In fact, the MePD has the densest 
concentration of fibers in the entire amygdala and is the only nucleus with pericellular 
baskets similar to those observed in the lateral septum (Figure 2.12F).  At this point, the 
innervation thins out laterally and only scattered fibers are observed in the posterolateral 
cortical amygdala.  Near the caudal end of the posterodorsal medial amygdala, a band of 
small fibers and terminals spreads out between the lateral and posterior basolateral 
amygdala (Figure 2.12G and H), which have been devoid of fibers up until this point.  As 
the hippocampus joins the amygdala fibers are seen in the amygdalohippocampal area.  
As described above fibers are also seen along the amygdala-hippocampus transition as 
well. 
 Up until this point, all of the fibers described in the amygdala have been small 
fibers and terminals.  There are very few medium fibers.  A few stray from the SON.  The 
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only other notable innervation is a scattered group of fibers in the central nucleus just 
dorsal to the rostral MePD (Figure 2.12E).  From here sparse medium fibers appear to 
enter the medial amygdala or pass through the basomedial amygdala into the ventral 
endopiriform nucleus.  
2.3.5  Fibers in the diencephalon 
2.3.5.1  Hypothalamus 
2.3.5.1.1  Preoptic Area 
 The preoptic region is marked by a rich innervation by vasopressin fibers likely 
deriving from multiple sources.  The rostral pole of the preoptic area is marked by 
scattered small fibers in the medial preoptic area (MPA) appearing just caudal to the 
vertical diagonal band (Figure 2.9B).  The MPA splits laterally making way for the 
vascular organ of the lamina termialis (VOLT) and the median preoptic nucleus at the 
midline both of which contain scattered to moderate innervation of medium fibers (Figure 
2.13A).  Just rostral to the anterior commissure, many medium fibers stretch dorsally 
through the median preoptic nucleus, wrapping around the front of the anterior 
commissure into the septal region (Figure 2.13B).  The MPA continues caudally with a 
scattered to moderate innervation and is marked by more terminals than in the VOLT and 
median preoptic nucleus.  The lateral preoptic area also contains a moderate innervation 
of fibers and terminals which spreads laterally into the ventral septal area, which has a 
very dense fiber plexus. 
 Caudal to the crossing of the anterior commissure, there is a dense terminal field 
in the parastrial nucleus (Figure 2.13C), which sits just ventromedial to a cluster of 
medium to large fibers in the ventral BNST.  At this level, the medial part of the preoptic 
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nucleus contains scattered fibers.  The periventricular nuclei such as the anteroventral 
periventricular nucleus, periventricular nucleus, and ventromedial preoptic area contain 
moderate to dense small fibers and terminals as well as a small number of large fibers 
(Figure 2.13D and E).   
2.3.5.1.2  Anterior hypothalamus 
 Based on cell grouping and fiber trajectories, there appear to be multiple semi-
distinct groups of vasopressin-ir cells in the PVN.  These cell groups send medium to 
large fibers out in three main projections through the anterior hypothalamus (AH).  The 
first fibers leave the ventral paraventricular nucleus rostrally and pass ventrolaterally 
toward the lateral edge of the optic chiasm (Figure 2.14A).  These fibers are joined by 
those from a number of accessory cells located in the AH.  The second group exits the 
PVN more dorsally and takes a ventrolateral route just below the fornix toward a point 
more lateral than the ventral fibers (Figure 2.14B).  The third group of fibers, which 
extends the furthest caudally (Figure 2.14C), passes over the top of the fornix and 
separates into a ventral and dorsal path.  The dorsal path turns up into the reticular 
nucleus of the thalamus.  The ventral path turns ventrally toward the SON.  Both dorsal 
and ventral routes pass accessory cells whose fibers seem to join the other fibers. 
 Small fibers are found almost exclusively near the midline except at the most 
anterior part of the AH where a moderate plexus is seen just below the fornix.  Caudally 
this moderate terminal field phases out rather quickly.  At the midline the 
suprachiasmatic nucleus starts and ends almost entirely at the level of the AH.  A dense 
cloud of small fibers and terminals spreads dorsally into the subparaventricular zone and 
periventricular area, which also contain some large diameter fibers (Figure 2.14A, B, and 
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C).  Only a few fibers stray into the anterolateral hypothalamus and AH.  Many small 
fibers appear to enter the PVN.  Sagittal sections reveal that the complex of large fibers is 
actually quite dense in the periventricular region along the wall of the third ventricle, and 
the innervation by small fibers forms the densest plexus of small fibers seen anywhere in 
the brain (Figure 2.14D).  In addition, sagittal sections reveal multiple trajectories for 
fibers coming from the SCN.  A sizable contingent travel rostrally with a particularly 
heavy stream of fibers aimed in anterodorsal orientation as if pointing at the anterior 
thalamus.  The densest cloud spreads dorsally into the subparaventricular zone, and a 
number of fibers travel caudally in a rather wide swathe near the ventricle (Figure 2.14E). 
2.3.5.1.3  Dorsomedial hypothalamus 
 The dorsomedial hypothalamus (DMH) begins just caudal to the PVN.  
Continuous with the caudal PVN, there is a moderate to dense innervation by small fibers 
and terminals near the top third of the ventral third ventricle as well as a substantial 
number of medium fibers, which are slightly lateral to the smaller fibers.  At first this 
plexus of small fibers stays close to the ventricle (Figure 2.15A).  However, caudally, the 
fiber plexus remains moderate to dense, but grows larger spreading almost out to the 
fornix (Figure 2.15B and C), which is at the lateral edge of the ventromedial 
hypothalamus (VMH).  As the small fibers spread laterally a number of medium fibers 
appear to spread medially and intermingle with the small fibers in the more lateral part of 
the DMH (Figure 2.15C).  The VMH is nearly devoid of fibers.  Below the fornix and the 
rostral VMH, dense collections of medium fibers forge a path toward the median 
eminence (Figure 2.15A and B).  Caudally, these fibers form a thin sheet as they reach 
the median eminence (Figure 2.15D).  Finally, the small fibers and terminals adjacent to 
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the third ventricle thin out as the ventricle recedes toward the mammillary recess.  In 
addition to the more dorsal fibers, small and medium fibers are seen in the 
retrochiasmatic area rostrally, the arcuate nucleus caudally, and the periventricular 
nucleus throughout.  
2.3.5.1.4  Lateral hypothalamus 
 The peduncular lateral hypothalamus (PLH) emerges caudal to the lateral preoptic 
area at the level of the anterior hypothalamus and is distinguished by a marked increase 
in the density of small vasopressin fibers and terminals (Figure 214A, B, and C and 
Figure 2.16A).  These fibers occur in a large cloud over much of the lateral hypothalamus 
and reach from the fornix medially to the extended amygdala, which also contains small 
fibers.  This moderate to dense fiber plexus spreads ventrally around the horizontal 
diagonal band, which is devoid of fibers.  The small fibers and terminals in the PLH 
become less dense caudally until they are quite sparse.  As the PLH transitions to fewer 
small fibers, there is an increase in the number of medium fibers, which appear to be 
coming from the PVN and SON based on their trajectory (Figure 2.16B).  
2.3.5.1.5  Mammillary bodies 
 As the caudal aspect of the dorsomedial hypothalamus ends, the mammillary 
bodies emerge in a ventral protrusion.  The mammillary nuclei themselves are completely 
devoid of vasopressin innervation.  However, just rostral to the mammillary nuclei a 
cloud of small immunoreactive fibers and terminals spreads lateral to medial in a band 
that spreads around the fornix from the edge of the brain almost to the midline (Figure 
2.16C).  Above and below this line more scattered medium fibers are observed in the 
ventral premammillary, posterior hypothalamic, parasubthalamic, and retromammillary 
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nuclei.  The dorsal and ventral tuberomammillary nuclei each have a moderate to dense 
innervation in a rather small space, and the arcuate nucleus near the bottom of the third 
ventricle only has sparse immunoreactive fibers.  As the mammillary nuclei emerge, the 
fibers surrounding the fornix are pushed ventrally (Figure 2.16D) until finally all that is 
left is a dense terminal plexus in the ventral tuberomammillary nucleus (Figure 2.16E).  
The majority of fibers in this region are small, but a number of medium fibers are also 
observed.   
2.3.5.2  Thalamus 
 With the exception of medium fibers in the reticular nucleus and sparse medium 
fibers in the paraventricular, reuniens, and xiphoid nuclei, most of the vasopressin 
innervation in the thalamus consists of small  fibers.   
 The anterior paraventricular nucleus of the thalamus (PVA) appears first in rostral 
coronal sections (Figure 2.17A).  There is generally a uniformly moderate to dense 
plexus of fibers and terminals throughout the PVA.  The paraventricular thalamus (PV) 
extends caudally following the ventral surface of the dorsal third ventricle all the way to 
the posterior commissure.  Small and medium vasopressin-ir fibers are found throughout, 
although they are most dense rostrally and become sparse at the caudal end of the PV 
(Figure 2.17B, C, D, and G). 
 A second dense plexus of fibers and terminals extends along a similar trajectory 
as do fibers to the PV, but sits laterally on either side of the PV rather than following the 
midline.  This projection appears rostrally at the bend in the stria medullaris (Figure 
2.17A).  At first a dense plexus of fibers and terminals is observed just dorsal to the less 
densely innervated paratenial nucleus (Figure 2.17A).  Caudally, this fiber plexus appears 
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to continue into the rostral tip of the mediodorsal thalamus (Figure 2.17B and C).  
Continuous with fibers in the mediodorsal thalamus is a band of fibers that invades the 
midline innervating the centromedial nucleus as well as other intralaminar nuclei such as 
the paracentral, interantordorsal, and interanteromedial nuclei (Figure 2.17B, C, and D).  
This band of innervation seems to reach down as far as the rhomboid nucleus (Figure 
2.17C).  Caudally, the lateral fibers begin to concentrate dorsally almost entirely within 
the lateral habenula in a region adjacent to the completely empty medial habenula (Figure 
2.17D and G).  A sagittal view shows fibers projecting caudally just vental to the stria 
medullaris and dense fiber plexuses in the mediodorsal thalamus and lateral habenula 
(Figure 2.17H).  Figures 2.17F and 2.17G show coronal views of the mediodorsal 
thalamus and lateral habenula, respectively. 
 In the ventral thalamus, small vasopressin fibers and terminals reach up through 
the dense paraventricular nucleus to innervate the xiphoid nucleus (Figure 2.17E) and to a 
lesser extent the paraxiphoid and reuniens nuclei.  These fibers do not extend dorsally 
into the other regions such as the rhomboid nucleus.  A light innervation of small fibers is 
also located in the zona incerta above the fornix (Figure 2.17I)   
2.3.6  Fibers in the mesencephalon 
2.3.6.1  Tectum 
 The tectum (i.e., superior and inferior colliculi) is nearly devoid of fibers.  The 
only exception is a small pocket of small fibers observed at the midline of the superior 
colliculus within and above the commissure of the superior colliculus at the level where 
small fibers and terminals are found in the dorsomedial periaqueductal gray as described 
below. 
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2.3.6.2  Tegmentum 
 Rostrally in the tegmentum, a moderate midline innervation of small fibers in the 
ventral tegmental area (VTA), pigmented parabrachial nucleus of the VTA, and 
interfascicular nucleus appears as the mammillary bodies recede below (Figure 2.18A).  
Caudally, these small fibers continue throughout the interfascicular and 
parainterfascicular nuclei (Figure 2.18B).  In addition, a number of small fibers spread 
laterally into the anteroventral tip of the substantia nigra pars reticulata (Figure 2.18A) 
and further out into the substantia nigra pars compacta (Figure 2.18B).  Other nuclei such 
as the rostral interpeduncular nucleus and red nucleus do not contain any fibers (Figure 
2.18B).  
 Medium fibers are found in most of these areas as well.  In fact, a rather 
prominent vasopressin-ir pathway passes above the substantia nigra through the 
parasubthalamic nucleus and zona incerta and becomes quite dense caudally as the 
substantia nigra begins to subside (Figure 2.18C).  The location of this caudal plexus is 
unclear.  It resides in a somewhat ambiguous area where the lateral part of the substantia 
nigra, subbrachial nucleus, and midbrain reticular formation come together and a slightly 
smaller vasopressin-ir plexus is seen medially in the retrorubral field.  Caudally, a few of 
these fibers rise dorsally and move medially toward the medial parabrachial nucleus.  
 As the pontine regions begin to overtake the tegmentum, small immunoreactive 
fibers pass from the interfascicular nucleus into the caudal linear raphe nucleus (Figure 
2.18D).  In addition, some fibers wrap around behind the rostral interpeduncular nucleus 
to provide a dense innervation of the caudal part of the interpeduncular nucleus (Figure 
2.18E).  
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2.3.6.3  Periaqueductal gray and dorsal raphe nuclei 
 The periaqueductal gray (PAG) is a distinct region that encircles entire cerebral 
aqueduct and ends at the 4th ventricle.  The vasopressin innervation of the PAG contains 
a few prominent small fiber plexuses along its length and contains a number of medium 
fibers that appear to pass through.  Many of these fibers can be seen entering the rostral 
PAG from the caudal hypothalamus as it transitions to the midbrain tegmentum (Figure 
2.19A).  The first plexus contains a moderate density of small fibers and terminals and is 
located in the dorsomedial PAG and spreads out into the dorsolateral PAG (Figure 2.19B 
and C).  This terminal field only innervates a small region of the rostral PAG.  In addition 
to this plexus, there are a number of medium to large vasopressin-ir fibers that are seen 
close to the aqueduct on all sides.  These fibers are typically very short suggesting that 
they are merely short pieces traveling orthogonal to the section; this is confirmed in 
sagittal sections (Figure 2.19J).  In the caudal ventrolateral PAG, medium fibers make a 
sharp turn laterally (into the plane of the coronal section; Figure 2.19H and I).  Many of 
these fibers appear to continue on into the lateral parabrachial nucleus and other caudal 
mesencephalic nuclei.   
 Around the level of the trochlear nucleus, fibers pass from the caudal linear raphe 
into the dorsal raphe.  At the rostral part of the dorsal raphe, fiber plexuses appear lateral 
to the midline (Figure 2.19D and F).  Caudally, these laterally located terminal fields join 
together into a very dense midline terminal field (Figure 2.19E and F).  As the 
laterodorsal and dorsal tegmental nuclei, which do not contain vasopressin-ir fibers, 
become more prominent, the caudal dorsal raphe is pressed into the midline and a 
moderate to dense innervation of small fibers and terminals continues (Figure 2.19H).  As 
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the 4th ventricle spreads out under the cerebellum, the periaqueductal gray region ends 
with the last few fibers turning laterally, into the lateral parabrachial nucleus or dorsally 
into the dorsomedial PAG (Figure 2.19H).  Sagittal sections at the midline show two 
distinct fiber pathways projecting toward the PAG and raphe nuclei (Figure 2.19J).  One 
pathway runs dorsally at the posterior hypothalamus and up to the rostral PAG as seen in 
Figure 2.19A.  The second pathway runs ventrally through the interfascilular nucleus, 
under the decussation of the superior cerebellar peduncle, over the interpeduncular 
nucleus, and up into the dorsal raphe.  Both pathways appear to contain both small and 
medium fibers. 
2.3.6.4  Caudal mesencephalic nuclei 
 Some fibers that turn laterally into the VLPAG appear to pass on to the lateral 
parabrachial nucleus.  At this same level, fibers are seen in the medial parabrachial 
nucleus.  These fibers are separated from the lateral parabrachial nucleus by the superior 
cerebellar peduncle and appear continuous with fibers passing through the midbrain 
reticular formation rather than those from the ventrolateral PAG.  Caudal to this point, the 
tegmental nuclei become prominent near the midline and do not contain vasopressin-ir 
fibers.  Lateral to the tegmental nuclei just inside the superior cerebellar peduncle the 
locus coeruleus and Barrington's nucleus emerge (Figure 2.20).  Both nuclei contain 
medium fibers.  As the vestibular nuclei become prominent caudally, the lateral 
parabrachial, locus coeruleus, and Barrington's nuclei subside.  All remaining fibers 
appear to travel caudally adjacent to the ventricle and do not enter into the plane of 
section until the solitary nucleus.  
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 2.3.7  Fibers in the metencephalon 
 Very few vasopressin-ir fibers are found in the metencephalon.  The cerebellum, 
deep cerebellar nuclei, vestibular nuclei, pontine nuclei, and pontine reticular formation 
are devoid of fibers.  However, small fibers and terminals are found in the median raphe 
which stretches back between the pontine reticular formation and tectospinal tract from 
the tegmentum (Figure 2.21A).  Adjacent to the median raphe on either side, a small but 
notable plexus is observed in what appears to be the anterior tegmental nucleus (Figure 
2.21B).  There are no plexuses of medium fibers, but sparse medium fibers do appear in 
the subcoerleus and intermediate reticular formation (Figure 2.21C). 
2.3.8  Fibers in the myelencephalon 
2.3.8.1  Dorsal myelencephalon 
 Stretching caudally from midbrain reticular formation, sparse vasopressin-ir fibers 
pass through the alpha part of the parvicellular reticular formation beneath the vestibular 
nuclei just prior to entering the solitary nucleus.  At the level of the facial nucleus, the 
number of immunolabeled fibers in the solitary nucleus increases compared to that of the 
reticular formation (Figure 2.21D and E).  Although no coronal sections were collected 
beyond this point, sagittal sections reveal that the solitary nucleus in the caudal medulla 
contains a moderate to dense innervation of medium fibers (Figure 2.21F and G).  These 
fibers appear to concentrate in the solitary nucleus and do not reach out into the 
hypoglossal nucleus immediately below (Figure 2.21G).  Some fibers actually appear to 
continue toward the back of the solitary nucleus into the rostral spinal cord, at which 
point the sagittal sections end. 
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2.3.8.2  Ventral myelencephalon 
 In the ventral medulla, vasopressin-ir fibers are found mostly at the midline in the 
raphe magnus and, caudally, the raphe pallidus (Figure 2.21E, F, and H).  In coronal 
sections some fibers are seen in a dorsal-ventral orientation passing into the raphe 
interpositus and, more caudally, the raphe obscurus.  This is especially clear in sagittal 
sections.  At the caudal level in which the facial nerve travels dorsally, fibers spread out 
from the midline into the alpha part of the gigantocellular region.  The fibers rarely stray 
into the larger gigantocellular region and do not extend past the facial nucleus.  Sparse to 
scattered fibers are also observed in the intermediate reticular formation from the facial 
nerve and caudal.  These fibers may be en route to the ventral raphe nuclei described 
above.  Finally, there are dense projections in the lateral reticular formation (Figure 
2.21I) and the caudal part of the spinal trigeminal nucleus (Figure 2.21J).  
2.4  Discussion  
 In general, the pattern of vasopressin immunoreactivity in the mouse brain is quite 
similar to that in other species although remarkably more robust in most areas.  For 
example, innervation of the peduncular lateral hypothalamus is much more pronounced 
than that reported for rats (DeVries et al., 1985).  Our results are in general agreement 
with those in the rat, although there are some subtle differences.  For example, the rat has 
vasopressin in the olfactory bulbs, olfactory tubercle, and cerebellum, whereas mice do 
not.  In addition vasopressin fibers are found in the nucleus accumbens and central 
amygdala of the mouse, but are not observed in the rat (DeVries et al., 1985).    
 A direct comparison is difficult to make for most other species, as only a limited 
dataset is available for any given species.  In general, areas that consistently have 
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vasopressin expression in multiple species such as rats, mice, voles, Brazilian opposums, 
jerboas, and more include the lateral septum, the perimeter of the diagonal band, medial 
amygdala, paraventricular thalamus, lateral habenula, preoptic area, periventricular 
region, dorsomedial hypothalamus, midbrain central gray, ventral tegmental area, raphe 
nuclei, and locus coeruleus (DeVries et al., 1985; Castel and Morris, 1988; Iqbal and 
Jacobson, 1995; Lakhdar-Ghazal et al., 1995; Wang et al., 1996; Abrahamson and Moore, 
2001).   
 Despite the many similarities, there are a number of species differences, some of 
which are rather unique.  A few such differences include the presence of vasopressin in 
auditory nuclei such as the dorsal cochlear nucleus and periolivary region of the guinea 
pig (Dubois-Dauphin et al., 1989); laterodorsal tegmental nuclei and vestibular nuclei of 
the jerboa, a desert dwelling rodent (Lakhdar-Ghazal et al., 1995); and the facial nucleus, 
pontine nuclei, and lateral geniculate of the Brazilian opossum (Iqbal and Jacobson, 
1995).  None of these regions appear to contain vasopressin immunoreactivity in the 
mouse.  Further, some hamster species do not produce vasopressin in the BNST or MeA, 
and as a consequence, all regions that might be innervated by those nuclei, such as the 
lateral septum and lateral habenula, do not appear to have vasopressin-ir fibers (Dubois-
Dauphin et al., 1990; Miller et al., 1999).  Another species, the naked mole rat, appears to 
lack vasopressin production in the BNST, MeA, and the SCN (Rosen et al., 2007).  As a 
consequence, even more areas such as the subparaventricular zone and dorsomedial 
hypothalmaus have reduced fibers. 
 Given the large number a similarities between the mouse vasopressin system and 
other species, the functional information that can be learned from the vasopressin system 
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in the mouse may have more general applicability.  With this in mind, my examination of 
the vasopressin system will hopefully provide greater insight into the role of vasopressin, 
especially in behavior.  In particular, there are a number of structural pathways that can 
be delineated from the anatomical observations made above that highlight particular 
functional systems.  However, before beginning this discussion of structure and function, 
there are a few potential limitations that must be considered.  In the current study we 
examined C57BL/6 mice.  A particular concern for this study may be that distinct 
differences in behavior occur across mouse strains and that these differences could reflect 
differences in vasopressin innervation.  For example, as compared to C57BL6 mice, 
129S6/SvEv mice had lower levels of aggression and increased social interaction in one 
study (Abramov et al., 2008).  Although an increasing number of interstrain comparisons 
have been made, the vasopressin system has not yet been examined across strains.  I 
would argue that even if vasopressin is not found in certain circuits within various strains 
or species, the gross morphology of circuits is probably not as different.  For example, 
even though cells in the BNST do not produce vasopressin in the hamster as they do in 
the rat, BNST cells still project to the lateral septum.  Specifically, vasopressin in rats is 
produced in a subset of galanergic cells that project to the septum (Miller et al., 1993).  
Golden hamsters still have this population of galanergic neurons, but none produce 
vasopressin (Miller et al., 1999).  Understanding vasopressin function in a given pathway 
in one species may increase our understanding of that pathway in general.  A second 
limitation is the fact that we examined a small number of animals in our study (three in 
earnest and twelve more for corroboration).  However, the observations made here do not 
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contradict anything seen previously in C57BL6 mice in our lab and agree with Castel and 
Morris (1988) and Abrahamson et al. (2001).  
 Two important aspects of the vasopressin system that must be addressed are the 
site of origin of fibers and the trajectory of projections from the various vasopressin 
producing nuclei.  Multiple possible pathways can be inferred from descriptions given 
above; although these inferences are only theoretical and must be validated by other 
means as discussed below.  For example, vasopressin-ir fibers from the SCN remain 
close to the midline and appear to follow three major paths: 1) an anterodorsal path 
toward the paraventricular thalamus, 2) a dorsal path through the subparaventricular zone 
and PVN into the thalamus, and 3) a caudal path toward the dorsomedial hypothalamus.  
These observation have also been noted in other species and in the mouse, and lesions of 
the SCN actually decrease vasopressin immunoreactivity in the all these regions in the rat 
and hamster (Hoorneman and Buijs, 1982; Delville et al., 1998).  Likewise, multiple 
pathways are suggested by the orientation of fibers near the PVN and SON.  Most of 
these fibers travel ventrolaterally and are thought to terminate in the neurohypophysis and 
the median emminence ultimately.  However, a number of vasopressin-ir fibers also 
curve dorsally into the reticular thalamus.  Medium fibers similar to those found near the 
PVN and SON are also found in the midbrain and hindbrain, and these fibers appear to 
follow a few distinct trajectories: 1) fibers pass dorsally along the third ventricle into the 
PAG and travel caudally to the ventrolateral PAG and lateral parabrachial nucei where 
they begin to branch out and have more boutons of passage and then continue caudally to 
the locus coeruleus and finally to the caudal solitary nucleus; 2) fibers travel ventrally 
through the interfascicular nucleus and caudal linear raphe into the raphe nuclei; and 3) 
 
 
47
fibers travel laterally and caudally over the substantia nigra toward the midbrain reticular 
formation where they curve back toward the midline passing through the medial 
parabrachial nucleus and into the rostral solitary nucleus or ventrally toward the ventral 
medullary raphe nuclei.  Rostrally, many medium fibers are found in the forebrain, but 
the most distinct pathway is the group of medium axons passing in front of the anterior 
commissure and reaching through the median preoptic nucleus to the subfornical organ.   
 Small fibers in other brain regions appear to follow various paths as well.  
Further, small fibers often seem to have continuous terminal fields that move through 
multiple regions.  One such path passes through the lateral preoptic area and becomes 
rather dense in the ventral septal region (between the nucleus accumbens and diagonal 
band) and curves dorsally and caudally into the lateral septum.  Other pathways like this 
occur in the extended amygdala toward the rostral amygdalar nuclei and from the rostral 
peduncular lateral hypothalamus toward the caudal lateral hypothalamus.  Other possible 
small fiber pathways include vasopressin-ir fibers passing from the BNST into the stria 
terminalis, dorsally through the rostral PAG, and caudally through the ventral tegmental 
area (VTA) and interfascicular nuclei.  This last pathway through the VTA and 
interfascicular nuclei has similar terminal field characteristics to pathways in the 
forebrain, such as the pathway through the ventral septal area. 
 The presence of vasopressin -ir fibers in various brain regions suggests an 
anatomical link between the function of the brain region and vasopressin.  For example, 
small fiber pathways that seem to come from the SCN innervate midline regions such as 
the periventricular nucleus, which is involved in neuroendocrine function; the 
subparaventricular zone, which is important for sleep-wake cycles (Chou et al., 2003; 
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Saper et al., 2005); and the dorsomedial hypothalamus, which has been implicated in 
food intake, locomotor activity, and sleep wake cycles (Chou et al., 2003).  Hindbrain 
sites innervated by medium fibers, such as the solitary nucleus are important in 
autonomic functions (Pittman and Franklin, 1985), whereas regions in the tegmentum and 
raphe nuclei innervated by small and medium fibers are involved in emotional and 
behavioral state functions (Beiderbeck et al., 2007; Michelsen et al., 2007).  Finally, areas 
such as the ventral pallidum and mediodorsal thalamus, which contain small fibers, are 
involved in basal ganglia circuits that regulate limbic system information (Chauveau et 
al., 2005; Antoniadis and McDonald, 2006; Mitchell et al., 2007). 
 Although suppositions can be made about the site of origin of fibers, the trajectory 
of various fiber pathways can be outlined, and sweeping functional generalizations can be 
suggested, a simple descriptive analysis as done here is not sufficient to draw complete 
and accurate conclusions about the vasopressin system.  This is made clear by past 
attempts to credit innervation of the lateral septum and lateral habenular nuclei to the 
suprachiasmatic nucleus based solely on fiber size and following the course of fibers in 
consecutive sections (Buijs, 1978; Castel and Morris, 1988; Abrahamson and Moore, 
2001), when in fact the innervation to the lateral septum comes from the BNST (De Vries 
and Buijs, 1983).  However, the scope of this study was to document the fibers in the 
mouse brain and fill in gaps and refine descriptions created by other authors.  Future 
studies in this dissertation will attempt to further elucidate the sites of origin of the fibers 
described here. 
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2.5  Figure legends 
 
Figure 2.1: Paraventricular nucleus 
 A) Bregma -0.46.  Vasopressin-ir neurons in the PaAP (10x).  B) Bregma -0.70.  
Magnocellular neurons are located close to the third ventricle in the PaMM and PaV 
(10x).  C) Bregma -0.82.  Magnocellular neurons in the PaLM, and parvocellular neurons 
in the PaMP medially near the ventricle (10x).  D) Magnocellular neurons in the PaLM 
part persist as other cell groups end caudally (10x).  3V, third ventricle; f, fornix; PaAP, 
anterior parvocellular PVN; PaLM, lateral magnocellular PVN; PaMM, medial 
magnocellular PVN; PaMP, medial parvocellular PVN; PaV, ventral PVN 
 
Figure 2.2: Supraoptic nucleus 
 A) Bregma -0.58.  Vasopressin-ir cells are first seen in the episupraoptic nucleus 
just above the tip of the optic tract (10x).  B) Bregma -0.82.  Cells begin to form an 
extremely dense cluster above and lateral to the optic tract (10x).  C) Bregma -0.94.  
Cells continue to form a dense cluster over the lateral edge of the optic tract, but many 
cells are also seen along the ventral brain surface closer to the midline (10x).  D) Bregma 
-1.06.  A few cells are seen lateral to the optic tract at the caudal edge of the supraoptic 
nucleus (10x).  f, fornix; opt, optic tract 
 
Figure 2.3: Suprachiasmatic nucleus 
 A) Bregma -0.34.  Rostral suprachiasmatic nucleus (SCN; 10x).  B) Bregma -
0.58.  Middle SCN (10x).  C) Bregma -0.82.  Caudal SCN (10x).  Vasopressin-ir cells in 
the SCN form a shell around a vasopressin cell free core.  The rostral and caudal sections 
pass through this outer shell; whereas, the middle section nicely shows the core, which 
contains many fibers but few cells. 
 
Figure 2.4: Accessory nuclei 
 A) Vasopressin-ir cells in the anterior hypothalamus (20x) amongst fibers of 
passage from other regions.  B) Cells in the perifornical lateral hypothalamus (10x) sit 
amongst fibers that appear to come from the direction of the PVN.  C) Cells near the 
cerebral peduncle in the caudal peduncular lateral hypothalamus (10x).  D) The nucleus 
circularis (40x) of the mouse is composed of a small cluster of neurons found in the 
anterior hypothalamus.  f, fornix; opt, optic tract 
 
Figure 2.5: Other hypothalamic nuclei 
 A) Vasopressin-ir cells are located in the striohypothalamic nucleus (20x) rostral 
to the paraventricular hypothalamus and directly ventral to the fornix.  B) Cells are found 
amidst the vasopressinergic pathway to the pituitary in the retrochiasmatic supraoptic 
nucleus (10x) in the tuberal lateral hypothalamus.  C) Cells in the ventrolateral preoptic 
nucleus (20x) lie along the ventral surface of the preoptic area.  f, fornix; opt, optic tract  
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Figure 2.6: BNST and medial amygdala 
 A) Bregma -0.10.  Vasopressin-ir cells are found above the fibers of the stria 
terminalis in the medial STMPM (10x).  The bounding box represents the magnified area 
in the panel to the right for all panels in this diagram.  Arrows point to specific cells.  B) 
Cells in the STMPM (20x).  C) Bregma -0.22.  Cells are also found in the STMPL (10x) 
slightly caudal to those cells in the STMPM.  D) Cells in the STMPL (20x).  E) Bregma -
1.34.  Cells are found at the dorsolateral edge of the MePD (4x).  F) Cells in the rostral 
MePD (20x).  G) Bregma -1.46.  Cells in the caudal MePD (4x).  H)  Cells in the caudal 
MePD (20x).  f, fornix; ic, internal capsule; MePD, posterodorsal medial amygdala; opt, 
optic tract; STMPL, medial posterolateral BNST; medial posteromedial, STMPM 
 
Figure 2.7: Small versus medium fibers 
 A) Small vasopressin-ir fibers in the lateral setptum (20x).  B) Medium 
vasopressin-ir fibers in the ventrolateral periqueductal gray (20x).  Small fibers are 
thinner than medium fibers and have terminal fields that consist of punctate staining.  
Often, the fibers associated with puncta are barely noticeable.  In contrast, medium fibers 
often have distinct "boutons of passage" with visible stalks.  Arrows in B point to boutons 
of passage. 
 
Figure 2.8: Cortex and hippocampus 
 A) Bregma 1.98.  Prelimbic cortex (10x).  Arrows point to fibers.  B) Bregma 
1.10.  Cingulate cortex (10x).  C) Insular cortex (20x).  D) Bregma -2.54.  Entorhinal 
cortex (4x).  E) Bregma -2.92.  Phase contrast image of CA1 region of the ventral 
hippocampus (4x).  F) Brightfield image of E showing small fibers (10x).  G) Bregma -
3.28.  Phase contrast image of CA1 region of the ventral hippocampus (4x).  H) 
Brightfield image of G showing medium fibers (20x). 
 
Figure 2.9: Basal ganglia and ventral forebrain 
 A) Bregma 0.98.  Small vasopressin fibers are found in the VP and VS in the 
rostral forebrain (4x).  Medium fibers are found in the nucleus accumbens core.  B) 
Bregma 0.62.  Caudally, small fibers are found in the VP, SI, and VS (4x).  Vasopressin-
ir fibers seem to avoid the diagonal band, islands of calleja, and shell of the nucleus 
accumbens.  ac, anterior commissure; AcbC, core of the nucleus accumbens; AcbSh, 
shell of the nucleus accumbens; ICjM, islands of calleja; HDB, horizontal diagonal band; 
LV, lateral ventricle; MPA, medial preoptic area; SI, substantia innominata; VDB, 
vertical diagonal band; VP, ventral pallidum; VS, ventral septum  
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Figure 2.10: Septal complex 
 A) Bregma 0.86.  The rostral lateral septum contains sparse medium fibers (4x 
magnification).  B) Bregma 0.62.  Small vasopressin fibers are found in the ventral and 
intermediate lateral septum (4x).  C) Bregma 0.38.  The caudal part of the ventral and 
intermediate lateral septum contains a very dense small fiber innervation (4x).  D) 
Bregma -0.10.  As the fimbria becomes prominent the vasopressin fibers diminish.  
Medium fibers are seen in the subfornical organ.  E) Higher magnification of the ventral 
lateral septum in B (10x).  F) Magnification of pericellular baskets in ventral lateral 
septum (20x).  Arrow points to one such basket.  ac, anterior commissure; cc, corpus 
callosum; f, fornix; MS, medial septum; LSD, dorsal lateral septum; LSI, intermediate 
lateral septum; LSV, ventral lateral septum; LV, lateral ventricle; SFi, septofimbrial 
nucleus; SFO, subfornical organ 
 
Figure 2.11: Bed nuclei of the stria terminalis 
 A) Bregma 0.50.  Rostral bed nuclei of the stria terminalis (BNST).  Small and 
medium vasopressin-ir fibers are found in the STMA and medium fibers in the STMV.  
B) Bregma 0.02.  Caudally small fibers begin to appear more in the STLV.  Medium 
fibers are prominent in the STMV  C) Bregma -0.10. The STMPM has two separate small 
fiber plexuses and a number of medium fibers.  STLV still has small fibers and the 
STMV medium.  D) Bregma -0.34. BNST cells become prominent in the STMPL and 
small fibers can be seen entering the stria terminalis.  E) Bregma -0.46.  Dense small 
fibers are seen under the stria medullaris.  Otherwise innervation of the caudal BNST 
becomes less dense.  3V, 3rd ventricle; ac, anterior commissure; f, fornix; D3V, dorsal 
3rd ventricle; ic, internal capsule; sm, stria medullaris; SM, nucleus of the stria 
medullaris; STLV, ventrolateral BNST; STMA, anteromedial BNST; STMPM, medial 
posteromedial BNST; STMPL, lateral posteromedial BNST; STMV, ventromedial BNST 
 
Figure 2.12: Amygdala 
 A) Bregma -0.58.  Diffuse small fibers found in the AA and EA (4x).  B)  
Magnification from A (10x).  Shows small fibers in the distinct EA between the densely 
innervated PLH and globus pallidus.  C) Bregma -0.70.  Small fibers are found in the AA 
and ACo, but not in the LOT (4x).  D) Magnification of C (10x) showing LOT and ACo.  
E) Bregma -1.34.  Medium fibers are seen in central amygdala (20x).  F) Bregma -1.58.  
A dense small fiber plexus is found in the MePD.  G) Bregma -2.18.  Small fibers are 
found in the caudal BLP (4x).  H) Magnification of G showing fibers in the BLP.  AA, 
anterior amygdaloid area; ACo, anterior cortical amygdaloid area; BLP, posterior 
basolateral amygdala; EA, extended amygdala; f, fornix; GP, globus pallidus; HDB, 
nucleus of the horizontal limb of the diagonal band; LOT, nucleus of the lateral olfactory 
tract; opt, optic tract; PLH, peduncular part of lateral hypothalamus; sm, stria medullaris 
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Figure 2.13: Preoptic area 
 A) Bregma 0.38.  Small vasopressin-ir fibers are found in the MPA.  Medium 
fibers are seen in the VOLT and MnPO (4x).  B) Bregma 0.26.  Magnification (10x) of 
the MnPO.  Medium fibers are oriented vertically in the plane of section.  C) Bregma 
0.14.  A dense small fiber plexus is seen in the PS ventral to the STMV (20x).  D) 
Magnification of E.  Scattered small and medium fibers are found in the MPOM (20x).  
The AVPe contains many small fibers and some medium fibers.  E) Bregma -0.10. Sparse 
small and medium fibers are seen in the caudal LPO and StHy.  ac, anterior commissure; 
AVPe, anteroventral periventricular nucleus; HDB, nucleus of the horizontal limb of the 
diagonal band; LPO, lateral preoptic area; MnPO, median preoptic nucleus; MPA, medial 
preoptic area; MPOM, medial preoptic nucleus, medial part; PS, parastrial nucleus; 
STHy, striohypothalamic nucleus; STMV, ventromedial BNST; VOLT, vascular organ of 
the lamina terminalis 
 
Figure 2.14: Anterior hypothalamus 
 A) Bregma -0.58.  Small fibers are seen in the AHA ventral to the fornix and in 
and dorsal to the SCN adjacent to the third ventricle (4x).  Medium fibers stretch between 
the PVN and SON through the more ventral AHA.  B) Bregma -0.82.  Small fibers are 
found only in the SCN and along the third ventricle dorsal into the PVN (4x).  Medium 
fibers dominate the AHC and numerous medium fibers pass over the fornix into the PLH.  
C) Bregma -0.94.  Caudally fewer medium fibers pass through the AHC, but many still 
pass into the PLH.  Large amounts of small fibers are still found along the third ventricle.  
The dotted line indicates the approximate location of the sagittal section seen in D and E.  
D)  In a sagittal section taken just lateral to the third ventricle, large fibers can be seen 
amongst the many PVN neurons (10x).  A dense haze of small fibers is also visible.  E) In 
the same sagittal section as in D, the dense small fibers of the SCN are seen.  Fibers can 
be seen passing in all direction with the largest groups passing dorsocaudal and 
rostrodorsal.  3V, 3rd ventricle; AHA, anterior hypothalamic area, anterior part; AHC, 
anterior hypothalamic area, central part; f, fornix; LA, lateroanterior hypothalamic 
nucleus; och, optic chiasm; opt, optic tract; PLH, peduncular part of lateral 
hypothalamus; PVN, paraventricular hypothalamus; SCN, suprachiasmatic nucleus; SPa, 
subparaventricular zone 
 
Figure 2.15: Dorsomedial hypothalamus 
 A) Bregma -1.46.  Small and medium fibers are found in the DM and Arc (4x).  
Many medium fibers are found in the TuLH.  The VMH contain almost no fibers.  B)  
Bregma -1.82.  Small and medium fibers are seen in the DM (4x).  The MTu contains 
fewer medium fibers than the TuLH in rostral areas.  The ME is located at the ventral 
midline.  C) Magnification (20x) of the DM from B.  D) Magnification (20x) of the 
median eminence from D.  Note dense staining in dorsal ME (to posterior pituitary) and 
less dense staining in the ventral part (local release).  3V, 3rd ventricle; Arc, arcuate 
hypothalamic nucleus; DM, dorsomedial hypothalamic nucleus; f, fornix; ME, median 
eminence; MTu, medial tuberal nucleus; TuLH, tuberal region of lateral hypothalamus; 
VMH, ventromedial hypothalamic nucleus 
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Figure 2.16: Lateral hypothalamus and mammillary bodies 
 A) Bregma -0.82.  Small fibers are found amongst medium fibers passing through 
the PLH (20x).  B) Bregma -1.22.  Fewer small fibers are seen in the caudal PLH, but a 
dense array of medium fibers is observed (10x).  C) Bregma -2.46.  Many small fibers are 
seen in the PeLH and DTM spreading around the fornix.  Scattered small and medium 
fibers are seen in the PMV and PH (4x).  D) Bregma -2.54.  No fibers are found in the 
MB (4x).  Dense small fibers are seen just ventral to MB and fornix.  Only scattered 
small fibers are seen in the PMV, and RMM has medium and small fibers.  E) Bregma -
2.80.  No fibers in MB (4x).  Dense small fibers in VTM, and scattered small and 
medium fibers in RMM.  3V, 3rd ventricle; DTM, dorsal tuberomammillary nucleus; f, 
fornix; MB, mammillary bodie; MRe, mammillary recess of the 3rd ventricle; mt, 
mammillothalamic tract; opt, optic tract; PeLH, perifornical part of lateral hypothalamus; 
PH, posterior hypothalamus; PLH, peduncular part of lateral hypothalamus; pm, principal 
mammillary tract; PMV, premammillary nucleus, ventral part; RMM, retromammillary 
nucleus, medial part; VTM, ventral tuberomammillary nucleus 
 
Figure 2.17: Thalamus 
 A) Bregma -0.34.  Many small fibers are seen in the PVA (4x).  The PT has small 
fibers around its periphery.  A dense cluster of fibers sits dorsal to the PT between the 
PVA and the stria medullaris.  B) Bregma -0.58.  A very dense plexus of small fibers is 
found in the MD (4x).  Less dense fibers are seen in the CM and PC surrounding the PT.  
C) Bregma -0.94.  Dense small fibers are found in the MD (4x).  Less dense small fibers 
are found in the PV, CM, and Rh.  Medium fibers are also seen in the PV and Rh.  D) 
Bregma -1.22.  Small fibers are seen in the LHb and IAD and in the PV just below the 
dorsal third ventricle (10x).  E) Bregma -1.22.  Small fibers are seen in the Xi just dorsal 
to the third ventricle (10x).  F) Magnification (20x) of MD from B.  G) Bregma -1.58.  
Dense small fibers are found in the LHb (10x).  Only a few small fibers are found in PV 
and IMD.  H) A sagittal section (lateral 0.48mm) shows the pathway of vasopressin-ir 
fibers arching dorsally just ventral to the stria medullaris (4x).  The dense plexuses of the 
LHb and MD can be seen.  I) Bregma -0.58.  Small fibers in the ZI (10x).  J) Bregma -
1.82.  In caudal thalamus scattered small fibers are seen in LHb, but PV contains 
primarily medium fibers (10x).  3V, 3rd ventricle; ac, anterior commissure; CM, central 
medial thalamic nucleus; D3V, dorsal 3rd ventricle; f, fornix; fr, fasciculus retroflexus; 
IMD, intermediodorsal thalamic nucleus; LHb, lateral habenular nucleus; MD, 
mediodorsal thalamic nucleus; mt, mammillothalamic tract; PC, paracentral thalamic 
nucleus; PT, paratenial thalamic nucleus; PV, paraventricular thalamic nucleus; PVA, 
paraventricular thalamic nucleus, anterior part; Re, reuniens thalamic nucleus; Rh, 
rhomboid thalamic nucleus; sm, stria medullaris; Xi, xiphoid thalamic nucleus; ZI, zona 
incerta 
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Figure 2.18: Tegmentum 
 A) Bregma -3.08.  Small fibers are found in the VTA, IF and ventromedial tip of 
the SNR.  Some medium fibers are also present in these areas (10x).  B) Bregma -3.52.  
Small fibers surround the IPR in the IF and PIF (10x).  C) Bregma -4.04.  In the caudal 
tegmentum, medium fiber form a dense plexus in the mRt and RRF just dorsal to the 
SNR (10x).  There are some small fibers here too.  D) Bregma -4.04.  Fibers in the CLi 
between the scp.  E) Bregma -4.04.  Fibers in the caudal part of the IP (20x).  3n, 
oculomotor nerve; CLi, caudal linear nucleus of the raphe; cp, cerebral peduncle; fr, 
fasciculus retroflexus; IF, interfascicular nucleus; IPF, interpeduncular fossa; IP, 
interpeduncular nucleus; IPR, interpeduncular nucleus, rostral subnucleus; MB, 
mammillary bodies; ml, medial lemniscus; mlf, medial longitudinal fasciculus; mRT, 
mesencephalic reticular formation; PBP, parabrachial pigmented nucleus of the VTA; 
PIF, parainterfascicular nucleus of the VTA; RMC, red nucleus, magnocellular part; 
RRF, retrorubral field; SNR, substantia nigra, reticular part; scp, superior cerebellar 
peduncle; SubB, subbrachial nucleus; VTA, ventral tegmental area; vtgx, ventral 
tegmental decussation 
 
Figure 2.19: Periaqueductal gray and dorsal raphe nuclei 
 A) Bregma -2.30.  Just rostral to the PAG small and medium fibers ascend 
dorsally between the fasciculus retroflexus (4x).  B) Bregma -3.52.  Medium fibers are 
seen in ventral parts of the PAG and small fibers are seen in the DMPAG (4x).  C) 
Magnification (20x) of small fibers in the DMPAG.  D) Bregma -4.36.  Dense clusters of 
small fibers are seen in the DRL, and medium fibers are seen in the VLPAG with some 
overlap (4x).  E) Bregma -4.60.  A dense plexus of small fibers is seen in the DRD at the 
midline.  Medium fibers in a medial to lateral orientation are seen in the VLPAG.  F) 
Magnification (20x) of the DRL from D.  G) Magnification (20x) of the DRD from E.  H) 
Bregma -5.02.  Small fibers are found in the DRC, and medium fibers continue to be 
found in the VLPAG (4x).  Some medium fibers also enter the DMPAG at this point.  I) 
Magnification (20x) of medium fibers in the VLPAG.  J) Sagittal section near the midline 
showing pathways travelling dorsally toward the PAG and caudally through the IF 
toward the dorsal raphe (4x).  2Cb, lobule 2 of the cerebellar vermis; 4N, trochlear 
nucleus; 4n, trochlear nerve; Aq, aqueduct; csc, commissure of the superior colliculus; 
DMPAG, dorsomedial PAG; DRC, caudal dorsal raphe; DRD, dorsal dorsal raphe; DRL, 
lateral dorsal raphe; fr, fasciculus retroflexus; IF, interfascicular nucleus; IPR, 
interpeduncular nucleus, rostral subnucleus; mlf, medial longitudinal fasciculus; PAG, 
periaqueductal gray; pc, posterior commissure; VLPAG, ventrolateral periaqueductal 
gray; xscp, decussation of the superior cerebellar peduncle 
 
Figure 2.20: Caudal mesencephalic nuclei 
 Bregma -5.52.  Medium fibers are shown in the LPB, LC, and Bar.  No fibers 
were observed in the adjacent LDTg (10x).  Bar, Barrington's nucleus; LC, locus 
coeruleus; LDTg, laterodorsal tegmental nucleus; LPB, lateral parabrachial nucleus; scp, 
superior cerebellar peduncle; vsc, ventral spinocerebellar tract 
 
 
 
 
55
 
 
56
Figure 2.21: Metencephalon and myelencephalon 
 A) Bregma -4.36.  Small fibers in the ATg at the intersection of the decussation of 
the superior cerebellar peduncle and the tectospinal tract (10x).  B) Bregma -4.72.  Small 
fibers in the MnR at the level of the pons (20x).  C) Bregma -5.52.  Medium fibers in the 
IRt (10x).  D)  Magnification (10x) of medium fibers in the Sol from E (10x).  E) Bregma 
-6.36.  Medium fibers are found in Sol and in RMg and GiA (4x).  F) Lateral -0.04.  
Sagittal section near the midline (4x).  Dense medium fibers are found in the Sol.  
Scattered medium fibers are seen in the medullary raphe  nuclei, including ROb, RMg, 
and RPa.  G)  Magnification (10x) of medium fibers in Sol.  H)  Magnification (10x) of 
medium fibers in the raphe.  I) Lateral 1.2.  Medium fibers in the LRT (4x).  J) Lateral 
1.56.  Medium fibers in the Sp5C (4x).  7n, facial nerve; 12N, hypoglossal nucleus; ATg, 
anterior tegmental nucleus; IO, inferior olivary nucleus; IRt, intermediate reticular 
nucleus; LSO, lateral superior olive; mlf, medial longitudinal fasciculus; PnC, pontine 
reticular nucleus, caudal part; py, pyramidal tract; RMg, raphe magnus nucleus; ROb, 
raphe obscurus nucleus; RPa, raphe pallidus nucleus; Sol, solitary nucleus; sp5, spinal 
trigeminal tract; Sp5C, spinal trigeminal nucleus, caudal part; SPO, superior paraolivary 
nucleus; ts, tectospinal tract; xscp, decussation of the superior cerebellar peduncle 
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Figure 2.2:  Supraoptic nucleus
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Figure 2.3:  Suprachiasmatic nucleus
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Figure 2.4:  Accessory nuclei
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Figure 2.5:  Other hypothalamic nuclei
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Figure 2.6:  BNST and medial amygdala
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Figure 2.7:  Small versus medium fibers
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Figure 2.8:  Cortex and hippocampus
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Figure 2.9:  Basal ganglia and ventral forebrain
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Figure 2.10:  Septal complex
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Figure 2.11:  Bed nuclei of the stria terminalis
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Figure 2.12:  Amygdala
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Figure 2.13:  Preoptic area
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Figure 2.14:  Anterior hypothalamus
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Figure 2.14:  Anterior hypothalamus (Continued)
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Figure 2.15:  Dorsomedial hypothalamus
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Figure 2.16:  Lateral hypothalamus and mammillary bodies
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Figure 2.17:  Thalamus
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Figure 2.17:  Thalamus (Continued)
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Figure 2.18:  Tegmentum
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Figure 2.18:  Tegmentum (Continued)
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Figure 2.19:  Periaqueductal gray and dorsal raphe nuclei
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Figure 2.19:  Periaqueductal gray and dorsal raphe nuclei (Continued)
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Figure 2.20:  Caudal mesencephalic nuclei
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Figure 2.21:  Metencephalon and myelencephalon
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Figure 2.21:  Metencephalon and myelencephalon (Continued)
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CHAPTER 3 
PROJECTIONS OF THE BNST AND MEDIAL AMYGDALA 
 
3.1  Introduction 
 Vasopressin is produced in a number of nuclei within the diencephalon and 
telencephalon of the mouse brain and is found in neuronal fibers and terminals in various 
brain regions throughout the rostral to caudal extent of the brain (Castel and Morris, 
1988; Abrahamson and Moore, 2001).  In order to truly understand the function of the 
various vasopressin cell groups, it is important to know the origin of each projection site.  
This task has been approached with some success in the rat.  Retrograde tracing and 
electrolytic lesions implicated the bed nuclei of the stria terminalis (BNST) as a major 
source of innervation to areas such as the lateral septum, lateral habenula, periaqueductal 
gray, and raphe nuclei (De Vries and Buijs, 1983).  Similar studies implicated the 
suprachiasmatic nucleus (SCN) in the innervation of the paraventricular thalamus, 
dorsomedial hypothalamus, preoptic area, and subparaventricular zone, and the medial 
amygdala (MeA) in the innervation of the lateral septum and ventral hippocampus 
(Hoorneman and Buijs, 1982; Caffe et al., 1987).  Lesions studies have also implicted the 
paraventricular nucleus of the hypothalamus (PVN) in vasopressin-ir projections to the 
hindbrain (De Vries et al., 1983).  In the mouse, the site of origin of vasopressin-ir fibers 
has yet to be examined, although up until this point it has been almost universally 
assumed to be similar to the rat.   
 Interestingly, vasopressin-immunoreactive (-ir) fibers and terminals have 
qualitative differences in physical characteristics such as fiber size and terminal 
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distribution (Castel and Morris, 1988; Abrahamson and Moore, 2001), which is one clue 
to identifying the different vasopressinergic afferent pathways.  These characteristically 
different projections innervate specific and often mutually exclusive regions of the brain.  
Early descriptions of vasopressin anatomy attempted to use fiber characteristics to 
identify site of origin (Buijs, 1978; Castel and Morris, 1988; Abrahamson and Moore, 
2001).  In general, small fibers were assumed to derive from the SCN and medium or 
large fibers form the PVN.  More extensive work in rats, as mentioned above, has 
corroborated that same observation in regard to the PVN.  However, these studies also 
indicate that the BNST and MeA are major sources of small fibers in addition to the SCN 
(De Vries and Buijs, 1983; Caffe et al., 1987). Thus, merely identifying projections by 
physical characteristics is not sufficient to identify site of origin and other methods must 
be employed.   
 The projections of the BNST and MeA are the focus of this study.  Vasopressin 
produced by these brain regions has been directly and indirectly implicated in 
thermoregulation during fever, social recognition, and aggression in the rat and pair-
bonding, parental behavior, and partner preference in the prairie vole (Ferris et al., 1984; 
Banet and Wieland, 1985; Naylor et al., 1985; Dantzer et al., 1987; Koolhaas et al., 1990; 
Insel et al., 1994; Wang et al., 1994; Lim et al., 2004).  In addition, recent studies have 
suggested that altering expression of the V1a receptor, the most abundantly expressed 
vasopressin receptor in the brain, can affect social behavior.  For example, mice with a 
prairie vole V1a receptor transgene have increased affiliative behavior (e.g., increased 
olfactory investigation and grooming of stimulus animal; (Young et al., 1999), simlar to 
that of prairie voles.  In addition, V1a knockout mice have impaired social recognition 
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(Bielsky et al., 2004; Bielsky et al., 2005), although a different V1a knockout mouse 
shows no such deficits (Wersinger et al., 2007). 
 One of the unique features of the BNST and MeA vasopressin system is its 
dependence on circulating gonadal steroids.  In the absence of testoserone or estradiol, 
the BNST and MeA appear to stop producing vasopressin, leading to an eventual 
depletion of vasopressin in their numerous projection sites in rats and mice (de Vries et 
al., 1984; Mayes et al., 1988; Miller et al., 1992; De Vries et al., 1994; Wang and De 
Vries, 1995).  In addition, vasopressin expression in the BNST and MeA is organized by 
testosterone perinatally resulting in a sexual dimorphism (De Vries et al., 1983; Wang et 
al., 1993; Han and De Vries, 2003); males typically have more cells than females in the 
BNST and MeA and a greater density of fibers in known projection sites such as the 
lateral septum and lateral habenula (de Vries et al., 1981; Miller et al., 1989; De Vries 
and al-Shamma, 1990; Wang and De Vries, 1995; Rood et al., 2008).  The function of sex 
differences in the vasopressin system is not well understood.  In some cases, the female 
vasopressin system does not respond as the male system does.  For example, social 
recognition cannot be blocked by vasopressin antagonists in females as it is in males 
(Bluthe and Dantzer, 1990), and vasopressin is not released and V1a antagonists do not 
delay defervescence in females during fever as occurs in males (Landgraf et al., 1990; 
Chen et al., 1997).  Currently, there are few hypotheses explaining the function of sex 
differences in vasopressin; one interesting hypothesis is that sex differences in 
vasopressin may actually serve to compensate for other sex differences in behavior or 
physiology resulting in more equivalent behavior in males and females (De Vries, 2004).  
Finally, the sex difference in the vasopressin system originating in the BNST and MeA 
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has been described as one of the most consistently observed sex differences among 
vertebrates (De Vries and Panzica, 2006).  For example, in mice, a sex difference in cell 
number in the BNST and MeA has been observed (Rood et al., 2008).  In addition, male 
mice have a greater vasopressin-immunoractive-ir fiber density than females in a number 
of brain regions, such as the lateral septum, mediodorsal thalamus, lateral habenula, and 
medial amygdala (De Vries et al., 2002; Bakker et al., 2006; Gatewood et al., 2006; Rood 
et al., 2008).  However, the vast vasopressin innervation of the mouse brain remains 
largely unexplored.  Therefore in addition to understanding which fibers derive from the 
BNST and MeA, the occurrence of sex differences is also a focus of this study.   
 In the current study, we used a simple strategy to determine the location of 
projections from the BNST and MeA: gonadectomy.  As described above the expression 
of vasopressin is dependent on the presence of circulating gonadal steroids, and loss of 
these hormones leads to a loss of vasopressin expression in the BNST and MeA, but not 
in other vasopressin producing sites in rats and mice (de Vries et al., 1984; Mayes et al., 
1988; Miller et al., 1992).  Using this principle we examined vasopressin 
immunoreactivity in the brains of male and female mice that had been gonadectomized or 
sham operated to confirm that only BNST and MeA vasopressin production depends on 
circulating gonadal steroids and to test the following hypotheses:  1) a subset of small 
vasopressin-ir fibers and terminals in the forebrain, midbrain, and hindbrain derive from 
the BNST and MeA and 2) vasopressin-ir projections that originate in the BNST or MeA 
and not in other vasopressin producing areas are sexually dimorphic with males having a 
greater vasopressin-ir fiber density than females. 
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3.2  Methods 
3.2.1  Animals 
 Male and female C57BL6 mice were studied in this experiment.  Animals were 
derived from a breeding colony at the University of Massachusetts.  Following weaning, 
animals were group-housed (5 or less per cage) with same-sex siblings under a 14:10 
light cycle with lights on at 6:00 am.  Animals had ad libitum access to food and water.  
All procedures conformed to NIH guidelines and were in accordance with a protocol 
approved by the University of Massachusetts. 
 Brains from three gonadectomized male mice were used for qualitative analyses.  
Corroboration of qualitative results and quantitative analyses of gonadal hormone 
dependence and sex differences were examined in male and female mice that were either 
gonadectomized (12 males and 12 females) or sham operated (12 males and 10 females).  
Vasopressin immunoreactivity in certain projections dissipates over a number of weeks 
following gonadectomy and is virtually undetectable around 12 to 15 weeks following 
surgery (Mayes et al., 1988).  We therefore chose a 15 week survival time following 
surgery.  During this period one male sham animal and three female sham animals died 
for unknown reasons.  Furthermore, after decoding and analyzing the data one 
"gonadectomized" female was found to have vasopressin immunoreactivity 
indistinguishable from intact females suggesting that at least one ovary was left intact.  
Because the quantitative measures of this subject were well within the range of intact 
females this subject was included as a "sham female."  Thus our quantitative measures for 
the sham groups include results from only 11 males and 8 females.   
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3.2.2  Gonadectomy surgeries 
 At approximately 60 days of age, all animals underwent bilateral gonadectomy 
under isoflurane anesthesia (2% in oxygen by inhalation; Halocarbon Laboratories, River 
Edge, NJ). Male gonadectomy was carried out through an incision at the midline of the 
scrotum.  Testes were exposed, the blood supply and vas deferens were ligated with 
suture, and testes were excised.  Sham animals received incisions to exposes the testes, 
but the blood supply and testes were left intact. Wounds were closed with surgical 
staples.  Female gonadectomy was carried out through incisions on each flank located 
between the rib cage and pelvis.  Ovaries were exposed, the blood supply and fallopian 
tubes were ligated with suture, and ovaries were excised.  Sham females underwent an 
identical procedure except the blood supply and ovaries were left intact.  The muscle wall 
of the body cavity was sutured closed, and the skin was closed with surgical staples.  All 
animals were given a single injection of buprenorphine (0.05 mg/Kg; Bedford 
Laboratories, Bedford, OH) immediately following surgery. 
3.2.3  Tissue collection and processing 
 Fifteen weeks following gonadectomy, animals were euthanized using CO2 
asphyxiation followed by rapid decapitation.  Brains were removed rapidly and placed in 
5% acrolein in 0.1 M phosphate buffer.  Fixation lasted for four hours at which time 
brains were transferred to 30% sucrose in 0.1M phosphate buffer and stored at 4° C until 
sectioning.  For gonadectomized animals used in qualitative analyses, each brain was 
sectioned at 30 m in a different plane: coronal, sagittal, or horizontal.  For each brain, 
every other section was collected for vasopressin immunohistochemistry.  Alternate 
sections were mounted on slides and Nissl stained.  Brains used for quantitative analyses 
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were sectioned in the coronal plane and every third section was collected for vasopressin 
immunocytochemistry.  All brain sections were stored in cryoprotectant at -20° C until 
staining. 
3.2.4  Immunohistochemistry 
 Immunohistochemical methods used in this experiment are identical to those 
described in CHAPTER 2.2.4. 
3.2.5  Qualitative and quantitative fiber density analysis 
 Qualitative descriptions were carried out using a bright field microscope.  
Quantitative analyses were carried out on images of selected representative areas 
illustrated in Figure 3.1 captured using a SPOT camera and software driver on a 
brightfield microscope equipped with a 20x objective.  Fibers were analyzed in each 
picture using ImageJ (NIH).  Briefly, each picture was modified using the "sharpen" tool.  
Then gray-level thresholding was carried out to determine the number of pixels covered 
by staining.  Thresholding was done by eye by a trained experimenter to ensure the most 
accurate measurement of fibers in all sections.  All slides were coded prior to analysis, so 
that the experimenter was blind to treatment groups.   
3.2.6  Statistics 
 Quantitative results were analyzed with two-factor ANOVAs.  The factors were 
sex (male or female) and surgery (sham or gonadectomy).  Fisher's least squared 
difference tests were used to determine group differences where appropriate.  A p-value 
of 0.05 or less was considered to be significant throughout.  Statistical values for all 
quantitative measures are listed in Table 3.1. 
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3.3  Results 
 Steroid-sensitive vasopressin-ir projections were defined as regions in which 
vasopressin-ir fibers and terminals decreased or disappeared altogether following 
gonadectomy.  In some regions gonadectomy resulted in a complete loss of 
immunoreactiviy.  It is not known whether or not there is an actual loss of axons and 
terminal boutons themselves.  Decreases in medium or large fibers were not observed in 
any brain region, but small fibers and terminals disappeared in numerous nuclei 
throughout the brain.   
 Further, quantitative analyses were made for 84 distinct regions of the brain.  In 
general brain regions were chosen because they had a quantifiable vasopressin 
innervation (i.e., at least scattered fibers) and could be accurately located in almost all 
subjects using a variety of anatomical criteria. Many of these areas contained small 
fibers.  Areas in which medium fibers predominate are often too sparsely and 
unpredictably innervated for analysis.  However, a number of the more heavily 
innervated medium fiber sites are included.  Strikingly, gonadectomy did not cause an 
increase in vasopressin-ir fibers in any area where a change was observed (N = 60).  
Please see Table 3.1 for all statistical values associated with figures below. 
3.3.1  Telencephalon 
3.3.1.1  Steroid-sensitive vasopressin projections 
 Vasopressin immunoreactivity appeared to decrease following castration in 32 of 
55 brain regions throughout the telencephalon that have previously been shown to contain 
vasopressin-ir fibers.  Qualitative results for the telencephalon are summarized in Table 
3.2.   
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 In the cortex, gonadectomy reduced vasopressin-ir fiber density in the dorsolateral 
entorhinal cortex and ventral endopririform claustrum.  In the hippocampus, the oriens 
and molecular layers of CA1 contain vasopressin fibers that disappeared following 
gonadectomy, although some dense tangles of medium to large fibers remain in the 
caudal molecular layer of CA1 (see figure 2.8H).  In the basal ganglia, the ventral 
pallidum lost vasopressin immunoreactivity following gonadectomy, but the nucleus 
accumbens did not.  Other basal ganglia nuclei do not contain vasopressin.  The ventral 
forebrain lost immunoreactivity in the navicular postolfactory cortex located near the 
rostral midline, the substantia innominta, and the ventral septal area. 
 The septal complex has one of the densest vasopressin-ir innervations in the brain, 
and gonadectomy eliminated all small fiber immunoreactivity in the lateral septum, 
septofimbrial nucleus, and septohypothalamic nucleus leaving only the sparse medium  
fibers.  Innervation of the dorsal division of the lateral septum, the most rostral parts of 
the lateral septum, triangular nucleus, and subfornical organ did not change. 
 The bed nuclei of the stria terminalis have a complex array of fibers of various 
types.  In the anterior nuclei, only the anteromedial (STMA) and lateroventral (STLV) 
nuclei had a decrease in vasopressin-ir fibers; these nuclei are also the only ones that 
contained small fibers in intact animals.  Laterodorsal nuclei had virtually no fibers to 
begin with and medioventral nuclei did not have a qualitative reduction in the medium  
fibers found there.  It is notable that despite the decrease in small fibers in the 
anteromedial nucleus and others, a number of medium  fibers remained.  In the 
posteromedial BNST, all three regions (i.e., medial, intermediate, and lateral) lost 
vasopressin-immunoreactivity.  However, some medium fibers were still observed in 
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each.  Further, vasopressin immunoreactivity in small fibers persisted in the dorsal part of 
the medial posteromedial BNST (STMPM), whereas immunoreactivity in fibers in the 
ventral portion of the STMPM disappeared following gonadectomy.  The nucleus of the 
stria medullaris also had decreased immunoreactivity following gonadectomy. 
 Every vasopressin innervated nucleus within the amygdala lost vasopressin 
immunoreactivity following gonadectomy with the exception of the central nucleus, in 
which medium fibers remained.  Some stray medium fibers also remained in the 
posteromedial and basomedial nuclei and in anteromedial regions adjacent to the 
supraoptic nucleus in gonadectomized animals. 
3.3.1.2  Sex differences and interactions 
 As mentioned above, all areas with small fibers examined in the telencephalon 
had decreased vasopressin immunoreactivity following gonadectomy.  In addition, a 
number of these regions were also sexually dimorphic with more vasopressin-ir fibers 
observed in males.  The decrease in vasopressin immunoreactivity was generally seen in 
both sexes; however, in many cases, larger decreases in males led to significant sex-by-
surgery interactions.  Exceptions to these general trends are noted below.   
 Of the 24 areas examined in the telencephalon sex differences were found in 15.  
All 15 areas had decreased vasopressin immunoreactivity following gonadectomy and 
significant sex-by-surgery interactions due to a larger decrease in immunoreactivity in 
males than females with one exception, the rostral medioventral BNST (STMV), for 
which details are described below.  An additional eight areas were steroid sensitive, but 
not sexually dimorphic.  Finally, one region was neither steroid sensitive nor sexually 
dimorphic 
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 (see Table 3.1 for statistics, Figures 3.1 for the location of regions analyzed, and Figures 
3.2 to 3.4 for data). 
 In the lateral septum (Figure 3.2), the densely innervated ventral part and the 
caudal part where the fibers of the fimbria begin to enter were strongly sexually 
dimorphic.  On the other hand, the intermediate part in a more rostral area was not.    
 In the anterior BNST (Figure 3.3A), only the STMA and STLV nuclei contain 
small fibers.  There was a small but significant decrease in immunoreactivity in the 
STMA of males and females, but in the STLV a decrease was observed only in males.  
Interestingly, intact females did not differ from gonadectomized animals in the STLV.  
Surprisingly, in the rostral medioventral (STMV) BNST, females had a significantly 
greater vasopressin-ir fiber density than males, and this difference was not present in 
castrated animals.  Typically sex differences in vasopressin-ir fiber density are in the 
male greater than female direction as was observed here, but, as described below, a 
number of regions in the mouse brain show a similar "atypical" sex difference as seen in 
the rostral STMV. 
 The posteromedial BNST nuclei are innervated primarily by small fibers, and this 
innervation is sexually dimorphic and steroid dependent (Figure 3.3B).  Males had more 
vasopressin-ir fibers than females in the medial and lateral parts of the posteromedial 
BNST and in the nucleus of the stria medullaris, and fibers decreased drastically in both 
sexes following gonadectomy. 
 All regions quantified in the amygdala, including multiple rostral to caudal levels 
through some regions, contained almost exclusively small fibers.  Although all regions 
responded to gondectomy with a massive decrease in vasopressin immunoreactivity, sex 
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differences were only observed in a subset of regions.  Specifically, the rostral and caudal 
extended amygdala (Figure 3.4A), caudal anterodorsal medial amygdala (Figure 3.4C), 
posteroventral medial amygdala (Figure 3.4D), posterior basolateral amygdala (Figure 
3.4E), and all levels of the posterodorsal medial amygdala (MePD; Figure 3.4F) all had 
significantly more vasopressin-ir fibers in intact males than females.  Notably, in the 
caudal MePD females did not differ from gonadectomized animals.  In contrast, no sex 
differences were observed in the rostral or caudal anterior cortical amygdala (Figure 
3.4B), rostral anterodorsal medial amygdala (Figure 3.4C), anteroventral medial 
amygdala (Figure 3.4D), basomedial amygdala, or ventral basolateral amygdala (Figure 
3.4E). 
3.3.2  Diencephalon 
3.3.2.1  Hypothalamus 
3.3.2.1.1  Steroid-sensitive vasopressin projections 
 The hypothalamus contains most of the vasopressin-producing nuclei in the brain, 
and accordingly has by far the densest and most complex patterns of innervation of the 
entire brain.  A decrease in small fiber immunoreactivity was observed in 15 out of 39 
brain regions throughout the hypothalamus following gonadectomy.  Notably and in 
contrast to the telencephalon, some regions actually retained small fibers following 
gonadectomy.  Qualitative results for the hypothalamus are summarized in Table 3.3 and 
are described below. 
 In the preoptic region, small fibers disappeared from the lateral preoptic area, 
medial preoptic area, parastrial nucleus, medial part of the medial preoptic nucleus, and 
to a very small extent the median preoptic nucleus.  Many regions retained medium  
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fibers.  In addition a number of regions also had some small fibers especially near the 
midline in the anteroventral periventricular nucleus and periventricular region. 
 In the medial regions of the hypothalamus at the levels of the anterior and 
dorsomedial hypothalamic nuclei, there are very dense vasopressin-ir projections, which 
can be seen exiting the PVN.  However, with the exception of a small terminal field in 
the most rostral part of the anterior hypothalamus, none of these regions lose vasopressin 
immunoreactivity following gonadectomy. 
 In contrast, the peduncular lateral hypothalamus, which is often referred to as just 
lateral hypothalamus, contains small fibers and terminals that disappear following 
gonadectomy at all rostral to caudal levels.  This innervation is most pronounced in the 
rostral lateral hypthalamus and decreases caudally, until almost no small fibers can be 
seen.  However, at the level of the mammillary bodies, a dense small fiber plexus is 
observed in the perifornical lateral hypothalamus. 
 In addition to the lateral hypothalamic regions, small fibers immunoreactivity 
disappears following gonadectomy from nuclei closer to the midline at the level of the 
mammillary bodies.  In particular, the dorsal tuberomammillary nucleus near the third 
ventricle and the ventral tuberomammillary region located ventral to the mammillary 
bodies lose immunoreactivity following gonadectomy.  The same is true for the posterior 
hypothalamus, ventral premammillary nucleus, and retromammillary nucleus also have a 
sparse to scattered innervation.  Each of these areas also contains a modest innervation be 
medium  fibers that persist following gonadectomy. 
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3.3.2.1.2  Sex differences and interactions 
 Unlike the telencephalon, there are many regions in the hypothalamus with 
medium to large fibers, and a number of these regions are included in quantitative 
measures of vasopressin immunoreactivity.  Of the 27 regions examined in the 
hypothalamus, 13 regions were sexually dimorphic.  Five of these were atypical sex 
differences (i.e., female greater than male) and were not affected by gonadectomy.  Other 
details regarding sex differences are described below.  Five other regions had reduced 
vasopressin immunoreactivity following goandectomy, but no sex differences.  Nine 
areas were not affected by gonadectomy and were not sexually dimorphic (see Table 3.1 
for statistics, Figure 3.1 for the location of regions analyzed, and Figure 3.5 for data). 
 In the preoptic region, the medial preoptic area and the middle and caudal parts of 
the medial preoptic nucleus (MPOM) were sexually dimorphic (Figure 3.5A and B); 
intact males had a greater fiber density than females.  In each of these areas, which 
contain other gonadal-steroid independent vasopressin fibers, the female did not differ 
from gonadectomized animals.  Other regions such as the median preoptic nucleus, 
vascular organ of the lamina terminalis, and the rostral part of the MPOM were not 
sexually dimorphic or responsive to gonadal hormones.  Despite the decrease of small 
fibers in males in the MPOM some small fibers remained. 
 In the anterior hypothalamus (AH; Figure 3.5C), there were no sex differences or 
effect of gonadectomy in the central part of the AH through which fibers of the PVN 
pass.  However, in the anterior part of the AH, where small fibers are noted, a small 
decrease was observed in males following gonadectomy suggesting and confirming the 
presence of a small BNST or MeA input. 
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 Similar to results in the central AH, medium fibers in the tuberal lateral 
hypothalamus and medial tuberal hypothalamus were not sexually dimorphic or affected 
by gonadal steroids (Figure 3.5F).  In contrast nuclei closer to the midline such as the 
dorsomedial hypothalamus (Figure 3.5G), periventricular area (Figure 3.5E), and 
retrochiasmatic area (Figure 3.5H) were sexually dimorphic although in the "atypical" 
fashion: females greater than males.  None of these regions were affected by 
gonadectomy, and each appears to receive both small fiber and medium  fiber 
innervation.  On the other hand the subparaventricular zone, which contains mostly small  
fibers was neither sexually dimorphic nor affected by gonadectomy (Figure 3.5E). 
 In the peduncular lateral hypothalamus (PLH; Figure 3.5D), as well as the caudal 
perifornical region (Figure 3.5H), there were effects of gonadectomy in all but the caudal 
PLH, but only the dense terminal field in the rostral part of the PLH has a typical sex 
difference: males had more fibers than females (Figure 3.5D).  Interestingly, the caudal 
PLH, where very few small fibers are observed, an atypical sex differences was found: 
females greater than males.   
 At the level of the mammillary bodies, gonadectomy reduced small fiber 
immunoreactivity in the ventral tuberomammillary nucleus and ventral premammillary 
nucleus (PMV); Figure 3.5H), as well as in the retromammillary nucleus (RMM), which 
was examined at three levels (Figure 3.5I).  The only sex difference was found in the 
caudal RMM.  At this level, males had more fibers than any other group, and females did 
not differ from gonadectomized animals.  Although there were no sex differences in 
intact animals in the PMV and rostral RMM; a significant interaction between sex and 
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hormonal status was present because gonadectomized males had significantly less 
vasopressin-ir fibers than other groups (Figure 3.5H and I). 
3.3.2.2  Thalamus 
3.3.2.2.1  Steroid-sensitive vasopressin projections 
 The majority of vasopressin immunoreactivity in the thalamus is found in small 
fibers and terminals.  Invariably, however, some medium fibers find their way into both 
lateral and medial nuclei.  Only the most caudal parts of the midline thalamus rostral to 
the periaqueductal gray (PAG) and the reticular thalamus contain medium fibers in the 
absence of small fibers.  Of the 14 areas containing vasopressin-immunoreactive fibers in 
the thalamus, eight appeared to have decreased immunoreactivity following 
gonadectomy.  Qualitative results for the thalamus are summarized in Table 3.4.   
 Gonadectomy caused a near total elimination of vasopressin-ir fibers in the 
thalamus, including the central medial, interanterodorsal, interanteromedial, mediodorsal, 
paracentral, rhomboid, paratenial, and lateral habenular nuclei.  No qualitative changes 
were observed in the paraventricular, reuniens, xiphoid, or reticular thalamic nuclei 
suggesting a site of origin other than the BNST or MeA.  However, as described below 
quantitative results suggest a small decrease in the rostral paraventricular nucleus 
following gonadectomy. 
3.3.2.2.2  Sex differences and interactions 
 Quantitative data show that areas where fiber immunoreactivity disappeared in the 
thalamus were generally sexually dimorphic as well: male greater than female (see Table 
3.1 for statistics, Figure 3.1 for the location of regions analyzed, and Figure 3.6 for data).  
This was true for the multiple rostral to caudal levels through the mediodorsal (Figure 
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3.6C), central medial (Figure 3.6E), and lateral habenular nuclei (Figure 3.6F), except the 
caudal lateral habenula where there was an effect of gonadectomy, but not sex.  The 
paratenial and rostral paraventricular nucleus were affected modestly by gonadectomy, 
but fiber-immunoreactivity was not sexually dimorphic in these areas (Figure 3.6A and 
B).  In the dorsal part of the anterior paraventricular thalamus at the level where the 
paratenial nucleus emerges there was a decrease in vasopressin-ir fiber density only in 
males following castration (Figure 3.6A).  An interesting feature of this area is the 
emergence of a dense plexus of gonadal steroid-dependent fibers adjacent to the stria 
medullaris.  This plexus may have contributed to gonadal status effects in the anterior 
paraventricular and paratenial nuclei.  Further caudal in the paraventricular nucleus 
(Figure 3.6D), there were no effects of gonadal status or sex. 
3.3.3  Mesencephalon 
3.3.3.1  Steroid-sensitive vasopressin projections 
 Unlike the thalamus, which is innervated almost entirely by small fibers, the 
mesencephalon contains regions of small and medium fiber innervation.  Eighteen of the 
31 brain regions containing vasopressin-ir fibers in the mesencephalon appeared to have a 
decrease in vasopressin immunorecativity following gonadectomy.  Qualitative results for 
the thalamus are summarized in Table 3.5. 
 In the most rostral part of the PAG a number of small and medium fibers can be 
seen ascending toward the aqueduct into the PAG.  Most of these remain following 
castration and fibers can be seen in gonadectomized males throughout the PAG.  Most of 
the fibers seen throughout the PAG of gonadectomized animals are short segments 
suggesting that they are fibers travelling somewhat rostral-to-caudal (i.e., orthogonal to 
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the plane of the section).  Rostrally, small fibers, which appear to arrive via the ascending 
projection through the rostral PAG, end in the dorsomedial PAG and at the midline in the 
commissure of the superior colliculus.  These small fibers and terminals lose vasopressin 
immunoreactivity following gonadectomy.      
 Caudally at the level of the trochlear nucleus, a dense plexus of small fibers and 
terminals begins to form in the dorsal raphe nuclei.  At the same level medium axons 
curve laterally into the plane of section in the ventrolateral PAG (VLPAG) and then pass 
into the lateral parabrachial nucleus (LPB). The small fibers in the dorsal raphe nuclei 
(e.g., dorsolateral, dorsal, and caudal) lose immunoreactivity following gonadectomy.  
Medium fibers in the VLPAG and LPB do not lose immunoreactivity.  These fibers 
appear continuous with fibers further caudal in the locus coeruleus and Barrington's 
nucleus that also retain immunoreactivity following gonadectomy.  From this point on 
some fibers continue orthogonal to the section adjacent to the fourth ventricle in both 
sham and castrated animals. 
 Ventrally in the tegmentum, a number of brain regions are innervated by small 
fibers from the BNST and MeA.  Gonadectomy reduces vasopressin immunoreactivity in 
the ventral tegmental area (VTA), parabrachial pigmented nucleus of the VTA, 
interfascicular, and parainterfascicular nuclei in more rostral and medial parts of the 
midbrain.  Laterally, small fiber immunoreactivity disappears from the ventromedial tip 
of the substantia nigra pars reticulata, the caudal substantia nigra pars compacta, and the 
retrorubral field.  The small fibers that pass through the VTA into the interfascular 
nucleus appear to continue on through the caudal linear raphe into the dorsal raphe 
nuclei.  These fibers are lost following gonadectomy.  There is also a group of medium 
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fibers that travel through the VTA, interfascicular nucleus, and caudal linear raphe in a 
similar path.  In addition, there is a lateral path of medium fibers that are not hormone-
dependent and travel dorsal to the substantia nigra into the midbrain reticular formation.  
As these fibers pass the substantia nigra there is an increase in branching and boutons.  
This fiber pathway appears to curve through the medial parabrachial nucleus into the 
solitary nucleus in the medulla.   
3.3.3.2  Sex differences and interactions 
 All of the regions with small fibers in the mesencephalon that were analyzed 
showed a decrease following gonadectomy (N = 11).  Eight of these 11 were also 
sexually dimorphic, although one was only sexually dimorphic in gonadectomized 
animals.  Five additional areas had atypical sex difference, but were not affected by 
gonadectomy.  Finally, one region was not sexually dimorphic or steroid-sensitive (see 
Table 3.1 for statistics, Figure 3.1 for the location of regions analyzed, and Figure 3.7 for 
data). 
 The small fibers of the mediodorsal PAG and dorsal and caudal aspects of the 
dorsal raphe (DRC) were sexually dimorphic: males greater than females (Figure 3.7A 
and C).  The dorsolateral dorsal raphe showed no sex differences although fiber density 
was decreased in gonadectomized animals (Figure 3.7C).  In the DRC intact females 
were not different from gonadectomized males or females.  In the ventrolateral PAG, 
there was a decrease in fibers at the most rostral level, but no sex differences.  The level 
of vasopressin immunoreactivity in the middle VLPAG was similar in all groups.  
However, caudally, there were atypical sex differences in the caudal VLPAG, LPB, and 
medial parabrachial nuclei: females greater than males (Figure 3.7B and F). 
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 In ventral regions, males had greater fiber densities than females in the VTA 
(Figure 3.7D), interfascicular nuclei (Figure 3.7E), and parainterfascicular nuclei (Figure 
3.7D).  There was no sex difference in the substantia nigra pars reticulata even though 
this area was affected by gonadectomy (Figure 3.7D).  The sex difference in the caudal 
interfascicular nucleus was found only in gonadectomized animals because males had 
less vasopressin-ir fibers than females following gonadectomy (Figure 3.7E).  Finally, an 
atypical sex difference was observed in the midbrain reticular formation at the top of the 
substantia nigra where the medium fibers begin to increase in number (Figure 3.7F). 
3.3.4  Metencephalon and myelencephalon 
3.3.4.1  Steroid-sensitive vasopressin projections 
 Qualitative results for the metencephalon and myelencephalon are summarized in 
Table 3.6.  There are very few innervated regions in the metencephalon.  However, small   
fibers are found in the median raphe nucleus and the anterior tegmental nucleus, which 
are found between the tectospinal tract and pontine reticular formation.  Both of these 
regions have no fibers at all following gonadectomy.  A few medium fibers are seen 
dorsally just below the fourth ventricle and laterally in the subcoeruleus and intermediate 
reticular formation.  These medium fibers seem to pass through the metencephalon on 
their way to innervate a number of regions throughout the medulla.   
 In the medulla itself, medium fibers are observed in the solitary nucleus through 
its entire rostal to caudal extent, especially in caudal regions (noted in sagittal sections; 
Figure 2.21F).  Vasopressin-ir fibers are found, ventrally, in the medullary raphe nuclei 
(e.g., raphe magnus, raphe pallidus, raphe obscurus, and raphe interpositus); laterally, in 
the alpha part and ventral part of the gigantocellular reticular nuclei, and caudally in the 
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lateral reticular formation and the most caudal parts of the spinal trigeminal nucleus.  
Fibers are observed in all of these areas following gonadectomy with no apparent 
decreases. 
3.3.4.2  Sex differences and interactions 
 Quantitative data were collected for the anterior tegmental nucleus and median 
raphe (see Table 3.1 for statistics, Figure 3.1 for the location of regions analyzed, and 
Figure 3.8 for data).  Sex differences were observed in both areas: males greater than 
females (Figure 3.8).  No region of the medulla appeared to receive steroid-sensitive 
vasopressin innervation. Quantitative analyses were not carried out for any area in the 
myelencephalon.  
3.4  Discussion 
 In rats, vasopressin cells in the bed nuclei of the stria terminalis (BNST) and 
medial amygdala (MeA) require gonadal hormones, in particular estrogens (De Vries et 
al., 1994), for vasopressin production.  Similar to rats, gonadectomy decreases 
vasopressin immunoreactivity in a number of brain regions (DeVries et al., 1985) some 
of which, at least in the rat, are known to derive their vasopressin innervation from the 
BNST or MeA (De Vries and Buijs, 1983; Caffe et al., 1987).  Given that some steroid-
sensitive vasopressin-ir projections in the rat are known to come from the BNST or MeA 
and the gross similarities between rat and mouse vasopressin systems, we believe that the 
loss of vasopressin immunoreactivity in a given brain area following gonadectomy in the 
mouse strongly suggests that that area receives vasopressin innervation from the BNST or 
MeA.  Conversely, areas that retain vasopressin immunoreactivity following 
gonadectomy presumably receive their innervation from other nuclei, most likely the 
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various hypothalamic nuclei such as the suprachiasmatic, supraoptic, pareventricular, or 
various accessory nuclei, which are the only other nuclei that produce vasopressin.  In the 
current study, brain regions throughout the telenencephalon, diencephalon, 
mesencephalon, and metencephalon lost vasopressin immunoreactivity following 
gonadectomy.  This subset of brain regions as detailed above comprises the likely output 
of the BNST and MeA.  Furthermore, many of these brain regions (25 of the 39 
quantified) have a sexually dimorphic vasopressin input.  In these cases males have 
significantly more vasopressin-ir fibers and terminals than females in the given brain 
region.  Interestingly and quite unexpectedly, vasopressin-ir fibers from other sources 
(i.e., fibers did not decrease following gonadectomy) were also sexually dimorphic.  
However, this sex difference was atypical in that females had a greater vasopressin-ir 
fiber density (i.e., more fibers) than males. 
 Before drawing too many conclusions from the results of this study, it is 
important to keep a few limitations in mind.  First and foremost is the quantity of data.  
While a somewhat exhaustive approach is beneficial in providing a great many things to 
think about, it also greatly amplifies the opportunity for statistical error.  While this is of 
theoretical concern, in this particular situation the presence or absence of small fibers in a 
region is almost always able to corroborate the statistical data.  Areas where no small 
fibers were observed were not affected by gonadectomy as shown when you compare the 
qualitative and quantitative data.  Furthermore, sex differences in the expected direction 
only occurred in areas with small fibers, which fits with the fact that the BNST and MeA 
are sexually dimorphic and the source of small fibers in many brain regions.  Perhaps the 
most interesting statistical question is the presence of atypical sex differences.  A couple 
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of areas in which this occurred could be expected based on statistical error, but there were 
10 different brain region in which females had a greater vasopressin-ir fiber density than 
males.  Furthermore, these 10 areas were all comparable in that they contained almost 
exclusively medium fibers.  Finally, not one region that changed following gonadectomy 
had an increase in vasopressin-ir fibers, which would be expected by chance given the 
number of observations made. 
 Aside from the number of tests, it is important to note that within each brain 
region the data can be quite variable.  Individual data points are illustrated in Figure 4.2 
for the caudal lateral septum of intact males.  The subject with the lowest value has a 
value that is only 18% of the highest animal (a 5-fold difference).  However, despite this 
variability we saw sex differences in many brain regions where one would expect to find 
a sex difference based on data from other species (De Vries and Panzica, 2006). 
 Finally, as with any study, we must be careful to not generalize too far.  We have 
thoroughly examined sex differences in the vasopressin system of only one mouse strain.  
It is possible that other strains may have differences in the amount of fibers projecting to 
different brain regions and that sex differences in these other strains could be bigger, 
small, or non-existent.  However, our data seem to fit well with what is known about the 
rat and sex differences in vasopressin expression observed in other species.  Furthermore 
the quantitative results presented here corroborate results found in mice previously (Rood 
et al., 2008).  Despite the limitations of this study, we have presented a significant pool of 
data that provide the foundation for hypotheses regarding the function and possible 
sexual dimorphisms in function of the vasopressin system. 
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 Unfortunately, an exhaustive functional review of each brain region is beyond the 
scope and purpose of the current project; however, a brief overview of a few functional 
systems highlights the widespread potential impact of vasopressinergic innervation 
deriving from the bed nuclei of the stria terminalis.  Systems involved in arousal and 
awareness, behavioral state, and emotional control and cognition all contain vasopressin, 
often at multiple levels of the circuits involved.  Below, I introduce some of the various 
functional circuits that contain vasopressin innervation, which presumably comes from 
the BNST or MeA.  Interestingly, the collection of areas discussed below suggests that 
vasopressin may be involved in regulating the behavioral state of an animal in addition to 
or instead of regulating individual behaviors. 
 One such region involved in controlling behavioral state hat contains vasopressin 
in the mouse is the midbrain raphe: dorsal and median raphe nuclei.  These regions 
produce serotonin.  Drugs that lead to an increase in serotonin neurotransmission have an 
anxiolytic effect.  Conversely, low levels of serotonin lead to an increase in anxiety.  Low 
serotonin levels are also associated with higher levels of aggression in humans (Berman 
et al., 1997).  The influence of serotonin on aggression has been reviewed elsewhere 
(Veenema and Neumann, 2007), but briefly research indicates that various forms of 
aggression can be correlated with both low and high levels of serotonin in different rat 
and mouse strains.  In the brain, serotonin is produced primarily in hind brain nuclei 
including the dorsal and median raphe nuclei (Michelsen et al., 2007).  Each of these 
brain regions in the mouse contains sexually-dimorphic vasopressin-ir fibers from the 
BNST and MeA.  The presence of vasopressin in the raphe, especially the very dense 
innervation of the dorsal raphe, suggests a functional link between vasopressin release 
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and serotonin neurons, although it must be noted that no direct evidence to this effect has 
yet been reported. 
 In addition to direct projections to the serotonin system, a dense plexus of 
vasopressin-ir fibers is found in the lateral habenular nucleus.  This innervation is also 
sexually dimorphic except possibly in more caudal regions of the nucleus.  The lateral 
habenular nucleus plays a key role in information flow through the "dorsal diencephalic 
conduction system (Sutherland, 1982)."  This title refers to a pathway from the forebrain 
to the hindbrain that passes through the stria medullaris into the habenular complex, the 
neurons of which send axons through the fasciculus retroflexus to the hindbrain (Wang 
and Aghajanian, 1977; Sutherland, 1982).  In fact, the neurons in the lateral habenula 
project directly to the dorsal raphe nucleus and inhibit serotonergic neurons (Wang and 
Aghajanian, 1977; Reisine et al., 1982).  The purpose and function of vasopressin at each 
of these levels (i.e., the dorsal raphe and lateral habenular nucleus) is currently unknown. 
 In addition to the dorsal raphe, the lateral habenular nucleus has projections to the 
ventral tegmental area (VTA) and substantia nigra pars compacta (Christoph et al., 1986; 
Hikosaka et al., 2008).  Similar to the effect on the raphe, stimulation of the lateral 
habenula inhibits dopamine neurons in both the VTA and substantia nigra (Reisine et al., 
1982; Christoph et al., 1986).  Dopaminergic neurons in the VTA and substantia nigra 
project extensively to the basal ganglia (de Olmos and Heimer, 1999).  These 
connections, in particular those from VTA, suggest that vasopressin is anatomically 
linked to another important regulatory system, namely, the "ventral striatopallidal system 
(de Olmos and Heimer, 1999)."  Structures in this pathway are also referred to as the 
"limbic loop of the basal ganglia."  Briefly, the VTA projects to the ventral striatum (i.e., 
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nucleus accumbens), which then projects to the ventral pallidum or substantia 
innominata.  Neurons in the ventral pallidum project to the mediodorsal thalamic nucleus, 
which then projects to specific brain regions, which in turn project to the ventral striatum 
among other regions.  Interestingly, vasopressin-ir fibers from the BNST and MeA 
intersect this "limbic loop" at multiple levels including the VTA, ventral pallidum, 
mediodorsal thalamus, and interfascicular nucleus, which also contains dopaminergic 
neurons with forebrain projections.  A functional link has yet to be made between 
vasopressin and most of these brain region; however, one region, the ventral pallidum, 
has been implicated in affilitive behavior and pair-bonding in the monogamous prairie 
vole.  Overexpression of the V1a receptor, the primary vasopressin receptor in the brain, 
in the ventral forebrain including the ventral pallidum increases affiliative behavior and 
partner preference in both socially monogamous (i.e., prairie vole) and promiscuous 
species (i.e., meadow voles; (Pitkow et al., 2001; Lim et al., 2004).  Further, Fos 
expression increases in the ventral pallidum, mediodorsal thalamus, and medial amygdala 
following mating stimuli, and injections of a V1a receptor antagonist into the ventral 
pallidum, but not the lateral ventricle, medial amygdala, or mediodorsal thalamus, 
inhibits partner preference formation (Lim and Young, 2004). 
 While in mice the densest BNST / MeA projections within the thalamus innervate 
the mediodorsal thalamus ("limbic loop") and the lateral habenula ("dorsal diencephalic 
conduction system"), vasopressin-ir fibers are also found in a number of midline and 
intralaminar nuclei, including the central medial, paracentral, and interanterodorsal 
nuclei.  The afferent and efferent projections of these nuclei are reviewed in (Van der 
Werf et al., 2002).  In general, the interanterodorsal nucleus appears to be connected to 
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the amygdala and limbic frontal cortex.  The central medial nucleus receives inputs from 
a number of regions including reticular formation, serotonin neurons, superior colliculus, 
and hindbrain cholinergic nuclei.  The paracentral nucleus receives multimodal sensory 
information from the auditory and visual systems.  These nuclei with their diverse inputs 
and outputs appear to play a role in attention and awareness.  Based on the patterns of 
inputs, it appears likely that these nuclei integrate sensory and limbic system information 
with midbain and hindbrain activational systems, such as the serotonergic and cholinergic 
nuclei.  
 Perhaps the most commonly studied area in terms of vasopressin function is the 
lateral septum.  This brain region receives massive topographic projections from the 
hippocampus, and projects to regions throughout the brain in a region specific manner 
(Swanson and Cowan, 1979; Risold and Swanson, 1997).  The ventral lateral septum and 
caudal lateral septum, which contain one of the largest and densest vasopressin terminal 
fields, project to the medial preoptic region (ventral lateral septum) and the lateral 
preoptic area and lateral hypothalamus (caudal lateral septum).  These areas themselves 
have vasopressin innervation from the BNST or MeA and are thought to be involved in a 
host of behaviors, including reproductive and aggressive behaviors, both of which require 
social interaction.  Vasopressin in the lateral septum has been studied in regard to social 
memory, aggression, parental behavior, partner preference, thermoregulation, and anxiety 
(Bernardini et al., 1983; Naylor et al., 1985; Dantzer et al., 1988; Insel et al., 1994; Wang 
et al., 1994; Everts and Koolhaas, 1999; Bielsky et al., 2005).  Currently, functional 
evidence most strongly supports a role for vasopressin in social recognition memory, 
particularly in male rats (Dantzer et al., 1987; Bluthe et al., 1990).  Vasopressin receptor 
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(V1a) antagonists, antisense, and null mutations all disrupt social recognition memory 
(Dantzer et al., 1987; Dantzer et al., 1988; Landgraf et al., 1995; Bielsky et al., 2004).  In 
V1a knock-out animals, rescue of V1a receptors in the lateral septum alone with the use 
of viral vectors restored social recognition memory (Bielsky et al., 2005).  In addition, 
V1a agonists injected into the lateral septum facilitate social recognition memory 
(Dantzer et al., 1987; Dantzer et al., 1988).  
 Clearly, given the anatomical location of vasopressin in the mouse brain, this 
peptide is likely to affect a number of brain pathways that mediate particular aspects of a 
behavioral response to stimuli.  However, surprisingly few data have been generated to 
this effect.  If links between brain areas and functions are summarized, our knowledge 
would look like this: social recognition = lateral septum; pair-bonding = ventral pallidum; 
thermoregulation in response to fever = ventral septal area; flank-marking = anterior 
hypothalamus; and aggression = lateral septum / raphe nuclei / anterior hypothalamus 
(Ferris et al., 1984; Naylor et al., 1985; Dantzer et al., 1988; Lim and Young, 2004; 
Bielsky et al., 2005; Beiderbeck et al., 2007).  However, as outlined above, a number of 
brain regions that constitute major modulatory systems are innervated by the vasopressin 
producing cells of the BNST and MeA.  I hypothesize that stimulation of the BNST / 
MeA vasopressin system initiates a brain wide mobilization of systems that guide the 
animal toward making ethologically relevant and "correct" behavioral responses to 
specific behavioral stimuli.  For example, when presented with a reproductively receptive 
female, a male mouse should most likely respond with affiliative and mating behavior 
rather than a display of offensive aggression.  Examining such a hypothesis will require a 
more global approach to thinking about vasopressin function compared to the relatively 
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narrow conclusions drawn thus far.  Nevertheless, the pieces of the puzzle that we do 
have give credence to the idea that research into vasopressin function will greatly 
increase our understanding of animal and perhaps human social behavior. 
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Table 3.1:  Statistics for quantitative analyses 
 Statistical values are given below for all quantitative comparisons made 
throughout CHAPTER 3.  Data are grouped by brain region and overall effect and 
alphabetized within each section. 
 
Telencephalon Sex Surgery Interaction 
Brain Region F p F p F p
Sex and surgery difference 
Anterodorsal medial amygdala, 
caudal (MeAD) 
(1, 35) 
0.406 
0.528 (1, 35) 
67.23 
<0.001 (1, 35) 
7.077 
0.012 
Extended amygdala, rostral (EA)
  
(1, 38) 
1.896 
0.177 (1, 38) 
62.158 
<0.001 (1, 38) 
6.012 
0.019 
Extended amygdala, caudal (EA) (1, 36) 
1.178 
0.285 (1, 36) 
119.13 
<0.001 (1, 36) 
5.834 
0.021 
Lateral amygdala, caudal (LA) (1, 27) 
10.876 
0.003 (1, 27) 
49.121 
<0.001 (1, 27) 
12.241 
0.002 
Lateral septal nucleus, ventral 
part (LSV) 
(1, 33) 
14.836 
0.001 (1, 33) 
65.154 
<0.001 (1, 33) 
15.635 
<0.001 
Lateral septal nucleus, ventral & 
intermediate part (LSV&I) 
(1, 36) 
11.826 
0.001 (1, 36) 
93.193 
<0.001 (1, 36) 
12.092 
0.001 
Lateroventral BNST (STLV) (1, 35) 
12.991 
0.001 (1, 35) 
23.5 
<0.001 (1, 35) 
10.627 
0.002 
Nucleus of the stria medullaris 
(SM) 
(1, 38) 
8.355 
0.006 (1, 38) 
45.062 
<0.001 (1, 38) 
9.733 
0.003 
Posterolateral medial BNST 
(STMPL) 
(1, 38) 
9.934 
0.003 (1, 38) 
59.137 
<0.001 (1, 38) 
10.682 
0.002 
Posteromedial BNST (STMPM) (1, 34) 
29.307 
<0.001 (1, 34) 
83.218 
<0.001 (1, 34) 
36.622 
<0.001 
Posterodorsal medial amygdala, 
rostral (MePD) 
(1, 34) 
6.733 
0.014 (1, 34) 
154.22 
<0.001 (1, 34) 
6.381 
0.016 
Posterodorsal medial amygdala, 
middle (MePD) 
(1, 33) 
18.475 
<0.001 (1, 33) 
88.758 
<0.001 (1, 33) 
23.147 
<0.001 
Posterodorsal medial amygdala, 
caudal (MePD) 
(1, 27) 
18.079 
<0.001 (1, 27) 
35.85 
<0.001 (1, 27) 
14.478 
0.001 
Posteroventral medial amygdala 
(MePV) 
(1, 33) 
12.893 
0.001 (1, 33) 
90.295 
<0.001 (1, 33) 
17.641 
<0.001 
Surgery difference only 
Anterior cortical amygdala, 
rostral (ACo) 
(1, 35) 
0.599 
0.444 (1, 35) 
55.195 
<0.001 (1, 35) 
0.269 
0.607 
Anterior cortical amygdala, 
caudal (ACo) 
(1, 34) 
0.579 
0.452 (1, 34) 
51.211 
<0.001 (1, 34) 
1.449 
0.237 
Anterodorsal medial amygdala, 
rostral (MeAD) 
(1, 34) 
0.004 
0.953 (1, 34) 
62.062 
<0.001 (1, 34) 
0.859 
0.361 
Anteromedial BNST (STMA) (1, 36) 
1.009 
0.322 (1, 36) 
8.163 
0.007 (1, 36) 
0.594 
0.446 
Anteroventral medial amygdala 
(MeAV) 
(1, 34) 
3.928 
0.056 (1, 34) 
13.902 
0.001 (1, 34) 
0.634 
0.431 
Basolateral Amygdala, Ventral 
(BLV) 
(1, 34) 
0.457 
0.504 (1, 34) 
36.411 
<0.001 (1, 34) 
0.639 
0.43 
Basomedial amygdala (BMA) (1, 34) 
0.438 
0.512 (1, 34) 
54.079 
<0.001 (1, 34) 
3.168 
0.084 
Lateral septal nucleus, 
intermediate part (LSI) 
(1, 35) 
1.636 
0.209 (1, 35) 
58.771 
<0.001 (1,35) 
1.792 
0.189 
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Table 3.1:  Statistics for quantitative analyses (continued) 
 
Telencephalon (Cont.) Sex Surgery Interaction 
Brain Region F p F p F p
Female > Male sex difference 
Medioventral BNST, rostral 
(STMV) 
(1, 36) 
6.422 
0.016 (1, 36) 
1.227 
0.275 (1, 36) 
10.9 
0.002 
No differences 
Medioventral BNST, caudal 
(STMV) 
(1, 34) 
0.302 
0.587 (1, 34) 
1.117 
0.298 (1, 34) 
0.047 
0.829 
Diencephalon Sex Surgery Interaction 
Brain Region F p F p F p
Sex and surgery difference 
Anterior hypothalamus, anterior 
(AHA) 
(1, 36) 
2.379 
0.132 (1, 36) 
3.515 
0.069 (1, 36) 
5.303 
0.027 
Anterior paraventricular 
thalamus, caudal and dorsal 
(PVA) 
(1, 37) 
3.5 
0.069 (1, 37) 
2.205 
0.146 (1, 37) 
4.111 
0.05 
Central medial n., rostral (CM) (1, 37) 
4.682 
0.037 (1, 37) 
26.613 
<0.001 (1, 37) 
6.140 
0.018 
Central medial n., middle (CM) (1, 37) 
2.969 
0.093 (1, 37) 
99.574 
<0.001 (1, 37) 
4.822 
0.034 
Central medial n., caudal (CM) (1, 38) 
6.836 
0.013 (1, 38) 
37.335 
<0.001 (1, 38) 
7.712 
0.008 
Lateral habenula, rostral (LHb) (1, 38) 
12.585 
0.001 (1, 38) 
122.43 
<0.001 (1, 38) 
13.371 
0.001 
Lateral habenula, middle (LHb) (1, 36) 
53.061 
<0.001 (1, 36) 
418.97 
<0.001 (1, 36) 
62.069 
<0.001 
Medial preoptic area (MPA) (1, 26) 
0.48 
0.494 (1, 26) 
7.018 
0.014 (1, 26) 
4.791 
0.038 
Medial part of medial preoptic 
nucleus, middle (MPOM)   
(1, 32) 
6.664 
0.015 (1, 32) 
9.844 
0.004 (1, 32) 
5.377 
0.027 
Medial part of medial preoptic 
nucleus, caudal (MPOM)   
(1, 33) 
9.991 
0.003 (1, 33) 
21.667 
<0.001 (1, 33) 
19.521 
<0.001 
Medial retromammillary 
nucleus, rostral (RMM) 
(1, 31) 
4.253 
0.048 (1, 31) 
12.405 
0.001 (1, 31) 
0.964 
0.334 
Medial retromammillary 
nucleus, caudal (RMM) 
(1, 21) 
7.975 
0.01 (1, 21) 
29.648 
<0.001 (1, 21) 
15.412 
0.001 
Mediodorsal thalamus, rostral 
(MD) 
(1, 38) 
4.753 
0.036 (1, 38) 
85.293 
<0.001 (1, 38) 
17.364 
<0.001 
Mediodorsal thalamus, middle 
(MD) 
(1, 37) 
7.2 
0.011 (1, 37) 
125.23 
<0.001 (1, 37) 
8.910 
0.005 
Mediodorsal thalamus, caudal 
(MD) 
(1, 38) 
9.453 
0.004 (1, 38) 
85.469 
<0.001 (1, 38) 
15.584 
<0.001 
Peduncular part of the lateral 
hypothalamus, rostral (PLH) 
(1, 36) 
6.715 
0.014 (1, 36) 
101.93 
<0.001 (1, 36) 
9.210 
0.004 
Premammillary nucleus, ventral 
(PMV) 
(1, 28) 
1.045 
0.315 (1, 28) 
1.313 
0.262 (1, 28) 
6.472 
0.017 
Surgery difference only       
Anterior paraventricular 
thalamus, rostral (PVA) 
(1, 37) 
0.005 
0.945 (1, 37) 
13.514 
0.001 (1, 37) 
1.249 
0.271 
Lateral habenula, caudal (LHb) (1, 36) 
0.409 
0.527 (1, 36) 
35.342 
<0.001 (1, 36) 
0.198 
0.659 
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Table 3.1:  Statistics for quantitative analyses (continued) 
 
Diencephalon (Cont.) Sex Surgery Interaction 
Brain Region F p F p F p
Surgery difference only 
Medial retromammillary 
nucleus, middle (RMM) 
(1, 32) 
0.363 
0.551 (1, 32) 
14.575 
0.001 (1, 32) 
2.276 
0.141 
Paratenial Nucleus (PT) (1, 38) 
3.393 
0.073 (1, 38) 
19.564 
<0.001 (1, 38) 
1.965 
0.169 
Peduncular part of the lateral 
hypothalamus, middle1 (PLH) 
(1, 35) 
0.965 
0.333 (1, 35) 
16.604 
<0.001 (1, 35) 
0.22 
0.642 
Peduncular part of the lateral 
hypothalamus, middle2 (PLH) 
(1, 37) 
0.842 
0.365 (1, 37) 
7.166 
0.11 (1, 37) 
0.319 
0.575 
Perifornical lateral 
hypothalamus (PeFLH) 
(1, 30) 
0.006 
0.941 (1, 30) 
38.848 
<0.001 (1, 30) 
0.529 
0.473 
Ventral Tuberomammillary 
Nucleus (VTM) 
(1, 32) 
0.269 
0.608 (1, 32) 
60.969 
<0.001 (1, 32) 
2.063 
0.161 
Female > Male sex difference 
Dorsomedial Hypothalamus 
(DM), rostral 
(1, 36) 
11.815 
0.001 (1, 36) 
0.124 
0.727 (1, 36) 
0.005 
0.946 
Dorsomedial Hypothalamus 
(DM), caudal 
(1, 37) 
21.123 
<0.001 (1, 37) 
3.09 
0.087 (1, 37) 
0.052 
0.821 
Peduncular part of the lateral 
hypothalamus, caudal (PLH) 
(1, 37) 
12.883 
0.001 (1, 37) 
0.032 
0.859 (1, 37) 
0.053 
0.82 
Periventricular Hypothalamic 
Nucleus (Pe) 
(1, 36) 
5.321 
0.027 (1, 36) 
0.046 
0.831 (1, 36) 
1.529 
0.224 
Retrochiasmatic area (RCh) (1, 35) 
10.227 
0.003 (1, 35) 
0.425 
0.519 (1, 35) 
0.194 
0.662 
No differences       
Anterior hypothalamus, central, 
rostral (AHC) 
(1, 35) 
2.235 
0.144 (1, 35) 
0.319 
0.576 (1, 35) 
0.494 
0.487 
Anterior hypothalamus, central, 
caudal (AHC) 
(1, 37) 
3.561 
0.067 (1, 37) 
0.77 
0.782 
 
(1, 37) 
0.469 
0.498 
Anterior paraventricular 
thalamus, caudal and ventral 
(PVA) 
(1, 38) 
1.751 
0.194 (1, 38) 
0.018 
0.894 (1, 38) 
1.063 
0.309 
Medial part of medial preoptic 
nucleus, rostral (MPOM)   
(1, 35) 
2.985 
0.093 (1, 35) 
2.573 
0.118 (1, 35) 
2.884 
0.098 
Medial tuberal hypothalamus 
(MTu) 
(1, 37) 
0.161 
0.691 (1, 37) 
0.943 
0.338 (1, 37) 
1.659 
0.206 
Median preoptic nucleus 
(MnPO) 
(1, 31) 
0.235 
0.631 (1, 31) 
2.984 
0.094 (1, 31) 
2.243 
0.144 
Paraventricular thalamus, rostral 
(PV) 
(1, 36) 
0.072 
0.79 (1, 36) 
1.185 
0.284 (1, 36) 
3.131 
0.085 
Paraventricular thalamus, caudal 
(PV) 
(1, 36) 
2.571 
0.118 (1, 36) 
2.075 
0.158 (1, 36) 
0.023 
0.881 
Subparaventricular zone (SPa) (1, 33) 
0.204 
0.654 (1, 33) 
2.668 
0.112 (1, 33) 
0.165 
0.688 
Tuberal region of hypothalamus 
(TuLH), rostral 
(1, 37) 
0.718 
0.402 (1, 37) 
0.569 
0.455 (1, 37) 
<0.001 
0.997 
Tuberal region of hypothalamus 
(TuLH), caudal 
(1, 38) 
3.751 
0.06 (1, 38) 
.624 
0.435 (1, 38) 
0.002 
0.966 
Vascular organ of the lamina 
terminalis (VOLT) 
(1, 31) 
1.166 
0.289 (1, 31) 
1.71 
0.201 (1, 31) 
0.604 
0.443 
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Table 3.1:  Statistics for quantitative analyses (continued) 
 
Mesencephalon Sex Surgery Interaction 
Brain Region F p F p F p
Sex and surgery difference 
Dorsomedial PAG (DMPAG) (1, 37) 
25.392 
<0.001 (1, 37) 
89.961 
<0.001 (1, 37) 
33.832 
<0.001 
Dorsal raphe, dorsal (DRD) (1, 36) 
14.012 
0.001 (1, 36) 
113.42 
<0.001 (1, 36) 
15.886 
<0.001 
Dorsal raphe, caudal (DRC) (1, 37) 
8.966 
0.005 (1, 37) 
28.34 
<0.001 (1, 37) 
8.438 
0.006 
Interfascicular nucleus (IF), 
rostral 
(1, 33) 
17.284 
<0.001 (1, 33) 
67.777 
<0.001 (1, 33) 
27.318 
<0.001 
Interfascicular nucleus (IF),  
middle 
(1, 38) 
3.207 
0.081 (1, 38) 
84.42 
<0.001 (1, 38) 
8.252 
0.007 
Interfascicular nucleus (IF),  
caudal 
(1, 38) 
7.074 
0.011 (1, 38) 
29.832 
<0.001 (1, 38) 
0.074 
0.787 
parainterfascicular nucleus (PIF) (1, 37) 
2.919 
0.096 (1, 37) 
63.963 
<0.001 (1, 37) 
11.229 
0.002 
Ventral tegmental area (VTA) (1, 34) 
1.489 
0.231 (1, 34) 
124.38 
<0.001 (1, 34) 
13.978 
0.001 
Surgery difference only       
Dorsal raphe, dorsolateral 
(DRDL) 
(1, 37) 
0.057 
0.813 (1, 37) 
72.525 
<0.001 (1, 37) 
2.846 
0.1 
Substantia nigra pars reticulata 
(SNR) 
(1, 34) 
0.377 
0.543 (1, 34) 
37.615 
<0.001 (1, 34) 
3.621 
0.066 
Ventrolateral PAG (VLPAG), 
rostral 
(1, 37) 
1.212 
0.278 (1, 37) 
16.301 
<0.001 (1, 37) 
<0.001 
0.996 
Female > Male sex difference 
Lateral parabrachial nucleus 
(LPB) 
(1, 36) 
9.366 
0.004 (1, 36) 
0.002 
0.964 (1, 36) 
0.172 
0.681 
Medial parabrachial nucleus 
(MPB) 
(1, 36) 
13.907 
0.001 (1, 36) 
0.417 
0.523 (1, 36) 
1.044 
0.314 
Midbrain reticular formation 
(mRT) 
(1, 38) 
7.936 
0.008 (1, 38) 
0.067 
0.797 (1, 38) 
0.218 
0.643 
Ventrolateral PAG (VLPAG), 
caudal 
(1, 35) 
4.261 
0.046 (1, 35) 
2.457 
0.126 (1, 35) 
0.164 
0.688 
No differences 
Ventrolateral PAG (VLPAG), 
middle 
(1, 36) 
0.31 
0.581 (1, 36) 
0.063 
0.804 (1, 36) 
<0.001 
0.988 
Metencephalon Sex Surgery Interaction 
Brain Region F p F p F p
Sex and surgery difference 
Median raphe nucleus (MnR) (1, 36) 
7.199 
0.011 (1, 36) 
56.013 
<0.001 (1, 36) 
7.131 
0.011 
Anterior tegmental nucleus 
(ATg) 
(1, 37) 
13.499 
0.001 (1, 37) 
48.195 
<0.001 (1, 37) 
12.298 
0.001 
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Table 3.2:  Vasopressin-ir fibers in the telencephalon 
  Summary of vasopressin-ir fibers throughout the telencephalon.  
Data are grouped by region and then by sensitivity to steroids.  Vasopressin 
immunoreactivity either decreased or did not change following 
gonadectomy (GDX).  A qualitative increase in vasopressin-ir fibers was not 
observed in any area.  In the intact and GDX columns, letters indicate the 
relative density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered; 
m, moderate; d, dense; -0-, no fibers observed. 
 
Cortex Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Dorsolateral entorhinal 
cortex 
F(sp-sc) F(sp) 
Ventral endopiriform 
claustrum (VEn) 
F(sp-sc) 
 
F(sp) 
 
No Change in Vasopressin Immunoreactivity 
Cingulate Cortex F(sp) F(sp) 
Dorsal endopiriform 
nucleus (DEn) 
F(sp) F(sp) 
Dorsal peduncular cortex 
(DP).   
F(sp) F(sp) 
Ectorhinal cortex.   F(sp) F(sp) 
Frontal cortex F(sp) F(sp) 
Infralimbic (IL) F(sp) F(sp) 
Insular Cortex F(sp) F(sp) 
Medial orbital cortex 
(MO) 
F(sp) 
 
F(sp) 
 
Piriform cortex (Pir) F(sp) F(sp) 
Prelimbic cortex (PrL) F(sp) F(sp) 
 
Hippocampus Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Lacunosum moleculare 
(LMol) 
F(sp-sc) F(sp) 
Oriens layer 
hippocampus 
F(sc) -0- 
Ventral Subiculum F(sp-sc) -0- 
No Change in Vasopressin Immunoreactivity 
Fimbria F(sp) F(sp) 
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Table 3.2: Vasopressin-ir fibers in the telencephalon (Continued) 
 
Basal
Ganglia Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Ventral Pallidum (VP) F(sp-d) F(sp) 
No Change in Vasopressin Immunoreactivity 
Nucleus Accumbens F(sp-sc) F(sp-sc) 
 
Septal
Complex Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Lateral septal nucleus, 
intermediate part (LSI) 
F(sc-d) 
T(sc-d) 
F(sp-sc) 
Lateral septal nucleus, 
ventral part (LSV) 
F(sc-d) 
T(sc-d) 
F(sp-sc) 
Septofimbrial nucleus 
(SFi) 
F(sp-sc) 
 
F(sp) 
Septohypothalamic 
nucleus (SHy) 
F(sc-m) 
T(sc-m) 
F(sp-sc) 
No Change in Vasopressin Immunoreactivity 
Lateral septal nucleus, 
dorsal part (LSD) 
F(sp) F(sp) 
Rostral lateral septum 
(LSD, I, & V) 
F(sp-sc) F(sp-sc) 
Subfornical organ (SFO) F(sp) F(sp) 
Triangular septal nucleus 
(TS) 
F(sp) F(sp) 
 
Ventral
Forebrain Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Navicular postolfactory 
cortex (Nv) 
F(sp-sc) F(sp) 
Substantia Innominata 
(SI) 
F(sp-d) F(sp) 
Ventral Septal Area F(m-d) F(sp) 
No Change in Vasopressin Immunoreactivity 
Dorsal tenia tecta F(sp-sc) F(sp-sc) 
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Table 3.2: Vasopressin-ir fibers in the telencephalon (continued) 
 
BNST Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Anteromedial BNST 
(STMA) 
F(m) 
T(m) 
F(sc) 
Lateroventral BNST 
(STLV) 
F(sp-sc) 
T(sc) 
F(sp-sc) 
Posterointermediate 
BNST (STMPI) 
F(sc-m) 
T(sc-m) 
F(sp) 
Nucleus of the stria 
medullaris (SM) 
F(sc) F(sp) 
Posterolateral medial 
BNST (STMPL) 
F(sc-m) 
T(sc-m) 
F(sp-sc) 
Posteromedial BNST 
(STMPM) 
F(m-d) 
T(m-d) 
F(sc) 
T(sc) 
No Change in Vasopressin Immunoreactivity 
 IPAC F(sp) F(sp) 
Juxtacapsular BNST 
(STLJ) 
F(sp) F(sp) 
Laterodorsal BNST 
(STLD) 
F(sp) 
 
F(sp) 
Lateroposterior BNST 
(STLP) 
F(sp) F(sp) 
Medioventral BNST 
(STMV) 
F(sc-m) 
 
F(sc-m) 
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Table 3.2: Vasopressin-ir fibers in the telencephalon (continued) 
 
Amygdala Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Anterior amygdaloid area 
(AA) 
F(sp-sc) F(sp) 
Anterior cortical 
amygdala (ACo) 
F(sc-m) 
T(sc-m) 
F(sp) 
Anterodorsal medial 
amygdala (MeAD) 
F(m-d) 
T(m-d) 
F(sp) 
Anterolateral 
amygdalohippocampal 
area (AHiAL) 
F(m) 
T(m) 
-0- 
Anteroventral medial 
amygdala (MeAV) 
F(sc) 
T(sc) 
F(sp) 
Basomedial amygdala 
(BMA) 
F(sc) 
T(sc) 
F(sp) 
Basolateral, posterior 
(BLP) 
F(sp-sc) 
T(sp-sc) 
-0- 
Extended amygdala (EA) F(m) 
T(m) 
F(sp) 
Intraamygdalar division 
of stria terminalis (STIA) 
F(sp) 
T(sp) 
F(sp) 
IPACM / IPACL F(sp)  T(sp) F(sp) 
Posterodorsal medial 
amygdala (MePD) 
F(m-d) 
T(m-d) 
F(sp) 
Posterolateral cortical 
amygdala (PLCo) 
F(sc) 
T(sc) 
F(sp) 
Posteroventral medial 
amygdala (MePV) 
F(sc-m) 
T(sc-m) 
F(sp) 
No Change in Vasopressin Immunoreactivity 
Central amygdala (CeA) F(sp) F(sp) 
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Table 3.3: Vasopressin-ir fibers in the diencephalon: Hypothalamus 
  Summary of vasopressin-ir fibers throughout the diencephalon: 
hypothalamus.  Data are grouped by region and then by sensitivity to 
steroids.  Vasopressin immunoreactivity either decreased or did not change 
following gonadectomy (GDX).  A qualitative increase in vasopressin-ir 
fibers was not observed in any area.  In the intact and GDX columns, letters 
indicate the relative density of staining: F, fibers; T, terminals; sp, sparse; 
sc, scattered; m, moderate; d, dense; -0-, no fibers observed. 
 
Hypothalamus Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Preoptic Region 
Lateral preoptic area 
(LPO) 
F(sp-m) 
T(sp-m) 
F(sp) 
Medial part of medial 
preoptic nucleus 
(MPOM)   
F(sc-m) 
T(sc-m) 
F(sp-sc) 
T(sp) 
Medial preoptic area 
(MPA) 
F(sc-m) 
T(sc-m) 
F(sp) 
Median preoptic nucleus 
(MnPO) 
F(m) 
T(m) 
F(sp-m) 
Parastrial nucleus (PS)  F(d) 
T(d) 
F(sp-sc) 
Anterior Hypothalamic Region 
Anterior hypothalamus, 
anterior (AHA) 
F(sp-d) 
T(sp-m) 
F(sp-sc) 
Mammillary Body Region 
Dorsal tuberomammillary 
nucleus (DTM) 
F(d) 
T(d) 
F(sc) 
T(sp) 
Medial retromammillary 
nucleus (RMM) 
F(sc) 
T(sc) 
F(sp-sc) 
Perifornical nucleus 
(PeF) 
F(m-d) 
T(m-d) 
F(sc-m) 
Posterior hypothalmaus 
(PH) 
F(sp-sc) F(sp) 
Ventral premammillary 
nucleus (PMV) 
F (sp-sc) 
T (sp) 
F(sp) 
Ventral 
tuberomammillary 
nucleus (VTM) 
F(d) 
T(d) 
F(sp-sc) 
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Table3.3: Vasopressin-ir fibers in the diencephalon: Hypothalamus (Continued) 
 
Hypothalamus
Cont. Intact GDX
Lateral Hypothamalic Region 
Lateral hypothalamus 
(LH) 
F(sc-d) 
T(sc-d) 
F(sp-sc) 
Peduncular part of the 
lateral hypothalamus 
(PLH) 
F(m-d) 
T(m-d) 
F(sp-d) 
Perifornical lateral 
hypothalamus (PeFLH) 
F(m-d) 
T(m-d) 
F(sp-sc) 
No Change in Vasopressin Immunoreactivity 
Preoptic Region 
Anteroventral 
periventricular Area 
(AVPe) 
F(sc-d) 
T(sc-d) 
F(sc-d) 
T(sc-d) 
Periventricular 
hypothalamic nucleus 
(Pe) 
F(sc-d) 
T(m-d) 
F(sc-d) 
T(m-d) 
Striohypothalamic 
nucleus (StHy).   
F(sc) 
T(sc) 
F(sc) 
T(sc) 
Vascular organ of the 
lamina terminalis 
(VOLT) 
F(sc) F(sc) 
Ventrolateral preoptic 
area (VLPO) 
F(sc) 
T(sc) 
F(sc) 
T(sc) 
Ventromedial preoptic 
nucleus (VMPO) 
F(sc) F(sc) 
Anterior Hypothalamic Region 
Anterior hypothalamus, 
central (AHC) 
F(m-d) F(m-d) 
Lateroanterior 
hypothalamus (LA) 
F(sp-sc) F(sp-sc) 
Paraventricular nucleus 
(PVN) 
F(m-d) 
T(sc-m) 
F(m-d) 
T(sc-m) 
Parvicellular 
paraventricular 
hypothalamus (PaAP) 
F(d) 
T(d) 
F(d) 
T(d) 
Periventricular region 
(Pe) 
F(d) 
T(d) 
F(d) 
T(d) 
Retrochiasmatic area 
(RCh) 
F(sc-d) 
T(sc-d) 
F(sc-d) 
T(sc-d) 
Subparaventricular zone 
(SPa).   
F(d) 
T(d) 
F(d) 
T(d) 
Suprachiasmatic nucleus 
(SCN) 
F(m-d) 
T(m-d) 
F(m-d) 
T(m-d) 
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Table 3.3: Vasopressin-ir fibers in the diencephalon: Hypothalamus (Continued) 
 
Hypothalamus
Cont. Intact GDX
Supraoptic commissure 
(sox) 
F(sc) F(sc) 
Tuberal lateral 
hypothalamus (TuLH) 
F(m-d) F(m-d) 
Dorsomedial Hypothalamic Nucleus 
Arcuate nucleus (Arc) F(sp-sc) 
T(sp-sc) 
F(sp-sc) 
T(sp-sc) 
Dorsomedial 
hypothalamus (DMH) 
F(sc-d) 
T(sc-d) 
F(sc-d) 
T(sc-d) 
Medial tuberal 
hypothalamus (MTu) 
F(sp-d) F(sp-d) 
Ventromedial 
hypothalamus (VMH) 
F(sp) F(sp) 
Zona incerta (ZI) F(sp) F(sp) 
Mammillary Body Region 
Dorsal hypothalamic area 
(DA) 
F(sp) F(sp) 
Lateral retromammillary 
nucleus (RML) 
F(sp-sc) F(sp-sc) 
Endopeduncular nucleus 
(EP) 
F(sp-sc) F(sp-sc) 
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Table 3.4: Vasopressin-ir fibers in the diencephalon: Thalamus 
  Summary of vasopressin-ir fibers throughout the diencephalon: 
thalamus.  Data are grouped by sensitivity to steroids.  Vasopressin 
immunoreactivity either decreased or did not change following 
gonadectomy (GDX).  A qualitative increase in vasopressin-ir fibers was not 
observed in any area.  In the intact and GDX columns, letters indicate the 
relative density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered; 
m, moderate; d, dense; -0-, no fibers observed.  
 
Thalamus Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Central medial thalamic 
nucleus (CM) 
F(sc-m) 
T(sc-m) 
F(sp) 
Interanterodorsal 
thalamic nucleus (IAD) 
F(m) 
T(m) 
-0- 
Interanteromedial 
thalamic nucleus (IAM) 
F(m) 
T(m) 
-0- 
Lateral habenular nucleus 
(LHb) 
F(sc-d) 
T(sc-d) 
-0- 
Mediodorsal thalamic 
nucleus  (MD) 
F(d) 
T(d) 
F(sp) 
T(sp) 
Paracentral thalamus 
(PC) 
F(m) 
T(m) 
-0- 
Paratenial thalamus (PT) F(sp-sc) 
T(sp-sc) 
F(sp) 
T(sp) 
Rhomboid thalamic 
nucleus (Rh) 
F(sp-sc) 
T(sp-sc) 
F(sp) 
No Change in Vasopressin Immunoreactivity 
Paraventricular thalamic 
nucleus, anterior (PVA) 
F(sc-d) 
T(sc-d) 
F(sc-d) 
T(sc-d) 
Paraventricular thalamic 
nucleus, middle (PV) 
F(sc-m) 
T(sc-m) 
F(sc-m) 
T(sc-m) 
Paraventricular thalamic 
nucleus, posterior (PVP) 
F(sp-sc) 
T(sp-sc) 
F(sp-sc) 
T(sp-sc) 
Reticular nucleus (Rt) F(sp) F(sp) 
Reuniens thalamic 
nucleus (Re) 
F(sp-sc) 
T(sp) 
F(sp-sc) 
T(sp) 
Xiphoid nucleus (Xi) F(sc-m) 
T(sc-m) 
F(sc-m) 
T(sc-m) 
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Table 3.5: Vasopressin-ir fibers in the mesencephalon 
  Summary of vasopressin-ir fibers throughout the mesencephalon.  
Data are grouped by region and then by sensitivity to steroids.  Vasopressin 
immunoreactivity either decreased or did not change following 
gonadectomy (GDX).  A qualitative increase in vasopressin-ir fibers was not 
observed in any area.  In the intact and GDX columns, letters indicate the 
relative density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered; 
m, moderate; d, dense; -0-, no fibers observed. 
 
PAG and
dorsal raphe Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Commissure of the 
superior colliculus (csc) 
F(sp-sc) 
T(sp-sc) 
F(sp) 
Dorsal raphe, caudal 
(DRC) 
F(sp-m) 
T(sp-m) 
F(sp-m) 
Dorsal raphe, dorsal 
(DRD) 
F(sp-d) 
T(sp-d) 
F(sp-sc) 
Dorsolateral PAG 
(DLPAG) 
F(sp-sc) 
T(sp-sc) 
F(sp-sc) 
Dorsomedial PAG 
(DMPAG) 
F(m-d) 
T(m-d) 
F(sp-sc) 
Periaqueductal gray, 
rostral (PAG) 
F(sp-sc) 
T(sp) 
F(sp-sc) 
Ventrolateral dorsal raphe 
(DRVL) 
F(m-d) 
T(m-d) 
F(sp-sc) 
Ventrolateral PAG 
(VLPAG) 
F(sc-d) 
T(sp-sc) 
F(sc-d) 
No Change in Vasopressin Immunoreactivity 
Dorsal raphe, 
interfascicular (DRI) 
F(sp-sc) F(sp-sc) 
Dorsal raphe, ventral 
(DRV) 
F(sp-sc) 
 
F(sp-sc) 
Lateral PAG (LPAG) F(sp-sc) F(sp-sc) 
 
Tegmentum Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Caudal linear raphe (CLi) (Fsp-m) F(sp-sc) 
Interfascicular nucleus 
(IF) 
F(sc-d) 
T(sc-d) 
F(sp) 
Medial retromammillary 
nucleus (RMM) 
F(sp-sc) 
T(sp-sc) 
F(sp) 
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Table 3.5: Vasopressin-ir fibers in the mesencephalon (continued) 
 
Tegmentum
Cont. Intact GDX
Parabrachial pigmented 
nucleus of the VTA 
(PBP) 
F(sp-sc) 
T(sp) 
F(sp-sc) 
Parainterfascicular 
nucleus (PIF) 
F(sp-d) 
T(sp-d) 
F(sp-sc) 
Retrorubral field (RRF) F(sp-m) 
T(sp-m) 
F(sp-sc) 
Substantia nigra pars 
compacta (SNC) 
F(sc-m) 
T(sp-m) 
F(sp-sc) 
Substantia nigra, lateral 
part (SNL) 
F(sc-m) 
T(sp-m) 
F(sp-sc) 
Substantia nigra pars 
reticulata (SNR) - 
ventromedial tip 
F(sp-sc) 
T(sp-sc) 
F(sp) 
Ventral tegmental area 
(VTA) 
F(sc-m) 
T(sc-m) 
F(sp-sc) 
No Change in Vasopressin Immunoreactivity 
Barrington's nucleus 
(Bar) 
F(sc-m) 
 
F(sc-m) 
 
Lateral parabrachial 
(LPB) 
F(sc-m) F(sc-m) 
Locus coeruleus (LC) F(sc-m) F(sc-m) 
Medial parabrachial 
(MPB) 
F(sp-sc) F(sp-sc) 
Midbrain reticular 
formation (mRt) 
F(sp-sc) F(sp-sc) 
Parasubthalamic nucleus 
(PSTh) 
F(sp-sc) F(sp-sc) 
Peripeduncular nucleus 
(PP) 
F(sp) F(sp) 
Rostral linear raphe (RLi) F(sp) F(sp) 
Subthalamic nucleus 
(STh) 
F(sp) 
 
F(sp) 
Zona incerta (ZI) F(sc) F(sc) 
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Table 3.6: Vasopressin-ir fibers in the metencephalon and myelencephalon 
  Summary of vasopressin-ir fibers throughout the metencephalon 
and Myelencephalon.  Data are grouped by region and then by sensitivity to 
steroids.  Vasopressin immunoreactivity either decreased or did not change 
following gonadectomy (GDX).  A qualitative increase in vasopressin-ir 
fibers was not observed in any area.  In the intact and GDX columns, letters 
indicate the relative density of staining: F, fibers; T, terminals; sp, sparse; 
sc, scattered; m, moderate; d, dense; -0-, no fibers observed. 
 
Metencephalon Intact GDX
Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity 
Anterior tegmental 
nucleus (ATg) 
F(sp-sc) 
T(sp-sc) 
-0- 
Median raphe (MnR) F(sp-sc) 
T(sp-sc) 
-0- 
 
Myelencephalon Intact GDX
No Change in Vasopressin Immunoreactivity 
Gigantocellular reticular 
nucleus, alpha part (GiA) 
F(sp-sc) F(sp-sc) 
Gigantocellular reticular 
n., ventral part (GiV) 
F(sp-sc) F(sp-sc) 
Intermediate reticular 
formation (IRt)
F(sp-sc) F(sp-sc) 
Lateral reticular n. (LRt) F(sp-m) F(sp-m) 
Parvicellular reticular n., 
alpha part (PCRtA) 
F(sp) F(sp) 
Raphe interpositus 
nucleus (RIP)
F(sp) 
 
F(sp) 
 
Raphe magnus nucleus 
(RMg) 
F(sp-sc) 
 
F(sp-sc) 
 
Raphe obscurus nucleus 
(ROb) 
F(sp) F(sp) 
Raphe pallidus nucleus 
(RPa) 
F(sp-sc) F(sp-sc) 
Spinal trigeminal n., 
caudal part (Sp5C) 
F(sp-m) F(sp-m) 
Solitary nucleus (Sol) F(sc-d) F(sc-d) 
Subcoeruleus nuclei 
(SubC) 
F(sp) F(sp) 
Supermedullary vellum 
(SMV) 
F(sp) 
 
F(sp) 
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3.5  Figure legends 
 
Figure 3.1: Regions chosen for quantitative analysis 
 All regions analyzed were chosen based on characteristic corresponding to atlas 
images images from The Mouse Brain (Franklin and Paxinos, 2008).  Modified images 
from that atlas are used to illustrate regions analyzed.  Location associated figure (graph) 
is given for each area. 
 2Cb, lobule 2 of the cerebellar vermis; 3V, 3rd ventricle; 4V, 4th ventricle; ac, 
anterior commissure; Aq, aqueduct; cp, cerebral peduncle; D3V, dorsal 3rd ventricle; f, 
fornix; fr, fasciculus retroflexus; ic, internal capsule; IPF, interpeduncular fossa; LV, 
lateral ventricle; mcp, middle cerebellar peduncle; ml, medial lemniscus; mlf, medial 
longitudinal fasciculus; MRe, mammillary recess of the 3rd ventricle; mt, 
mammillothalamic tract; opt, optic tract; pm, principal mammillary tract; scp, superior 
cerebellar peduncle; sm, stria medullaris; SNR, substantia nigra, reticular part; ts, 
tectospinal tract; xscp, decussation of the superior cerebellar peduncle 
 
A)  i. medioventral BNST ..................................................................................3.3A 
 ii. median preoptic nucleus ..........................................................................3.5A 
 iii. vascular organ of the lamina terminalis..................................................3.5A 
 iv.  medial preoptic area...............................................................................3.5A 
B) i.  lateral septum, intermediate........................................................................3.2 
 ii. lateral septum, ventral.................................................................................3.2 
 iii. anteromedial BNST ................................................................................3.3A 
C) i. medioventral BNST ..................................................................................3.3A 
 ii. medial part of medial preoptic nucleus....................................................3.5B 
D) i. lateral septum, caudal ..................................................................................3.2 
E) i. lateroventral BNST...................................................................................3.3A 
 ii. medial part of medial preoptic nucleus....................................................3.5B 
F) i. medial part of medial preoptic nucleus.....................................................3.5B 
G) i. medial posteromedial BNST.....................................................................3.3B 
H) i. medial posterolateral BNST......................................................................3.3B 
 ii. anterior paraventricular nucleus ..............................................................3.6A 
I) i. anterior paraventricular nucleus, dorsal....................................................3.6A 
 ii. mediodorsal thalamus, rostral..................................................................3.6C 
 iii. paratenial thalamus .................................................................................3.6B 
 iv. anterior paraventricular thalamus. ventral ..............................................3.6A 
J) i. nucleus of the stria medullaris ..................................................................3.3B 
 ii. extended amygdala, rostral ......................................................................3.4A 
 iii. peduncular lateral hypothalamaus ..........................................................3.5D 
 iv. anterior hypothalamus, anterior ..............................................................3.5C 
J) i. peduncular lateral hypothalamus ..............................................................3.5D 
 ii. anterior hypothalamus, central.................................................................3.5C 
 iii. subparaventricular zone.......................................................................... 3.5E 
K) i. extended amygdala ...................................................................................3.4A 
 ii. anterodorsal medial amygdala .................................................................3.4C 
 iii. anterior cortical amygdala ......................................................................3.4B 
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L) i. paraventricular thalamus...........................................................................3.6D 
 ii. mediodorsal thalamus ..............................................................................3.6C 
 iii. central medial thalamus .......................................................................... 3.6E 
M) i. mediodorsal thalamus ...............................................................................3.6C 
 ii. paraventricular thalamus..........................................................................3.6D 
 iii. central medial thalamus ......................................................................... 3.6E 
N) i. peduncular lateral hypothalamus ..............................................................3.5D 
 ii. anterior hypothalamus, central.................................................................3.5C 
O) i. mediodorsal thalamus ...............................................................................3.6C 
 ii. paraventricular thalamus..........................................................................3.6D 
 iii. central medial thalamus .......................................................................... 3.6E 
P) i. tuberal lateral hypothalamus..................................................................... 3.5F 
 ii. periventricular nucleus............................................................................. 3.5E 
 iii. retrochiasmatic nucleus ..........................................................................3.5H 
Q) i. basomedial amygdala................................................................................ 3.4E 
 ii. anterodorsal medial amygdala .................................................................3.4C 
 iii. anterior cortical amygdala ......................................................................3.4B 
 iv. anteroventral medial amygdala...............................................................3.4D 
R) i. tuberal lateral hypothalamus..................................................................... 3.5F 
S) i. lateral habenula ......................................................................................... 3.6F 
 ii. interanterodorsal thalamus....................................................................... 3.6E 
T)  i. dorsomedial hypothalamus .......................................................................3.5G 
U) i. ventral basolateral amygdala .................................................................... 3.4E 
 ii. posterodorsal medial amygdala ............................................................... 3.4F 
 iii. posteroventral medial amygdala.............................................................3.4D 
V) i. lateral habenula ......................................................................................... 3.6F 
W) i. peduncular lateral hypothalamus ..............................................................3.5D 
 ii. dorsomedial hypothalamus ......................................................................3.5G 
 iii. tuberal lateral hypothalamus................................................................... 3.5F 
X) i. posterodorsal medial amygdala ................................................................ 3.4F 
Y) i. lateral habenula ......................................................................................... 3.6F 
Z) i. posterior basolateral amygdala ................................................................. 3.4E 
 ii. posterodorsal medial amygdala ............................................................... 3.4F 
AA) i. medial retromammillary nucleus ............................................................... 3.5I 
 ii. ventral premammillary nucleus ...............................................................3.5H 
 iii. perifornical lateral hypothalamus ...........................................................3.5H 
BB)  i. medial retromammillary nucleus ............................................................... 3.5I 
 ii. ventral tuberomammillary nucleus ..........................................................3.5H 
CC) i. substantia nigra pars reticulata..................................................................3.7D 
 ii. ventral tegmental area..............................................................................3.7D 
 iii. interfascicular nucleus ............................................................................ 3.7E 
 iv. medial retromammillary nucleus ............................................................. 3.5I 
DD) i. interfascicular nucleus .............................................................................. 3.7E 
 ii. parainterfascicular nucleus ......................................................................3.7D 
EE)  i. dorsomedial periaqueductal gray ..............................................................3.7A 
FF) i. midbrain reticular formation..................................................................... 3.7F 
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GG) i. interfascicular nucleus .............................................................................. 3.7E 
HH) i. anterior tegmental nucleus ...........................................................................3.8 
II)  i. ventrolateral periaqueductal gray..............................................................3.7B 
 ii. dorsolateral raphe nucleus .......................................................................3.7C 
JJ) i. median raphe nucleus...................................................................................3.8 
KK) i. ventrolateral periagueductal gray..............................................................3.7B 
 ii. dorsal raphe, dorsal part...........................................................................3.7C 
LL) i. ventrolateral periaqueductal gray..............................................................3.7B 
 ii. dorsal raphe, caudal .................................................................................3.7C 
 iii. lateral parabrachial nucleus .................................................................... 3.7F 
 iv. medial parabrachial nucleus.................................................................... 3.7F 
 
Figure 3.2: Quantitative results:  Lateral septum 
 Significant main effects are shown with labeled bars.  In cases where post-hoc 
tests were carried out, letters are used to illustrate significant differences between groups 
(p < 0.05).  Different letters indicate group differences.   
 
Figure 3.4: Quantitative results:  Amygdala 
 Significant main effects are shown with labeled bars.  In cases where post-hoc 
tests were carried out, letters are used to illustrate significant differences between groups 
(p < 0.05).  Different letters indicate group differences.   
 
Figure 3.5: Quantitative results:  Hypothalamus 
 Significant main effects are shown with labeled bars.  In cases where post-hoc 
tests were carried out, letters are used to illustrate significant differences between groups 
(p < 0.05).  Different letters indicate group differences.   
 
Figure 3.6: Quantitative results:  Thalamus 
 Significant main effects are shown with labeled bars.  In cases where post-hoc 
tests were carried out, letters are used to illustrate significant differences between groups 
(p < 0.05).  Different letters indicate group differences.   
 
Figure 3.7: Quantitative results:  Mesencephalon 
 Significant main effects are shown with labeled bars.  In cases where post-hoc 
tests were carried out, letters are used to illustrate significant differences between groups 
(p < 0.05).  Different letters indicate group differences.   
 
Figure 3.8: Quantitative results:  Metencephalon 
 Significant main effects are shown with labeled bars.  In cases where post-hoc 
tests were carried out, letters are used to illustrate significant differences between groups 
(p < 0.05).  Different letters indicate group differences.   
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Figure 3.1: Regions chosen for quantitative analysis
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
GG HH
II JJ
KK LL
i
ii
iii
iv
i
i
i
i
i
ii
ii
cp
ml
xscp
ts
Aq
2Cb
mlf
scp
4V
mcp
mlf
mlf
scp
mlf
Aq
ts
134
Figure 3.2: Quantitative results - Lateral septum
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Figure 3.3:  Quantitative results - BNST
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Figure 3.5: Quantitative results - Hypothalamus
139
DE
F
Figure 3.5: Quantitative results - Hypothalamus (Continued)
140
GH
I
Figure 3.5: Quantitative results - Hypothalamus (Continued)
141
AB
C
Figure 3.6: Quantitative results - Thalamus
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Figure 3.7: Quantitative results - Mesencephalon (Continued)
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Figure 3.8: Quantitative results - Metencephalon
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CHAPTER 4 
INTRACRANIAL STEROID IMPLANTS AS AN ANATOMICAL TOOL 
 
4.1  Introduction 
 Vasopressin neurons in the BNST and MeA project to numerous distinct areas 
throughout the brain.  Many of these projections are sexually dimorphic and project to 
brain regions implicated in the control or modulation of social behavior (reviewed briefly 
in CHAPTER 3).  Using the steroid-dependent nature of neurons in the BNST and MeA, 
we have identified a subset of brain regions innervated by these two nuclei, creating a 
more well-defined picture of the telencephalic vasopressin system as a whole.  However, 
delineation of the independent projections of the BNST and MeA remains to be 
elucidated. 
 In the rat, the BNST and MeA are both sensitive to circulating gonadal steroid 
hormones, and gonadectomy results in a loss of immunoreactivity in their projections (de 
Vries et al., 1984; De Vries and al-Shamma, 1990; De Vries et al., 1994).  A similar 
gonadal steroid dependence is likely for the BNST and MeA of the mouse.  Thus other 
approaches must be taken to isolate each region's independent subset of projection sites.  
One such approach used with some success historically is brain lesions.  In particular, 
large unilateral electrolytic lesions of the medial amygdala eliminated vasopressin 
immunoreactivity in the ventral hippocampus and decreased immunoreactivity in the 
lateral septum (Caffe et al., 1987).  In addition, these lesions did not appear to impact 
vasopressin immunoreactivity in the lateral habenula, mediodorsal thalamus, ventral 
tegmental area, central gray, dorsal raphe nuclei, or locus coeruleus (Caffe et al., 1987).  
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Unilateral electrolytic lesions of the BNST in rats led to a decrease in vasopressin 
immunoreactivity in the lateral septum, ventral diagonal band, anterior amygdala, lateral 
habenula, periventricular gray and locus coeruleus (De Vries and Buijs, 1983). One 
caveat with electrolytic lesions is the destruction of fibers of passage.  This is especially 
poignant when discussing the BNST and MeA, which share extensive bidirectional 
projections (Simerly, 2002; Cooke and Simerly, 2005).  Thus vasopressin-ir fibers 
passing through either of these areas would be damaged during lesioning and site of 
origin could be misinterpreted.  This caveat could be avoided by using excitoxic lesions, 
which spare fibers of passage.  However, vasopressin cells in the BNST, especially, are 
spread across a large region.  In order to kill the correct cells, a large region must be 
damaged, and the potential for spread of neurotoxin would be high. 
 Given the potential problems with using lesions to determine BNST and MeA 
projections, we returned to the idea that the steroid sensitivity of BNST or MeA neurons 
can be manipulated.  Even though gross hormone manipulations, such as gonadectomy, 
would not be effective for sorting projections of the medial amygdala and BNST, we 
reasoned that hormones delivered locally could rescue vasopressin immunoreactivity in 
one nucleus (i.e., BNST or MeA) without affecting the other in a gonadectomized animal.  
Previous research showed that testosterone melted into a cannula aimed at the BNST is 
able to restore vasopressin gene expression unilaterally in the BNST as measured by 
vasopressin mRNA expression (Brot et al., 1993).  In another study carried out in musk 
shrews, local steroid implants made of steroid hormone, bone wax, and graphite were 
placed in specific brain regions in order to examine regional effects of hormones on sex 
 
 
148
behavior.  In this experiment, spread of hormone was demonstrated to be local and 
unilateral at one week following implantation (Veney and Rissman, 2000). 
 In the current study, we used steroid hormone implants similar to those used by 
Veney and Rissman (2000) in an attempt to selectively restore vasopressin expression to 
the BNST following long-term gonadectomy.  We predicted that steroid hormones 
delivered directly to the BNST would result in a restoration of vasopressin 
immunoreactivity in a subset of fibers known to be innervated by the BNST or MeA.  
Surprisingly testosterone proprionate implants did not restore vasopressin 
immunoreactivity after a survival time of four weeks post-implantation.  This unforeseen 
result forced us to reevaluate our implant strategy.  Below we chronicle the work carried 
out to optimize the implantation of steroid hormones in the BNST. 
4.2  Methods 
4.2.1  Animals 
 Male C57BL6 mice were studied in this experiment.  Animals were derived from 
a breeding colony at the University of Massachusetts.  Following weaning, animals were 
group-housed (5 or less per cage) with same-sex siblings under a 14:10 light cycle with 
lights on at 6:00 am.  Animals had ad libitum access to food and water.  All procedures 
conformed to NIH guidelines and were in accordance with a protocol approved by the 
University of Massachusetts. 
4.2.2  Gonadectomy surgeries 
 At approximately 60 days of age, animals underwent bilateral gonadectomy.  
Surgical procedures were similar to those described above (see CHAPTER 3.2.2). 
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4.2.3  Intracranial implants 
 Animals were anesthetized with 2% isoflurane (Halocarbon Laboratories, River 
Edge, NJ) prior to being placed in a Kopf stereotaxic apparatus and received 2% 
isoflurane for the duration of the surgery.  After exposing the skull, a hole was drilled at 
0.1 mm to the right of the midline and 0.03mm caudal to bregma (Experiment 1) or 0.09 
mm to the right and 0.05mm (Experiments 3a-3c).  A 26 gauge stainless steel cannula 
that projected 4 mm below a plastic pedestal (Plastics One, Roanoke, VA) was used to 
deliver implants.  Implants were a mix of bone wax (Lukens, Reading, PA), graphite, and 
steroid hormone (implant specifications are given below with experimental designs).  To 
place the implant, the cannula was lowered until the pedestal touched the skull, and a 33 
gauge inner cannula, which projected 1mm past the end of the guide, was used to 
dislodge the implant from the guide.  Immediately after placing the implant, the guide 
and inner cannula were removed, the hole in the skull was patched with bone wax, and 
the wound was sutured closed.  Animals received an injection of buprenorphine (0.05 
mg/Kg; Bedford Laboratories, Bedford, OH) immediately following surgery. 
4.2.4  Subcutaneous implants 
 Animals were anesthetized with 2% isoflurane throughout the procedure.  Briefly, 
a small incision was made at the nape of the neck and a small silicone implant containing 
either testosterone or estradiol (implant specifications are given below with experimental 
designs) was placed under the skin.  The wound was closed with a surgical staple.  
Animals received an injection of buprenorphine (0.05 mg/Kg ) immediately following 
surgery. 
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4.2.5  Tissue collection and processing 
 One to four weeks following implant surgery, animals were sacrificed using CO2 
asphyxiation followed by rapid decapitation.  For immunohistochemistry, brains were 
removed rapidly and placed in 5% acrolein in 0.1 M phosphate buffer.  Fixation lasted for 
four hours at which time brains were transferred to 30% sucrose in 0.1M phosphate 
buffer and stored at 4° C until sectioning.  Brains were sectioned in the coronal plane at 
30 m using a freezing microtome, and every third section was collected and stored in 
cryoprotectant at -20° C prior to vasopressin immunohistochemistry.  In addition, an 
alternate series of sections were mounted on gel coated slides, allowed to dry at least 
overnight, and Nissl stained.  For in situ hybridization (Experiment 3c), brains were 
removed rapidly and placed in 2-methyl butane, which had been stored on dry ice, for 
approximately 10 sec and then stored at -80° C until sectioning.  Brains were sectioned in 
the coronal plane at 20 m using a cryostat.  Every third section was collected and stored 
at -80° C until processing for vasopressin in situ hybridization. 
4.2.6  Nissl staining 
 Nissl staining methods are identical to those described in CHAPTER 2.2.3 
4.2.7  Immunohistochemistry 
 Immunohistochemical methods used in this experiment are identical to those 
described in CHAPTER 2.2.4 except the antibody used was from a new lot and a 
concentration of 1:8000 was used. 
4.2.8  In situ hybridization 
 Prior to hybridization, slides were soaked in the following rinses under gentle 
agitation: 1) 4% paraformaldehyde in 0.1M sodium phosphate buffer at 4° C for 15 min; 
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2) 0.1M phosphate buffered saline at 4° C for 2 min; 3) 0.1M triethanolamine buffer (pH 
8.0) for 1 min at room temperature (remainder of rinses were done at room temperature 
also); 4) 0.1M triethanolamine buffer (pH 8.0) with 2.5ul / ml acetic anhydride for 10 
min; 5) 2x standard sodium citrate buffer (SSC, 0.3 M sodium chloride and 0.03 M 
sodium citrate in distilled water, pH 7.0) for 1 min; 6) 70% ethanol for 2 min; 7) 100% 
ethanol for 2 min; 8) chloroform for 5 min; 9) 100% ethanol for 2 min  Hybridization was 
carried out by adding 60 l of [35S] labeled probe in hybridization buffer (50% 
formamide, 10% dextran sulfate, 0.3M NaCl, 10mM Tris, 1mM  EDTA, 1x Denhardt’s 
solution, 10 mM dithiothreitol) to each slide, covering the mixture with parafilm, and 
incubating it at 37° C for 18 hours.  All solutions for pre-hybridization steps were made 
with DEPC-treated water.  Following hybridization, slides were dipped in 1x SSC to 
remove parafilm and hybridization buffer.  Sections were rinsed in 1x SSC for 4 x 15 min 
at 55° C.  Subsequent rinses were done at room temperature in the following order: 1) 1x 
SSC for 3 x 35 min; 2) 70% ethanol for 2 min; 3) 95% ethanol for 2 min; 4) 100% 
ethanol for 2 min.    
 After verifying the hybridization by placing test slides against film, slides were 
dipped in emulsion (NTB2, Kodak, Rochester, NY) and preheated for 1 hour in a 42° C 
water bath.  Once slides were dry, they were stored at 4° C in light tight boxes containing 
desiccant capsules.  Twenty-four days later, slides were developed in the following 
solutions at 14° C: 1) Dektol-19 developer (Kodak, Rochester, NY) for 2 min; 2) distilled 
water for 30 seconds; 3) fixer (Kodak, Rochester, NY) for 5 min; 4) distilled water for 5 
min.  Brain sections were then counterstained with methyl green: 1) slides were rinsed 
under running water for 3 min; 2) 2% methyl green for 30 seconds; 3) running water for 1 
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min; and 4) 2 rapid dips into 50% ethanol.  Finally, slides were coverslipped using 
Cytoseal (Richard Allen Scientific, Kalamazoo, MI).  
4.2.9  Experimental designs 
4.2.9.1  Experiment 1 
 Between 15 and 18 weeks following gonadectomy, animals received either 
testosterone proprionate (TP; Sigma-Aldrich, St. Louis, MO) or control intracranial 
implants.  TP implants were made from bone wax, graphite, and TP (3:1:1 by weight).  
Control implants contained bone wax and graphite (3:1 by weight).  After mixing, the 
wax mixture was pressed thin between two glass slides.  Implant pellets were formed by 
tapping a cannula into the wax five times. 
 Animals were euthanized at either two (n=4 TP and n=2 control) or four weeks 
(n=4 TP and n=2 control) following implant surgery.  Brains were collected and 
processed for vasopressin immunohistochemistry as described above. 
4.2.9.2  Experiment 2  
 Fifteen weeks following gonadectomy, animals received subcutaneous implants 
of either testosterone (T) or estradiol (E2).  T implants were made from silicone tubing 
(0.062” ID / 0.125” OD, Helix Medical, Carpinteria, CA), totaled 7 mm in length, were 
loaded with 3mm of T (Sigma-Aldrich, St. Louis, MO), and sealed with medical grade 
silicone adhesive (Dow Corning, Midland, MI).  E2 implants were made from Silastic 
tubing (1.57mm ID / 2.41mm OD, Dow Corning, Midland, MI), totaled 9 mm in length, 
were packed with 5 mm of a 1:1 mixture of 17- estradiol and cholesterol, and sealed 
with medical grade silicone adhesive (Dow Corning, Midland, MI). 
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 Animals were euthanized at either one (n=2 T and n=2 E2), two (n=2 T and n=2 
E2), or four weeks (n=2 T and n=2 E2) following implant surgery.  Brains were collected 
and processed for vasopressin immunohistochemistry as described above.   
4.2.9.3  Experiment 3a 
Twenty weeks following gonadectomy, animals received either E2 or control 
intracranial implants.  E2 implants were made from bone wax, graphite, and E2 (3:2:1 by 
weight).  Control implants contained bone wax and graphite (3:2 by weight).  After 
mixing, the wax mixture was pressed thin between two glass slides.  Implant pellets were 
formed by tapping a cannula into the wax five times. 
 Animals were euthanized four weeks following implant surgery (n=6 E2 and n=2 
control).  Brains were collected and processed for vasopressin immunohistochemistry as 
described above.   
4.2.9.4  Experiment 3b 
 Twenty weeks following gonadectomy, animals received E2 intracranial implants.  
E2 implants were made as described in experiment 3a except pellets were formed by 
tapping a cannula a single time into the wax mixture. 
 Animals were euthanized one week following implant surgery (n=3 E2).  Brains 
were collected and processed for vasopressin immunohistochemistry as described above.   
4.2.9.5  Experiment 3c 
 Twelve months following gonadectomy, animals received either concentrated or 
dilute E2 intracranial implants.  E2 implants were made from bone wax, graphite, and E2 
(3:2:1 by weight for concentrated pellets and 3:2:0.1 by weight for dilute implants).  
Implant pellets were formed by tapping a cannula into the wax mixture a single time. 
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 Animals were euthanized two weeks following implant surgery (n=3 E2).  Brains 
were collected and processed for either vasopressin immunohistochemistry (n=1 
concentrated ( 3:2:1) E2 and n=2 dilute (3:2:0.1) E2) or vasopressin in situ hybridization 
(n=2 concentrated ( 3:2:1) E2 and n=4 dilute (3:2:0.1) E2) as described above. 
4.3  Results and Conclusions 
4.3.1  Experiment 1: Intracranial TP implants 
 As expected animals receiving control implants did not have any small caliber 
fibers in the lateral septum, mediodorsal thalamus, or lateral habenula.  In each case 
implants were located near the BNST (Figure 4.1).  TP was expected to cause an increase 
in small vasopressin-ir fibers in the lateral septum, mediodorsal thalamus, and lateral 
habenula; however, only a tiny fraction of normal immunoreactivity was restored.  All TP 
implants were located directly adjacent to or near the BNST (Figure 4.1).  Animals killed 
at both 2 weeks and 4 weeks had a few small faint fibers in the three areas examined.  
However, as quantitative measures of vasopressin-ir fiber density for the caudal lateral 
septum show, none of the males had a fiber density that reached the minimum for intact 
males (see Figure 4.2 for data and photomicrographs).  Data for intact males were 
obtained from experiments described in CHAPTER 3.  The most impressive subject had 
only lightly stained fibers in the lateral septum (Figure 4.2C), lateral habenula, and 
mediodorsal thalamus.   
 Although a small amount of immunoreactivity was observed following implant 
surgery at both two and four weeks, it was not enough to provide conclusive evidence of 
BNST derived projections throughout the brain, which was the intended goal.  This 
limited effect raised the question, "Why did the TP not adequately increase vasopressin 
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production?"  Several explanations could have led to our results.  It may not be possible 
to completely reestablish vasopressin production after long-term castration in mice.  
Alternatively, the release of steroid from the pellet may have been inadequate or too fast 
(i.e., removed from the system too quickly).  Finally, it is possible that TP was not 
efficiently converted to estrogens in long-term gonadectomized animals, which is 
required for vasopressin production (De Vries et al., 1994). 
 In subsequent experiments, we attempted to address some of these possibilities.  
First, we used subcutaneous hormone implants to see if we could actually reinstate 
adequate levels of vasopressin production after long-term castration.  Second we 
attempted to stimulate vasopressin production with E2 implants placed directly in the 
BNST.  The results of these experiments are given below. 
4.3.2  Experiment 2: Subcutaneous T or E2 implants 
 Both T and E2 rescued vasopressin immunoreactivity at 1, 2, and 4 weeks 
following subcutaneous capsule implantation (Figure 4.3).  However, the amount of 
immunoreactivity was quite low at 1 week.  In fact, vasopressin-ir fiber density analysis 
of the caudal lateral septum indicates that immunoreactivity at one week was lower than 
the lowest intact male in a previous study (Figure 4.3G).  T treated animals appeared to 
be within a normal range by 2 weeks following implantation.  E2 animals had less 
immunoreactivity at 2 weeks, but were similar to T treated animals by 4 weeks.   
 Based on these results, we concluded that both T and E2 have the ability to rescue 
vasopressin immunoreactivity in fibers of the lateral septum two weeks following steroid 
exposure.  Therefore we know that long term gonadectomy does not eliminate the 
capability of vasopressin neurons to make protein in response to hormones. 
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 However, we still cannot conclude whether or not TP would have acted 
differently than T, and we still cannot determine whether intracranial implants would be 
as effective as a subcutaneous implant.  However, because E2 was also able to reinstate 
fiber immunoreactivity and is the hormone most directly responsible for vasopressin 
expression (De Vries et al., 1994), we decided to test the effectiveness of intracranial E2 
implants in order to resolve the question about the efficacy of intracranial implants. 
4.3.3  Experiment 3a: Large E2 implants in the BNST 
 All animals that received E2 implants had vasopressin fibers in the lateral septum 
and mediodorsal thalamus four weeks following implantation (Figure 4.6B).  The two 
control animals did not have any vasopressin-immunoreactivity in the septum or 
mediodorsal thalamus (Figure 4.5A).  A few of the implants were located in the thalamus 
at the caudal end of the PVN (Figure 4.4).  Because these subjects still had 
immunoreactivity in the LS, the implants likely supplied high doses of E2 that had a large 
diffusion range.  In experiment 3b, we implanted subjects with a 1-tap pellet as opposed 
to the 5-tap pellet used in the current experiment. 
4.3.4  Experiment 3b: Small E2 implants in the BNST 
 All three subjects had E2 implants that were located in or adjacent to the BNST 
(Figure 4.4).  Despite the short one week survival period all subjects had vasopressin-ir 
fibers in the lateral septum and mediodorsal thalamus (Figure 4.6C).  However no 
qualitative difference was observed between the side ipsilateral and contralateral to the 
implant.  Therefore, we believe that the spread of E2 was still too large.  In experiment 
3c, we implanted subjects with a 10-fold lower dose of E2 in a 1-tap implant.   
 
 
 
157
4.3.5  Experiment 3c: Dilute, small E2 implants in the BNST 
 Three animals were examined using vasopressin immunohistochemistry.  Six 
other animals were examined using in situ hybridization to examine vasopressin mRNA 
levels.  These subjects had a two week survival period following steroid implantation.  
Subject DB68 received a 3:2:1 implant similar to those in experiment 3b.  This subject 
had vasopressin fibers in the lateral septum, mediodorsal thalamus, medial amygdala, and 
amygdalohippocampal zone.  The other two subjects (DB67 and 71) received 3:2:0.1 E2 
implants.  These animals had qualitatively lighter staining in the lateral septum.  In fact 
the level of vasopressin-ir fiber density was below the lowest intact male from 
CHAPTER 3.  It should be noted that for DB67, the implant was located caudally at the 
level of the dorsomedial hypothalamus.  The fact that there were fibers in the septum at 
all suggests that either the amygdala, which occurs at this level, was actually being 
stimulated, or the spread of hormone was still enough to reach the BNST, which was 
about the same rostral distance from the implant as the amygdala was lateral.  It is 
possible that a better placed implant would be more efficacious.  However, DB68 had an 
implant that, while caudal to the BNST, was still much closer than DB67 and still 
vasopressin immunoreactivity was low in the lateral septum. 
 None of the four subjects receiving 3:2:0.1 implants or the two subjects receiving 
3:2:1 implants had silver grains in parvocellular cells of the BNST.  Cells were observed 
in other nuclei that are not dependent on gonadal steroids such as the PVN, SCN, and 
accessory nuclei.  This result suggests that at two weeks following implantation, the 
implants are no longer providing adequate stimulation to increase vasopressin expression 
in the BNST.  Subsequent studies would be required to examine the time course of 
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estradiol stimulation of vasopressin expression in the BNST.  This result does not conflict 
with immunohistochemical results, as it is known that peptide immunoreactivity is 
present often long after hormones have been removed in the mouse, whereas vasopressin 
mRNA levels decline within one day following hormone removal, gonadectomy (Mayes 
et al., 1988; Miller et al., 1992).  
4.4  Discussion 
 In the current study, we attempted to reinstate vasopressin specifically in the 
BNST by implanting steroid containing micro-implants into the BNST.  In our first 
attempt, testosterone propionate implants failed to stimulate adequate vasopressin 
immunoreactivity at 2 and 4 weeks post-implantation.  Consequently, we implanted 
animals with subcutaneous implants of estradiol or testosterone to show that we could 
actually reinstate vasopresisn immunoreactivity.  In fact, animals had a substantial 
increase, and vasopressin immunoreactivity was similar to intact animals at 2-4 weeks 
post implantation, although immunoreactivity was low at one week.  Knowing that we 
could reinstate vasopressin immunoreactivity, we then implanted estradiol implants.  
Estradiol implants were able to raise vasospressin immunoreactivity to intact levels at 4 
weeks post-implantation.  However, the large concentrated (3:2:1) E2 implants led to 
increases in vasopressin immunoreactivity in BNST and medial amygdala cells both 
ipsilateral and contralateral to the implant site.  We thought that perhaps smaller and less 
concentrated implants would prevent hormone from reaching the medial amygdala.  
Small concentrated pellets were also able to increase vasopressin immunoreactivity even 
at one week and two weeks.  However small dilute implants did not raise vasopressin 
immunoreactivity to intact male levels at two weeks.  In addition, neither dilute nor 
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concentrated small pellets appeared to stimulate vasopressin expression for two full 
weeks as no mRNA positive cells were observed in the BNST after two weeks.  Further 
investigation would be required to determine the actual timecourse of E2 action on 
mRNA expression. 
 Our original goal was to identify vasopressin projections of the BNST versus the 
medial amygdala by selectively stimulating expression of the BNST, but not the medial 
amygdala and eventually the amygdala, but not the BNST.  However, given the extensive 
diffusion of concentrated estradiol implants and the inadequate vasopressin 
immunoreactivity with smaller, less concentrated implants, it appears that this approach 
is unlikely to effectively induce BNST, but not amygdala vasopressin production for our 
purposes.  However, the fact that estradiol implants (even the less concentrated dose) was 
able to affect vasopressin production at all suggests that these types of implants may be 
useful for studies examining functional actions of gonadal hormones on the BNST, but 
not the medial amygdala.  The small implant did increase vasopressin production as seen 
by a small increase in vasopressin immunoreactivity in the lateral septum, but it did not 
increase staining in the hippocampus, which in rats receives input from the amygdala 
(Caffe et al., 1987). 
 Interestingly, at two weeks following intracranial estradiol implantation 
vasopressin immunoreactivity was apparent.  However, vasopressin mRNA expression 
visualized by situ hybridization was not evident in the BNST, although cells were 
observed in hypothalamic nuclei.  This suggests that the steroid hormone estradiol 
maintained expression for only a short time (i.e., less than two weeks).  Further work 
would be required to characterize the time course of estradiol release from the implants.  
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This could be done using vasopressin mRNA expression as a bioassay for steroid 
availability.  In theory, the vasopressin cells in the BNST will produce as long as 
estradiol is present. 
 As stated above, estradiol implants of the type used here are not likely to provide 
reliable data on projections of the BNST or MeA, although others have had success in 
delivering steroids to just the BNST with steroid packed canullae in rats (Brot et al., 
1993).  Other methods may be more effective in pursuing the goal of identifying the 
individual projections of the BNST and MeA.  In particular, classical techniques such as 
tract tracing and brain lesions could be useful despite their caveats.  In particular, large 
lesions are required to get all of the vasopressin cells ruling out excitotoxic strategies, 
bilateral BNST lesions are fatal (De Vries and Buijs, 1983), and electrolytic lesions 
damage reciprocal pathways from the BNST to the MeA (Simerly, 2002; Cooke and 
Simerly, 2005).  Tracing studies also present some unique challenges.  Typically, 
adequate staining of vasopressin cells in the BNST and medial amygdala cannot be 
achieved without colchicine injections making a dual-label tracing-
immunohistochemistry strategy difficult although not impossible (Caffe et al., 1987).  
Despite these caveats lesions have been used successfully in rats (De Vries and Buijs, 
1983; Caffe et al., 1987). 
 One of the rationales for studying the anatomy of the mouse vasopressin system is 
the importance of the mouse model in the use of molecular transgenic and gene targeting 
approaches.  It may be that some of these more molecular tricks will actually allow us to 
completely understand the anatomy.  One molecular tool currently available is a chimeric 
gene that codes for a glucocorticoid receptor / estrogen receptor.  This chimera contains 
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the DNA binding domain of the estrogen receptor and the ligand binding of the 
glucocorticoid receptor (Kaufer et al., 2004).  In rats, this chimeric gene has been 
transfected into brains using viral vectors.  When transfected into the hippocampus, the 
effects of high levels of glucocorticoids fail to cause spatial memory impairment and 
neuronal injury causes less hippocampal damage (Kaufer et al., 2004; Ferguson et al., 
2008).  Presumably, glucocorticoids are acting on protective estrogenic mechanisms due 
to the chimeric protein.  Because vasopressin gene expression in the BNST and MeA is 
most likely controlled by the estrogen receptor (De Vries et al., 1994), it is possible that 
we could use a similar approach with the goal of using ubiquitous glucocorticoids to 
drive expression of vasopressin mRNA in the BNST in long-term gonadectomized 
animals.  Other future alternatives could include vasopressin cell specific targeting 
systems.  Recently, viral vector systems have been created that combine the vasopressin 
gene promoter with a reporter gene in an effort to track region specific gene expression 
dependent upon the vasopressin promoter.  However, at present expression of the reporter 
gene has only been shown in cells of the PVN and SON (Dr. Valery Grinevich, personal 
communications).  Cell-type specific transgenic animals are also a possibility.  However, 
cell-type specific approaches, while interesting, are not currently available or or refined 
enough to answer our questions about BNST versus MeA projections.   
 In summary, intracranial estradiol implants were able to restore vasopressin 
immunoreactivity; however, implants capable of adequately restoring fibers for 
anatomical investigations affected both the BNST and MeA as opposed to just the BNST.  
This suggests that intracranial estradiol implants at present are not a viable method for 
examining the unique projections of the BNST or MeA.  In addition, testosterone 
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propionate implants were unable to adequately restore vasopressin immunoreactivity 
bringing into question the effectiveness of this modified steroid in the brain.  Future 
studies with different techniques, driving vasopressin expression with a chimeric GR / 
ER receptor for example, will be required to delineate the separate projections of these 
brain regions. 
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4.5  Figure legends 
 
Figure 4.1:  Experiment 1 - Implant locations 
 Implant locations for experiment 1 are shown above.  All implants were located 
adjacent to or near the bed nuclei of the stria terminalis.  Bregma coordinates are listed in 
the top left corner of each panel.  Control implants are marked with a "C".  The 
photomicrograph in the bottom right corner shows the implant location for animal DB1, 
which received a control implant.  Diagrams are modified from Franklin and Paxinos 
(2008).  ac, anterior commissure; f, fornix; LV, lateral ventricle; sm, stria medullaris  
 
Figure 4.2:  Experiment 1 - Data and photomicrographs 
 TP implants resulted in only a minimal increase in vasopressin immunoreactivity.  
Photomicrographs above show vasopressin-immunoreactive (-ir) fibers in the caudal 
lateral septum in animals that received control implants and were killed at 2 (A) or 4 (B) 
weeks following implantation.  These animals, as expected, did not have an increase in 
vasopressin fibers.  In addition, some animals received TP implants and were killed at 2 
(C) or 4 (D) weeks following implantation.  Vasopressin-ir fibers were present, but not in 
large quantities.  A scatter plot (E) shows the measured vasopressin-ir fiber density in the 
caudal lateral septum for subjects under each condition.  Each dot represents a single 
subject.  The "Mean" and "Min." lines indicate the mean and minimum values for 
vasopressin-ir fiber density in intact male mice for the same region; these data are from 
animals studied in CHAPTER 3 (see Figure 3.2). 
 
Figure 4.3:  Experiment 2 - Data and photomicrographs 
 Both estradiol (E2) and testosterone (T) subcutaneous implants restored 
vasopressin immunoreactivity to the lateral septum.  However the response was much 
lower at 1 week than at 2 or 4 weeks.  Photomicrographs above show vasopressin-
immunoreactive (-ir) fibers in male mice treated with E2 and killed at 1 (A), 2 (B), or 4 
(C) weeks following implantation and those treated with T and killed at 1 (D), 2 (E), or 4 
(F) weeks following implantation.  A scatter plot (G) shows the measured vasopressin-ir 
fiber density in the caudal lateral septum for subjects under each condition.  Each dot 
represents a single subject.  The "Mean" and "Min." lines indicate the mean and 
minimum values for vasopressin-ir fiber density in intact male mice for the same region; 
these data are from animals studied in CHAPTER 3 (see Figure 3.2).  At 1 week, 
vasopressin-ir fibers were fewer than in intact male mice, but by 2 and 4 weeks post-
implantation values were within the normal range. 
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Figure 4.4: Experiment 3 - Implant locations 
 Implant locations for experiment 3 are shown above.  Implants were not as 
consistently located as in experiment 1.  Some implants were located near the caudal 
BNST (Bregma -0.34), but others were as far caudal as the dorsomedial hypothalamus 
(Bregma -1.34).  Bregma coordinates are listed in the top left corner of each panel.  The 
particular experiment that each animal belonged to is demarcated by the letters "a-c" 
except for numbered implants, which correspond to particular animals for which 
photomicrographs of the caudal lateral septum are shown in Figures 4.5A-D.  Diagrams 
are modified from Franklin and Paxinos (2008).  3V, third ventricle; DM, dorsomedial 
hypothalamus; EP, entopeduncular nucleus; f, fornix; ic, internal capsule; LV, lateral 
ventricle; PVN, paraventricular hypothalamus; sm, stria medullaris  
 
Figure 4.5: Experiment 3 - Data and photomicrographs 
 Large, concentrated estradiol implants (B) restored vasopressin immunoreactivity, 
while control implants (A) had no effect.  Small, concentrated implants (C) were also 
able to increase vasopressin immunoreactivity in a surprisingly short time period (1 
week).  Finally, small, dilute implants (D) were only able to marginally increase 
immunoreactivity, but not to levels of intact males.  Placement of small, dilute implants 
may be a factor as they were well caudal to the bed nuclei, which was their intended 
target.  A scatter plot (E) shows the measured vasopressin-ir fiber density in the caudal 
lateral septum for subjects under each condition.  Each dot represents a single subject.  
The "Mean" and "Min." lines indicate the mean and minimum values for vasopressin-ir 
fiber density in intact male mice for the same region; these data are from animals studied 
in CHAPTER 3 (see Figure 3.2).  Only animals with the large, concentrated implants 
approached the mean value of intact males.    
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CHAPTER 5 
PROJECTIONS OF THE SUPRACHIASMATIC NUCLEUS 
 
5.1  Introduction 
 The suprachiasmatic nucleus (SCN) contains a dense cluster of parvocellular 
neurons that stain darkly for vasopressin immunohistochemistry.  In the mouse, as in the 
rat (Buijs, 1978; Abrahamson and Moore, 2001), vasopressin cells are found in the outer 
shell of the suprachiasmatic nucleus (see Figure 2.3).  These cells are surrounded by a 
dense cloud of fibers and terminals.  Within the coronal plane, many fibers can be seen 
ascending into the subparaventricular zone and some appear to extend farther into the 
paraventricular nucleus (PVN) and thalamus. 
 Prior to the discovery of vasopressin expression in the bed nuclei of the stria 
terminalis (BNST) and medial amygdala (MeA), the SCN was thought to be the site of 
origin for all small caliber vasopressin-immunoreactive (-ir) fibers and associated 
terminal fields (Buijs, 1978; Sofroniew and Weindl, 1978b; de Vries et al., 1981).  
However, lesions of the SCN in the rat resulted in a loss of vasopressin immunoreactivity 
in only a subset of brain regions including the vascular organ of the lamina terminalis, 
dorsomedial hypothalamus, and paraventricular nucleus of the thalamus (Hoorneman and 
Buijs, 1982).  Other regions such as the lateral septum, lateral habenula, and dorsal raphe 
retained their vasopressin innervation.  The subparaventricular zone, which is adjacent to 
the SCN and contains dense terminal fields and small vasopressin-ir fibers was not 
mentioned, however, photomicrographs suggest that this region was damaged in the 
lesion process (Hoorneman and Buijs, 1982).   
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 Retrograde tracing of projections to the lateral septum implicated the BNST even 
though vasopressin expression had not yet been described in this area (De Vries and 
Buijs, 1983).  The SCN and paraventricular nucleus did not appear to project to the 
lateral septum at all suggesting the existence of other vasopressin producing sites 
(Hoorneman and Buijs, 1982; De Vries and Buijs, 1983).  The discovery of parvocellular 
vasopressin-ir cells in the bed nuclei of the stria terminalis and the medial amygdala was 
actually reported around the same time as the tracing and lesion studies (Caffe and van 
Leeuwen, 1983; van Leeuwen and Caffe, 1983).  Lesions of these sites has suggested that 
in fact many of the regions throughout the brain with small caliber fibers and terminal 
fields, including the lateral septum, receive their innervation from the BNST and MeA  
(De Vries and Buijs, 1983; DeVries et al., 1985).  However, even when these sources of 
vasopressin are removed by removing circulating gonadal steroid hormones (e.g., through 
gonadectomy), a diverse set of central vasopressin-immunoreactive (-ir) projections 
remain (DeVries et al., 1985).  Presumably, many of these derive from the SCN. 
 In the current study, we used electrolytic lesions of the SCN to eliminate fibers 
derived from this nucleus.  Lesions were carried out on gonadectomized animals.  
Gonadectomy eliminates immunoreactivity in projections from the BNST and MeA, 
which by decreasing the complexity of the overall vasopressin distribution increases the 
resolution of SCN small caliber fibers.  This made our results much easier to interpret.  
We predicted that lesions to the SCN would eliminate the small fibers and terminal fields 
after remaining after gonadectomy leaving behind only medium to large caliber fibers of 
the PVN, SON and accessory nuclei.  
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5.2  Methods 
5.2.1  Animals 
 Male C57BL6 mice were studied in this experiment.  Animals were derived from 
a breeding colony at the University of Massachusetts.  Following weaning, animals were 
group-housed (5 or less per cage) with same-sex siblings under a 14:10 light cycle with 
lights on at 6:00 am.  Animals had ad libitum access to food and water.  All procedures 
conformed to NIH guidelines and were in accordance with a protocol approved by the 
University of Massachusetts. 
 Fourteen male mice were used in this experiment.  All 14 were gonadectomized.  
After a number of months, 7 animals received lesions of the SCN, and 7 received sham 
lesions. 
5.2.2  Gonadectomy surgeries 
 At approximately 60 days of age, animals underwent bilateral gonadectomy.  
Surgical procedures were similar to those described above (see section 3.2.2). 
5.2.3  Suprachiasmatic nucleus lesions 
 Approximately 8 months following gonadectomy, male mice underwent 
stereotaxic surgery and received either a lesion of the SCN or a sham lesion.  Mice were 
anesthetized with isoflurane (2% isoflurane, Halocarbon Laboratories, River Edge, NJ) 
and positioned in a stereotaxic apparatus.  A hole was drilled at bregma, and a plastic 
coated tungsten electrode was lowered at the midline and 0.1 mm rostral to bregma to a 
depth of 5.5 mm below the dura.  An electrolytic lesion was made by applying a 0.5 mA 
current to the electrode for 20 seconds; no current was applied during sham lesions.  The 
electrode was removed immediately following lesion-making, the hole in the skull was 
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filled with bone wax, and the wound was sutured closed.  All animals were given a single 
injection of buprenorphine (0.05 mg/Kg; Bedford Laboratories, Bedford, OH) 
immediately following surgery. 
5.2.4  Tissue collection and processing  
 Three weeks following stereotaxic surgery, animals were sacrificed using CO2 
asphyxiation followed by rapid decapitation.  Brains were removed rapidly and placed in 
5% acrolein in 0.1 M phosphate buffer.  Fixation lasted for four hours at which time 
brains were transferred to 30% sucrose in 0.1M phosphate buffer and stored at 4° C until 
sectioning.  Brains were sectioned in the coronal plane at 30 m using a freezing 
microtome, and every third section was collected and stored in cryoprotectant at -20° C 
prior to vasopressin immunohistochemistry.  In addition, every third section was mounted 
on gel coated slides, allowed to dry at least overnight, and Nissl stained.   
5.2.5  Nissl staining 
 Nissl staining methods are identical to those described in CHAPTER 2.2.3 
5.2.6  Immunohistochemistry 
 Immunohistochemical methods used in this experiment are identical to those 
described in CHAPTER 2.2.4 except the antibody used was from a new lot a 
concentration of 1:8000 was used. 
5.2.7  Analysis 
 The small number of subjects made a quantitative analysis impractical.  Therefore 
visual inspection was made of each of the animals receiving large SCN lesions as well as 
several control animals.  Qualitative observations are detailed below. 
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5.3  Results 
5.3.1  Location of SCN lesions 
 Seven gonadectomized males received lesions of the SCN.  In two animals the 
lesions were too far caudal resulting in an incomplete lesion of the SCN.  In another 
animal the lesion was quite small damaging vasopressin-ir neurons only at the medial 
part of the SCN.  These three animals were excluded from the study.  Lesions of the 
remaining subjects and one of the sham subjects are depicted in Figure 5.1.  Subjects 
DD33 and DD35, had extensive unilateral lesions with some contralateral damage.  
Subjects DD37 and DD44 had extensive bilateral damage to the SCN.   
5.3.2  Vasopressin immunoreactivity following SCN lesions 
 Sham lesioned animals had vasopressin-ir fibers in similar areas as compared to 
gonadectomized mice described in CHAPTER 3.  The four subjects with large lesions of 
the SCN showed reduction in vasopressin-ir fibers in similar areas.  However, the fiber 
loss in subjects 37 and 44 was more complete.  The remaining fibers in subjects DD33 
and DD35 were mostly unilateral suggesting a more complete lesion on one side than the 
other.  In all cases where immunoreactivity disappears, it is likely there is actually a loss 
of fibers as opposed to just vasopressin.  The lesion of the SCN would destroy cell bodies 
that support the vasopressin containing fibers.  Qualitative observations are summarized 
in Table 5.1.   
 SCN lesions affected only small fibers in the diencephalon and the medial 
posteromedial bed nuclei of the stria terminalis (STMPM; Figure 5.2).  This part of the 
BNST is very close to the rostra-most anterior paraventricular thalamus and some fibers 
could make their way into the STMPM from here. 
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 The small fiber innervation of the diencephalon is most extensive among midline 
nuclei in the thalamus and periventricular nuclei in the hypothalamus.  In cross sections, 
the dense cloud of fibers surrounding the SCN does not appear to spread very far laterally 
and many fibers can be seen extending dorsally (see Figure 2.14).  In sagittal sections 
fibers of the SCN appear to spread out in multiple directions including major rostral, 
dorsal, and caudal projections (see figure 2.14D).  Following SCN lesion a decrease in 
small fibers in the diencephalon was observed.  In fact, a virtual elimination of all small 
fibers and terminal fields throughout the brain was observed in animals that were 
gonadectomized with SCN lesions.   
 In the rostral hypothalamus (i.e., preoptic region), vasopressin immunoreactivity 
disappears from the anteroventricular periventricular region, ventromedial preoptic area, 
striohypothalamic nucleus, and the medial preoptic nucleus (Figure 5.3).  All of these 
nuclei are found adjacent to the third ventricle except the striohypothalamic nucleus, 
which lies slightly more lateral ventral to the fornix.  No qualitative changed was 
observed in regions further forward such as the vascular organ of the lamina terminalis.   
 The SCN is situated at the transition of the anterior hypothalamus and preoptic 
area, and the densest regions of SCN derived vasopressin are found here.  The 
subparaventricular zone (SPa) is easily the densest region as almost all vasopresin-ir 
fibers emanating from the SCN pass through it.  These fibers are eliminated following 
SCN lesions (Figure 5.4); a number of them are destroyed directly by the lesion as well.  
As the fibers ascend through the SPa some appear to stray laterally into the more medial 
parts of the  anterolateral hypothalamus and anterior hypothalamus.  Indeed these these 
regions showed a decrease in vasopressin-ir staining following SCN lesioning as well 
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(Figure 5.4).  Most of these ascending fibers appear to enter the PVN and some continue 
into the thalamus.   
 One of the largest projections of the SCN is the ascending projection that leaves 
the SCN in an anterodorsal path (see Figure 2.14D) and enters the anterior 
paraventricular thalamus (PV; Figure 5.5).  Many fibers can be seen passing through the 
striohypothalamic area and parvicellular paraventricular hypothalamus between the third 
ventricle and the fornix into the thalamus.  There are also a number of fibers that appear 
to cross the midline at this location.  This large ascending projection is mostly confined to 
the anterior PV, although there is some infiltration into the most rostral parts of the 
mediodorsal and paratenial nuclei.  Fibers in all of these locations lose immunoreactivity 
following SCN lesion.  Caudally, as the mediodorsal nucleus becomes prominent there is 
almost no crossover of medial fibers into more lateral regions and all dorsal small 
vasopressin-ir fibers in gonadectomized animals are found in the PV (Figure 5.6).  A few 
small fibers make their way back into the posterior PV as well.  In the ventral thalamus, 
there are small fibers in the xiphoid and reuniens nuclei (Figure 5.7).  These nuclei lie 
dorsal to the PVN, and the fibers that enter them appear to enter via the PVN below.  As 
in other areas, these small fibers disappear following SCN lesions. 
 Finally, some projections of the SCN pass caudally again following the midline.  
Following SCN lesions, fiber immunoreactivity disappears from the arcuate nucleus, 
periventricular area, retrochiasmatic area (Figure 5.8), and the dorsomedial nucleus (DM; 
Figure 5.9).  Some fibers appear to continue through the DM until the level of the 
mammillary bodies as fibers in the dorsal tuberomammillary nucleus disappear as well, 
although this innervation appears slight.  Interestingly, areas that lose vasopressin 
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immunoreactivity often have medium caliber fibers that remain.  This is especially true 
for the DM, which has a moderate innervation of medium fibers even after SCN lesions. 
5.4  Discussion 
 In the current study, we compared gonadectomized animals with or without a 
lesion of the SCN in order to identify the projection sites of this nucleus.  Gonadectomy 
eliminates vasopressin expression in the BNST and MeA causing a subsequent decrease 
in vasopressin immunoreactivity within the projections of those nuclei (de Vries et al., 
1984; DeVries et al., 1985; Mayes et al., 1988; Miller et al., 1992).  This eliminates much 
of the clutter of fibers throughout the brain presumably leaving behind only small caliber 
fibers of the SCN.  Cells from other nuclei have larger caliber fibers.  Thus following 
gonadectomy all remaining small caliber vasopressin-ir fibers should derive from the 
SCN and be eliminated by SCN lesions. This was the case. 
 Interestingly, all of the nuclei that lost vasopressin-ir fibers were located at or near 
the midline.  The only projections ascribed to the SCN with a modest lateral spread of 
small fibers were the medial preoptic nucleus and dorsomedial hypothalamus.  Even the 
projections to the thalamus maintain a strictly midline path innervating the PV and 
xiphoid nuclei most strongly.  By far the densest terminal field that is eliminated by SCN 
lesions is the SPa, which is located just dorsal to the SCN itself.   
 One of the limitations of this study is the small number of subjects.  Only two 
animals had complete lesions of the SCN and even these appeared to have at least a few 
cells that escaped lesion.  This was likely due to a rather modest lesion size as most of the 
lesions hit close enough to destroy part of the SCN on both sides.  In a previous study in 
rats, lesions were much larger extending well into the SPa almost to the PVN.  However, 
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the patterns of fiber loss were similar in each of the four animals examined and likely are 
representative of the population of C57BL6 mice in our colony.  Gonadectomized 
controls that did not have lesions of the SCN had small caliber fibers in only a subset of 
brain regions following gonadectomy.  This subset of brain regions matches well with 
areas where vasopressin was lost in the lesioned animals.   
 Our results mostly corroborate observations made in other species.  Lesions of the 
SCN in rats lead to a decrease in fibers in the paraventricular and dorsomedial 
hypothalmaus as well as the vascular organ of the lamina terminalis (VOLT; (Hoorneman 
and Buijs, 1982)).  In the current study, no or extremely few small fibers made it to the 
OVLT, although fibers do track rostrally in the periventricular region including the 
anteroventral periventricular area and the ventromedial preoptic area.  We describe a 
number of regions in the mouse brain that were not mentioned studies using rats such as 
the two just mentioned, the xiphoid nucleus, the arcuate nucleus, the PVN, and the 
subparaventricular zone.  SCN lesions in golden hamsters also affect vasopressin 
immunoreactivity similar to the current study (Delville et al., 1998).  Fibers were present 
in intact hamsters and disappeared in lesioned hamsters from all the same nuclei as 
reported here.  This includes the VOLT, which also contained medium fibers that did not 
disappear following SCN lesions in mice or in hamsters (Delville et al., 1998).  Finally, 
our results contradict the previous descriptions of vasopressin-ir projections of the SCN 
for mice (Castel and Morris, 1988; Abrahamson and Moore, 2001).  Through the use of 
castration followed by SCN lesions, we have unequivocally determined which 
vasopressin-ir fibers derive from the SCN, whereas in the aforementioned study, the 
authors based the site of origin solely on fiber size and morphology and consequently 
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misjudged the site of origin for a number of brain regions including the lateral septum 
and lateral habenula.  Work in this manuscript and others clearly demonstrate the BNST 
or MeA as site of origin (Castel and Morris, 1988; Abrahamson and Moore, 2001).    
 The suprachiasmatic nucleus has been known as the master pacemaker of the 
biological clock since the early 1970's (Stephan and Zucker, 1972), and the presence of 
vasopressin in the SCN has been known for almost as long (Vandesande et al., 1975).  
The function of vasopressin in the SCN has only been examined in a small number of 
studies as the focus of circadian research has long been the mechanism of the biological 
clock (Bittman, 2009).  The anatomical data from the mouse suggest that vasopressin 
fibers are well placed to affect neuroendocrine rhythms given the dense innervation of the 
periventricular region.  Projections to the paraventricular thalamus may be involved in 
rhythms in arousal and behavioral state as this area receives multiple other inputs from 
various monoaminergic cell groups involved in these functions (Van der Werf et al., 
2002).  Projections to the subparaventricular zone and dorsomedial hypothalamus are 
likely involved in regulating a large number of behavioral processes including sleep, food 
intake, and locomotor activity (Chou et al., 2003; Saper et al., 2005).  Lesions of the 
dorsomedial hypothalamus lead to decreased circadian rhythms of wakefulness, food 
intake, locomotor activity, and glucocorticoid levels (Chou et al., 2003; Kalsbeek et al., 
2008).  A recent study provides the first solid evidence for a vasopressin function in 
circadian rhythms.  V1a receptor mRNA was shown to be expressed under circadian 
control in the SCN even under constant darkness (Jin et al., 1999; Li et al., 2009).  
Further, in a V1a receptor knock-out but not wild type mice lose periodicity in home cage 
activity levels and wheel running during constant darkness.  The rhythmic regulation of 
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the protein prokineticin 2 was also disrupted in V1a knock-outs (Li et al., 2009).  These 
data suggest a role of vasopressin in the regulation of circadian rhythms, although the 
actual circuitry and circuit level mechanism of action have yet to be identified. 
 Given the similarity to other species of the projections from the SCN to midline 
regions of the diencephalon, it is possible that the function of these vasopressin 
projections is rather well conserved across species.  In general, the vasopressin fibers of 
the SCN project to neuroendocrine, arousal, and behavioral control centers all of which 
mediate functions with distinct biological rhythms.  One final point should be made in 
regard to vasopressin-ir projections.  In this study, we eliminated vasopressin from the 
bed nuclei of the stria terminalis, medial amygdala, and SCN by using a combination of 
gonadecotmy and SCN lesions.  The fibers that are left after this joint approach 
presumably constitute the innervation from the paraventricular hypothalamus, supraoptic 
nucleus, and a number of accessory nuclei located throughout the mouse hypothalamus as 
these are the only other areas that show appreciable levels of vasopressin production.  
Another somewhat daunting task is to isolate the projections of these different cell groups 
in order to understand their individual functions.  However, as discussed in CHAPTER 4, 
certain viral vector and transgenic targeting approaches may be useful.  In particular, 
injections of a viral vector encoding the vasopressin promoter and a reporter gene have 
been shown to be expressed only in neurons of the PVN or SON (Valery Grinevich, 
personal communications).  Thus, while not useful for separating BNST versus MeA 
projections, this technique may prove extremely useful for delineating certain 
hypothalamic projections.  
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Table 5.1:  Vasopressin-ir fibers following SCN lesions 
 Summary of vasopressin-ir changes in response to 
suprachiasmatic nucleus lesions of gonadectomized (GDX) male mice.  A 
detailed summary is given for the diencephalon as this was the primary 
region in which fibers were lost following lesioning.  Areas are grouped by 
effect of SCN lesion and then by region.  A qualitative increase in 
vasopressin-ir fibers was not observed in any area.  In the "GDX / Sham 
lesion" and "GDX / SCN lesion" columns, letters indicate the relative 
density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered; m, 
moderate; d, dense; -0-, no fibers observed. 
Telencephalon GDX / 
Sham lesion 
GDX /
SCN Lesion 
Medial posteromedial 
BNST (STMPM) 
F(sc) F(sp) 
Diencephalon:
Hypothalamus
GDX / 
Sham lesion 
GDX / 
SCN lesion 
Decreased following SCN Lesion 
Preoptic Region 
Anteroventral 
periventricular Area 
(AVPe) 
F(sc-d)
T(sc-d)
F(sp-sc) 
Medial part of medial 
preoptic nucleus 
(MPOM)   
F(sp-sc) 
T(sp) 
F(sp) 
Striohypothalamic 
nucleus (StHy).   
F(sc)
T(sc)
F(sc)
Ventromedial preoptic 
nucleus (VMPO) 
F(sc) F(sp) 
Anterior Hypothalamic Region 
Anterior hypothalamus, 
anterior (AHA) 
F(sp-sc) 
T(sc)
F(sp-sc) 
Anterior hypothalamus, 
central (AHC) 
F(m-d) 
T(sc)
F(m-d) 
Lateroanterior 
hypothalamus (LA) 
F(sp-sc) 
T(sc)
F(sp-sc) 
Paraventricular nucleus 
(PVN) 
F(m-d) 
T(sc-m) 
F(sc)
Parvicellular 
paraventricular 
hypothalamus (PaAP) 
F(d)
T(d)
F(sp-sc) 
Periventricular region 
(Pe)
F(d)
T(d)
F(sc)
Retrochiasmatic area 
(RCh) 
F(sc-d)
T(sc-d)
F(sc)
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Table 5.1:  Vasopressin-ir fibers following SCN lesions (continued)
Diencephalon:
Hypothalamus
GDX / 
Sham lesion 
GDX / 
SCN lesion 
Decreased following SCN lesion 
Anterior Hypothalamic Region 
Subparaventricular zone 
(SPa).   
F(d)
T(d)
F(sp-sc) 
Suprachiasmatic nucleus 
(SCN) 
F(m-d) 
T(m-d) 
Lesioned 
Mammillary Body Region 
Dorsal tuberomammillary 
nucleus (DTM) 
F(sc)
T(sp) 
F(sp) 
Dorsomedial Hypothalamus 
Arcuate nucleus (Arc) F(sp-sc) 
T(sp-sc) 
F(sp) 
Dorsomedial 
hypothalamus (DMH) 
F(sc-d)
T(sc-d)
F(sp-m) 
No change following SCN lesion 
Preoptic Region 
Lateral preoptic area 
(LPO) 
F(sp) F(sp) 
Medial preoptic area 
(MPA) 
F(sp) F(sp) 
Median preoptic nucleus 
(MnPO).   
F(sp-m) F(sp-m) 
Parastrial nucleus (PS).   F(sp-sc) F(sp-sc) 
Periventricular 
hypothalamic nucleus 
(Pe)
F(sc-d)
T(m-d) 
F(sp) 
Vascular organ of the 
lamina terminalis 
(VOLT) 
F(sc) F(sc)
Ventrolateral preoptic 
area (VLPO) 
F(sc)
T(sc)
F(sc)
Anterior Hypothalamic Region 
Supraoptic commissure 
(sox) 
F(sc) F(sc)
Tuberal lateral 
hypothalamus (TuLH) 
F(m-d) F(m-d) 
Lateral Hypothalamus 
Endopeduncular nucleus 
(EP) 
F(sp-sc) F(sp-sc) 
Lateral hypothalamus 
(LH) 
F(sp-sc) F(sp-sc) 
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Table 5.1:  Vasopressin-ir fibers following SCN lesions (continued)
Diencephalon:
Hypothalamus
GDX / 
Sham lesion 
GDX / 
SCN lesion 
No change following SCN lesion 
Lateral Hypothalamus 
Peduncular part of the 
lateral hypothalamus 
(PLH) 
F(sp-d) F(sp-d) 
Perifornical lateral 
hypothalamus (PeFLH) 
F(sp-sc) F(sp-sc) 
Mammillary Body Region 
Dorsal hypothalamic area 
(DA) 
F(sp) F(sp) 
Lateral retromammillary 
nucleus (RML) 
F(sp-sc) F(sp-sc) 
Medial retromammillary 
nucleus (RMM) 
F(sp-sc) F(sp-sc) 
Perifornical nucleus 
(PeF) 
F(sc-m) F(sc-m) 
Posterior hypothalmaus 
(PH) 
F(sp) F(sp) 
Ventral premammillary 
nucleus (PMV) 
F(sp) F(sp) 
Ventral 
tuberomammillary 
nucleus (VTM) 
F(sp-sc) F(sp-sc) 
Dorsomedial Hypothalamus 
Medial tuberal 
hypothalamus (MTu) 
F(sp-d) F(sp-d) 
Ventromedial 
hypothalamus (VMH) 
F(sp) F(sp) 
Zona incerta (ZI) F(sp) F(sp) 
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Table 5.1:  Vasopressin-ir fibers following SCN lesions (continued) 
Diencephalon:
Thalamus
GDX / 
Sham lesion 
GDX / 
SCN lesion 
Decreased following SCN lesion 
Mediodorsal thalamic 
nucleus  (MD) 
F(sp) 
T(sp) 
-0- 
Paratenial thalamus (PT) F(sp) 
T(sp) 
F(sp) 
Paraventricular thalamic 
nucleus, anterior (PVA) 
F(sc-d)
T(sc-d)
F(sp) 
Paraventricular thalamic 
nucleus, middle (PV) 
F(sc-m) 
T(sc-m) 
F(sp) 
Paraventricular thalamic 
nucleus, posterior (PVP) 
F(sp-sc) 
T(sp-sc) 
F(sp) 
Reuniens thalamic 
nucleus (Re) 
F(sp-sc) 
T(sp) 
F(sp) 
Xiphoid nucleus (Xi) F(sc-m) 
T(sc-m) 
F(sp) 
No change following SCN lesion 
Central medial thalamic 
nucleus (CM) 
F(sp) F(sp) 
Interanterodorsal 
thalamic nucleus (IAD) 
-0- -0- 
Interanteromedial 
thalamic nucleus (IAM) 
-0- -0- 
Lateral habenular nucleus 
(LHb) 
-0- -0- 
Paracentral thalamus 
(PC)
-0- -0- 
Reticular nucleus (Rt) F(sp) F(sp) 
Rhomboid thalamic 
nucleus (Rh) 
F(sp) F(sp) 
Mesencephalon GDX / 
Sham lesion 
GDX / 
SCN lesion 
Metencephalon GDX / 
Sham lesion 
GDX / 
SCN lesion 
Myelencephlon GDX / 
Sham lesion 
GDX / 
SCN lesion 
5.5  Figure legends 
 
Figure 5.1:  Location of SCN lesions  
 Each row corresponds to one subject.  The top row shows the SCN from a 
representative sham lesioned animal.  Lesions are shown for the four subjects used for 
descriptive analyses in the bottom four rows.  The columns depict lesions at rostral to 
caudal levels of the SCN anatomically matched to the sham lesioned animal in the top 
row. 
 
Figure 5.2:  Vasopressin -ir fibers in the STMPM 
 Vasopressin-ir fibers in the STMPM of gonadectomized mice with either a sham 
lesion (A) or SCN lesion (B).  Note the lack of small fibers in the dorsal STMPM 
(indicated by arrows).  ac, anterior commissure; f, fornix; ic, internal capsule; SCN, 
suprachiasmatic nucleus; st, stria terminalis; STMPM, medial posteromedial bed nucleus 
of the stria terminalis 
 
Figure 5.3:  Vasopressin -ir fibers in the preoptic area 
 Vasopressin-ir fibers in the preoptic area of gonadectomized mice with either a 
sham lesion (A) or SCN lesion (B).  Note the lack of small fibers in the AVPe and 
VMPO (indicated by arrows) and the MPOM.  3V, 3rd ventricle; AVPe, anteroventral 
periventricular nucleus; MPOM, medial preoptic nucleus, medial part; SCN, 
suprachiasmatic nucleus; VMPO, ventromedial preoptic nucleus 
 
Figure 5.4:  Vasopressin -ir fibers in the subparaventricular zone 
 Vasopressin-ir fibers in the SPa of gonadectomized mice with either a sham lesion 
(A) or SCN lesion (B).  Note the lack of small fibers in the SPa (indicated by arrows).  
3V, 3rd ventricle; AH, anterior hypothalamus; LA, lateroanterior hypothalamic nucleus; 
SCN, suprachiasmatic nucleus; SPa, subparaventricular zone  
 
Figure 5.5:  Vasopressin -ir fibers in the anterior paraventricular thalamus 
 Vasopressin-ir fibers in the PVA of gonadectomized mice with either a sham 
lesion (A) or SCN lesion (B).  Note the lack of small fibers entering the PVA adjacent to 
the third ventricle (indicated by arrows).  3;, 3rd ventricle, PVA, anterior paraventricular 
thalamus; SCN, suprachiasmatic nucleus 
 
Figure 5.6:  Vasopressin -ir fibers in the paraventricular thalamus  
 Vasopressin-ir fibers in the PV of gonadectomized mice with either a sham lesion 
(A) or SCN lesion (B).  Note the lack of small fibers especially near the dorsal 3rd 
ventricle.  D3V, dorsal 3rd ventricle; PV, paraventricular thalamus; SCN, 
suprachiasmatic nucleus 
 
Figure 5.7:  Vasopressin -ir fibers in the xiphoid nucleus 
 Vasopressin-ir fibers in the Xi of gonadectomized mice with either a sham lesion 
(A) or SCN lesion (B).  Note the lack of small fibers in and around the PVN adjacent to 
the 3rd ventricle (indicated by arrows).  3V, 3rd ventricle; PVN; paraventricular 
hypothalamus; Re, reuniens nucleus; SCN, suprachiasmatic nucleus; Xi, xiphoid nucleus 
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Figure 5.8:  Vasopressin -ir fibers in the retrochiasmatic area 
 Vasopressin-ir fibers in the RCh of gonadectomized mice with either a sham 
lesion (A) or SCN lesion (B).  Note the lack of small fibers around the 3rd ventricle in the 
Pe and ventral in the RCh (indicated by arrows).  3V, 3rd ventricle; Pe, periventricular 
hypothalamic nucleus; RCh, retrochiasmatic area; SCN, suprachiasmatic nucleus; VMH, 
ventromedial hypothalamic nucleus 
 
Figure 5.9:  Vasopressin -ir fibers in the dorsomedial hypothalamus 
 Vasopressin-ir fibers in the DM of gonadectomized mice with either a sham 
lesion (A) or SCN lesion (B).  SCN lesioned animal had a unilateral lesion.  Note the lack 
of small fibers adjacent to the 3rd ventricle only on the right side (see arrows).  3V, 3rd 
ventricle; DM, dorsomedial hypothalamus; SCN, suprachiasmatic nucleus; VMH, 
ventromedial hypothalamic nucleus 
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CHAPTER 6 
GENERAL DISCUSSION 
6.1  General comments and conclusions 
 The studies presented in this manuscript provide a thorough examination of the 
vasopressin anatomy of the mouse brain.  Previous work described neurophysin II 
immunoreactivity in Oxford University mice and vasopressin immunoreactivity in 
C57BL6 mice (Castel and Morris, 1988; Abrahamson and Moore, 2001).  However, each 
study focused on the forebrain and did not give complete details, but simply described the 
presence of immunoreactivity in, for instance, the amygdala.  However, based on the 
work presented above, it is clear that vasopressin is hardly ubiquitous in any given region 
and often shows distinct regional innervation.  One example in particular is the ventral 
forebrain where vasopressin fibers innervate the region between the nucleus accumbens 
and vertical limb of the diagonal band with virtually no fibers entering either nucleus 
(Figure 2.9A).  In this same fiber plexus, the islands of Calleja are also specifically 
avoided demonstrating the rather specific nature of vasopressin innervation.  Further, 
previous attempts to describe the site of origin of vasopressin-ir fibers in the mouse were 
based purely on fiber characteristics leading to a number of anatomical errors in 
interpretation (Castel and Morris, 1988; Abrahamson and Moore, 2001).     
 As discussed in more detail above, estradiol-sensitive vasopressin-ir projections 
reach a diverse and large subset of brain nuclei from the telencephalon to the 
metencephalon.  These areas probably receive vasopressin innervation from the bed 
nuclei of the stria terminalis (BNST) or medial amygdala (MeA), as vasopressin 
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expression in these areas, but not others, depends on circulating gonadal steroids (Miller 
et al., 1992; Wang and De Vries, 1995; Rood et al., 2008).  In addition, vasopresin-ir 
fibers presumably from the BNST and MeA innervate brain regions with proposed 
behavioral roles, the lateral septum and social memory for example (Dantzer et al., 1988; 
Landgraf et al., 1995; Landgraf et al., 2003; Bielsky et al., 2005), as well as areas with 
major modulatory functions (de Olmos and Heimer, 1999; Lecourtier and Kelly, 2007; 
Michelsen et al., 2007; Hikosaka et al., 2008).  In particular, the anatomical descriptions 
above suggest an anatomical link between vasopressin-ir fibers and serotonin and 
dopamine systems, as steroid-sensitive vasopressin innervation is found in the substantia 
nigra and raphe nuclei.  Serotonin plays a role in the regulation of behavioral state and 
has been studied in great detail in relation to anxiety and depression (Michelsen et al., 
2007).  Vasopressin innervation of the ventral tegmental area and interfascicular nucleus 
suggests a link to the dopamine system involved in reward and ventral striatopallidal 
circuits involved in emotion-regulated decision making (Lecourtier and Kelly, 2007; 
Hikosaka et al., 2008).  In addition, vasopressin is found in much of the extended 
amygdala (de Olmos and Heimer, 1999), typically in rather discrete areas.  Vasopressin 
function in the lateral septum has perhaps been the most thoroughly studied, although a 
clear functional role for lateral septum innervation has only been proven for social 
recognition memory (Dantzer et al., 1988; Landgraf et al., 1995; Landgraf et al., 2003; 
Bielsky et al., 2005). 
 Vasopressin cells in the SCN appear to innervate a number of midline regions 
that, with the exception of the medial preoptic area and a small number of areas in the 
most rostral parts of the thalamus, are mutually exclusive with projections from the 
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BNST and MeA.  This separation is readily apparent in the medial posteromedial BNST 
(STMPM; see Figure 2.11C) and paraventricular thalamus (PV; see Figure 2.17C).  In the 
STMPM, small fibers from the SCN are usually observed in the dorsal region near the 
dorsal third ventricle.  On the other hand, vasopressin fibers from the BNST or MeA 
reside ventrally near the stria terminalis.  The thalamus contains a clear buffer zone, void 
of vasopressin, between the dense innervation of the mediodorsal nucleus (which comes 
from the BNST or MeA) and the less dense innervation of the PV (which comes from the 
SCN).  The hypothalamic regions innervated by the SCN include those involved in 
neuroendocrine systems and various behavior regulation centers, such as the medial 
preoptic nucleus (sex behavior) and the dorsomedial hypothalamus (sleep, food intake, 
and locomotion; (Chou et al., 2003)). 
 One interesting observation is that practically all areas that receive small fibers 
presumably from the SCN, BNST, and MeA also contain medium caliber fibers. Areas 
such as the lateral septum, paraventricular thalamus, dorsomedial hypothalamus, raphe 
nuclei, and ventral tegmental area all contain small numbers of medium caliber fibers 
even though this innervation can be as little as a single fiber.  Aside from this general 
colocalization of fibers from the various anatomically and functionally distinct cell 
groups, medium caliber fibers are also exclusively found in a number of other brain 
regions.  Although not the focus of this manuscript and thus not discussed in great detail, 
these projections primarily innervate regions involved in autonomic function, such as the 
solitary nucleus in the hindbrain, the central nucleus of the amygdala, and the lateral 
parabrachial nucleus among others.  Finally, the presence of mutiple fiber types in 
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different areas such that different functional systems may each influence some brain 
regions.
 In future work, it will be important to ascertain the functional importance of the 
various vasopressin circuits at both physiological and more global behavioral levels.
Electrophysiological data suggest that vasopressin leads to a net inhibition of cells in the 
lateral septum (Allaman-Exertier et al., 2007) and a direct excitation in most other 
neuronal populations examined (Charpak et al., 1989; Raggenbass et al., 1989; 
Raggenbass et al., 1991).  The direct mechanism of excitability has yet to be determined, 
although the V1a receptor, which acts through the Gq receptor to stimulate phospholipase 
C and increase intracellular calcium signaling, is known to be involved (Stephens and 
Logan, 1986; Shewey and Dorsa, 1988; Morel et al., 1992).  The inhibition in the lateral 
septum was interpreted to be mediated by the excitation of a population of inhibitory 
interneurons that inhibited septal projection neurons (Allaman-Exertier et al., 2007).  In 
addition to understanding the functional circuitry involved in vasopressin projections, it is 
crucial that work be done to ascertain which stimuli elicit vasopressin release from the 
BNST and MeA in the first place.  Some work has been done to this effect using 
microdialysis in researching aggression (Beiderbeck et al., 2007), but much more data on 
the topic is required. 
6.2  The human condition 
 One important question that has yet to be addressed is, "Are any of these 
anatomical data relevant to the human condition?"  First of all, is there vasopressin in the 
human brain?  Second, is there vasopressin outside of the PVN and SON, two nuclei that 
contain vasopressin immunoreactivity in all other mammals studied?  The answer to both 
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questions is unequivocally, "Yes."  Detection of vasopressin using radioimmunoassay 
and tissue punches suggests that there are high levels of vasopressin in the hypothalamus, 
which is to be expected,  However, moderate levels of vasopressin were detected in other 
regions such as the locus coeruleus, substantia nigra pars compacta, substantia nigra pars 
reticulata, periaqueductal gray, and globus pallidus (Rossor et al., 1981; Jenkins et al., 
1984).  In addition, a number of other regions contained vasopressin in some, but not all 
individuals.  These areas included nuclei such as the amygdala, lateral septum, nucleus 
accumbens, and others (Rossor et al., 1981; Jenkins et al., 1984).    
 Currently, the most extensive immunohistochemical study of vasopressin in the 
human brain reports only on small tissue blocks from the septal area, amaygdala, 
hippocampus, and locus coeruleus (Fliers et al., 1986).  Very few vasopressin-ir fibers 
were found in the lateral septum, an area that is very densely innervated and sexually 
dimorphic in most other species, and no sex differences were apparent.  There was also 
immunoreactivity in the diagonal band region, which may be the ventral septal area, as 
this area is often referred to as the diagonal band, which in mice contains no vasopressin 
fibers at all.  In these sections, some small vasopressin-ir cells were observed in the 
BNST of a few subjects.  The amygdala contained almost no vasopressin except for a few 
fibers at the tip of the lateral ventricle near the transition between the amygdala and 
hippocampus.  The locus coeruleus on the other hand was densely innervated and many 
terminal swellings were observed (Fliers et al., 1986).  Additionally, the 
immunohistochemistry in this study was carried out on paraffin embedded tissue.  
Paraffin embedding causes a reduction in immunoreactivity as compared to free floating 
sections (compare, for example, (Buijs, 1978; DeVries et al., 1985)).   Clearly, our 
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knowledge of vasopressin in the human brain lags far behind our knowledge of other 
species.  The next closest species for comparison is the macaque, which likely does not 
have much vasopressin in the lateral septum either, as it went unmentioned in the authors' 
descriptions, even though they mention a moderate innervation of the medial septum 
(Caffe et al., 1989).  A number of other regions, however, are described to have a dense 
innervation including the ventral and dorsal raphe, the ventral tegmental area, the lateral 
and medial parabrachial nuclei, the solitary nucleus, and the periaqueductal gray.  In 
addition, midline nuclei in the diencephalon such as the subparaventricular zone, reuniens 
of the thalamus, and paraventricular nucleus of the thalamus all have a dense innervation 
(Caffe et al., 1989).  Many of these regions have not been well studied in humans.  Of 
particular interest to the discussion presented earlier in this manuscript are the dorsal 
raphe and ventral tegmental area.  In the mouse and rat, these regions receive most of 
their innervation from the BNST or MeA (DeVries et al., 1985).  In macaques, we do not 
currently have any evidence on site of origin, and in humans, we do not even have 
immunhistochemical or radioimmunoassay data for these regions. 
 Behavioral data are also lacking in the human literature.  Only two studies to date 
appear to have shown a link between behavior and vasopressin.  One study showed a 
correlation between vasopressin levels in cerebrospinal fluid and a life history of 
aggression (Coccaro et al., 1998).  In a second study, intranasal administration of 
vasopressin led to an increase in frowning in response to neutral faces in men, whereas 
women had decreased frowning in response to angry faces and increased smiling in 
response to neutral faces, suggesting a sex difference in vasopressin function (Thompson 
et al., 2006).  In addition, there has been a recent interest in examining the promoter 
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region of the V1a receptor gene, which codes for the receptor most commonly found in 
the brain.  Interest in this topic came about from the discovery that microsatellite repeat 
sequences in the promoter of the V1a receptor gene of the prairie vole were responsible 
for highly differential receptor distribution between vole species (Hammock et al., 2005; 
Hammock and Young, 2005).  Further, transgenic mice with the prairie vole V1a 
promoter region expressed V1a in a more prairie vole-like pattern and had altered social 
behaviors compared to wild-type mice (Young et al., 1999).  In humans, polymorphisms 
have recently been found to correlate with differences in pre-pulse inhibition, an 
autonomic response to conditioned sound stimuli that is often altered in certain 
psychiatric illnesses (Levin et al., 2009).  Researchers have also tried to find variation in 
the V1a gene promoter than can account for some forms of autism, but results are quite 
weak (Levin et al., 2009).  Most relevant to behavior observed in rodents, polymorphism 
in the V1a gene were related to marital satisfaction and marital status as measures of 
pairbonding (Walum et al., 2008).  All of the data are correlative, and, despite the 
interest, we know surprisingly little about the actual brain anatomy in humans. 
 So after all of this, what do we know?  Very little!  We must certainly as a 
research community work toward a better understanding of the anatomy of the 
vasopressin system in the human brain.  Without this, conjecturing about the relevance of 
microsatellites and SNP's will do us little good.  And what if the extra-hypothalamic 
vasopressin innervation, which is so impressive in mice, is lacking or at least diminished 
in humans?  This is the case for some species such as golden hamsters and naked mole 
rats (Miller et al., 1999; Rosen et al., 2007).  This in my mind is the beauty of the 
vasopressin system in the mouse.  The diverse projections and dense innervation by 
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vasopressinergic cells acts much like nature's highlighter, marking off brain regions and 
circuits that are noteworthy to examine in the control of social behavior.  Almost 
certainly in the absence of vasopressin, the serotonergic system, extended amygdala, 
ventral striatopallidal system, dorsal diencephalic conduction system, limbic loop, and 
hippocampal-septal connections area are still present and functioning.  In some species 
they may just function a little different with vasopressin on board. 
6.3  Conclusion 
 Vasopressin-ir fibers reach a number of brain regions that working in concert can 
alter anxiety levels or behavioral state, regulate the integration of limbic system 
information with decision making strategies in the forebrain, enhance memory functions, 
and influence cells in behavioral control regions of the lateral hypothalamus.  Taken 
together, this information suggests that stimuli which lead to vasopressin 
neurotransmission from the BNST and MeA may simultaneously alter circuits that 
enhance or diminish the expression of various behaviors.  Perhaps it is time that we 
divorce ourselves from the idea that individual vasopressin projections directly regulate 
specific social behaviors.  Instead, we can explore the idea that vasopressin encourages a 
specific behavioral state working through multiple interconnected pathways that 
enhances some patterns of behavior while inhibiting others in a context and species 
specific manner.  
204
BIBLIOGRAPHY
Abrahamson EE, Moore RY. 2001. Suprachiasmatic nucleus in the mouse: retinal 
innervation, intrinsic organization and efferent projections. Brain Res 916:172-
191.
Abramov U, Puussaar T, Raud S, Kurrikoff K, Vasar E. 2008. Behavioural differences 
between C57BL/6 and 129S6/SvEv strains are reinforced by environmental 
enrichment. Neurosci Lett 443:223-227. 
Allaman-Exertier G, Reymond-Marron I, Tribollet E, Raggenbass M. 2007. Vasopressin 
modulates lateral septal network activity via two distinct electrophysiological 
mechanisms. Eur J Neurosci 26:2633-2642. 
Antoniadis EA, McDonald RJ. 2006. Fornix, medial prefrontal cortex, nucleus 
accumbens, and mediodorsal thalamic nucleus: roles in a fear-based context 
discrimination task. Neurobiol Learn Mem 85:71-85. 
Bakker J, De Mees C, Douhard Q, Balthazart J, Gabant P, Szpirer J, Szpirer C. 2006. 
Alpha-fetoprotein protects the developing female mouse brain from 
masculinization and defeminization by estrogens. Nat Neurosci 9:220-226. 
Banet M, Wieland UE. 1985. The effect of intraseptally applied vasopressin on 
thermoregulation in the rat. Brain Res Bull 14:113-116. 
Barry J. 1961. Recherches morphologiques et experimentales sur la glande 
diencephalique et l'appareil hypothalamo-hypophysaire. Ann. Sci. Univ. 
Besancon, Zool. Physiol. Ser. 2:3-133. 
Baskin DG, Petracca F, Dorsa DM. 1983. Autoradiographic localization of specific 
binding sites for [3H][Arg8]vasopressin in the septum of the rat brain with 
tritium-sensitive film. Eur J Pharmacol 90:155-157. 
Beiderbeck DI, Neumann ID, Veenema AH. 2007. Differences in intermale aggression 
are accompanied by opposite vasopressin release patterns within the septum in 
rats bred for low and high anxiety. Eur J Neurosci 26:3597-3605. 
Berman ME, Tracy JI, Coccaro EF. 1997. The serotonin hypothesis of aggression 
revisited. Clin Psychol Rev 17:651-665. 
Bernardini GL, Lipton JM, Clark WG. 1983. Intracerebroventricular and septal injections 
of arginine vasopressin are not antipyretic in the rabbit. Peptides 4:195-198. 
Bielsky IF, Hu SB, Ren X, Terwilliger EF, Young LJ. 2005. The V1a vasopressin 
receptor is necessary and sufficient for normal social recognition: a gene 
replacement study. Neuron 47:503-513. 
205
Bielsky IF, Hu SB, Szegda KL, Westphal H, Young LJ. 2004. Profound impairment in 
social recognition and reduction in anxiety-like behavior in vasopressin V1a 
receptor knockout mice. Neuropsychopharmacology 29:483-493. 
Bittman EL. 2009. Vasopressin: more than just an output of the circadian pacemaker? 
Focus on "Vasopressin receptor V1a regulates circadian rhythms of locomotor 
activity and expression of clock-controlled genes in the suprachiasmatic nuclei". 
Am J Physiol Regul Integr Comp Physiol 296:R821-823. 
Bluthe RM, Dantzer R. 1990. Social recognition does not involve vasopressinergic 
neurotransmission in female rats. Brain Res 535:301-304. 
Bluthe RM, Schoenen J, Dantzer R. 1990. Androgen-dependent vasopressinergic neurons 
are involved in social recognition in rats. Brain Res 519:150-157. 
Brinton RE, McEwen BS. 1989. Vasopressin neuromodulation in the hippocampus. J 
Neurosci 9:752-759. 
Brot MD, De Vries GJ, Dorsa DM. 1993. Local implants of testosterone metabolites 
regulate vasopressin mRNA in sexually dimorphic nuclei of the rat brain. Peptides 
14:933-940.
Buijs RM. 1978. Intra- and extrahypothalamic vasopressin and oxytocin pathways in the 
rat. Pathways to the limbic system, medulla oblongata and spinal cord. Cell 
Tissue Res 192:423-435. 
Buijs RM, Swaab DF. 1979. Immuno-electron microscopical demonstration of 
vasopressin and oxytocin synapses in the limbic system of the rat. Cell Tissue Res 
204:355-365.
Buijs RM, Swaab DF, Dogterom J, van Leeuwen FW. 1978. Intra- and 
extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res 
186:423-433.
Buijs RM, Van Heerikhuize JJ. 1982. Vasopressin and oxytocin release in the brain--a 
synaptic event. Brain Res 252:71-76. 
Caffe AR, van Leeuwen FW. 1983. Vasopressin-immunoreactive cells in the dorsomedial 
hypothalamic region, medial amygdaloid nucleus and locus coeruleus of the rat. 
Cell Tissue Res 233:23-33. 
Caffe AR, van Leeuwen FW, Luiten PG. 1987. Vasopressin cells in the medial amygdala 
of the rat project to the lateral septum and ventral hippocampus. J Comp Neurol 
261:237-252.
206
Caffe AR, Van Ryen PC, Van der Woude TP, Van Leeuwen FW. 1989. Vasopressin and 
oxytocin systems in the brain and upper spinal cord of Macaca fascicularis. J 
Comp Neurol 287:302-325. 
Caldwell HK, Lee HJ, Macbeth AH, Young WS, 3rd. 2008. Vasopressin: behavioral roles 
of an "original" neuropeptide. Prog Neurobiol 84:1-24. 
Castel M, Morris JF. 1988. The neurophysin-containing innervation of the forebrain of 
the mouse. Neuroscience 24:937-966. 
Caverson MM, Ciriello J, Calaresu FR, Krukoff TL. 1987. Distribution and morphology 
of vasopressin-, neurophysin II-, and oxytocin-immunoreactive cell bodies in the 
forebrain of the cat. J Comp Neurol 259:211-236. 
Charpak S, Dubois-Dauphin M, Raggenbass M, Dreifuss JJ. 1989. Vasopressin excites 
neurones located in the dorsal cochlear nucleus of the guinea-pig brainstem. Brain 
Res 483:164-169. 
Chauveau F, Celerier A, Ognard R, Pierard C, Beracochea D. 2005. Effects of ibotenic 
acid lesions of the mediodorsal thalamus on memory: relationship with emotional 
processes in mice. Behav Brain Res 156:215-223. 
Chen X, Landgraf R, Pittman QJ. 1997. Differential ventral septal vasopressin release is 
associated with sexual dimorphism in PGE2 fever. Am J Physiol 272:R1664-
1669.
Chou TC, Scammell TE, Gooley JJ, Gaus SE, Saper CB, Lu J. 2003. Critical role of 
dorsomedial hypothalamic nucleus in a wide range of behavioral circadian 
rhythms. J Neurosci 23:10691-10702. 
Christoph GR, Leonzio RJ, Wilcox KS. 1986. Stimulation of the lateral habenula inhibits 
dopamine-containing neurons in the substantia nigra and ventral tegmental area of 
the rat. J Neurosci 6:613-619. 
Coccaro EF, Kavoussi RJ, Hauger RL, Cooper TB, Ferris CF. 1998. Cerebrospinal fluid 
vasopressin levels: correlates with aggression and serotonin function in 
personality-disordered subjects. Arch Gen Psychiatry 55:708-714. 
Compaan JC, Buijs RM, Pool CW, De Ruiter AJ, Koolhaas JM. 1993. Differential lateral 
septal vasopressin innervation in aggressive and nonaggressive male mice. Brain 
Res Bull 30:1-6. 
Cooke BM, Simerly RB. 2005. Ontogeny of bidirectional connections between the 
medial nucleus of the amygdala and the principal bed nucleus of the stria 
terminalis in the rat. J Comp Neurol 489:42-58. 
207
Cooper KE, Naylor AM, Veale WL. 1987. Evidence supporting a role for endogenous 
vasopressin in fever suppression in the rat. J Physiol 387:163-172. 
Crenshaw BJ, De Vries GJ, Yahr P. 1992. Vasopressin innervation of sexually dimorphic 
structures of the gerbil forebrain under various hormonal conditions. J Comp 
Neurol 322:589-598. 
Dantzer R, Bluthe RM, Koob GF, Le Moal M. 1987. Modulation of social memory in 
male rats by neurohypophyseal peptides. Psychopharmacology (Berl) 91:363-368. 
Dantzer R, Koob GF, Bluthe RM, Le Moal M. 1988. Septal vasopressin modulates social 
memory in male rats. Brain Res 457:143-147. 
de Olmos JS, Heimer L. 1999. The concepts of the ventral striatopallidal system and 
extended amygdala. Ann N Y Acad Sci 877:1-32. 
De Vries GJ. 2004. Minireview: Sex differences in adult and developing brains: 
compensation, compensation, compensation. Endocrinology 145:1063-1068. 
De Vries GJ, al-Shamma HA. 1990. Sex differences in hormonal responses of 
vasopressin pathways in the rat brain. J Neurobiol 21:686-693. 
De Vries GJ, Best W, Sluiter AA. 1983. The influence of androgens on the development 
of a sex difference in the vasopressinergic innervation of the rat lateral septum. 
Brain Res 284:377-380. 
De Vries GJ, Buijs RM. 1983. The origin of the vasopressinergic and oxytocinergic 
innervation of the rat brain with special reference to the lateral septum. Brain Res 
273:307-317.
de Vries GJ, Buijs RM, Sluiter AA. 1984. Gonadal hormone actions on the morphology 
of the vasopressinergic innervation of the adult rat brain. Brain Res 298:141-145. 
de Vries GJ, Buijs RM, Swaab DF. 1981. Ontogeny of the vasopressinergic neurons of 
the suprachiasmatic nucleus and their extrahypothalamic projections in the rat 
brain--presence of a sex difference in the lateral septum. Brain Res 218:67-78. 
De Vries GJ, Panzica GC. 2006. Sexual differentiation of central vasopressin and 
vasotocin systems in vertebrates: different mechanisms, similar endpoints. 
Neuroscience 138:947-955. 
De Vries GJ, Rissman EF, Simerly RB, Yang LY, Scordalakes EM, Auger CJ, Swain A, 
Lovell-Badge R, Burgoyne PS, Arnold AP. 2002. A model system for study of 
sex chromosome effects on sexually dimorphic neural and behavioral traits. J 
Neurosci 22:9005-9014. 
208
De Vries GJ, Wang Z, Bullock NA, Numan S. 1994. Sex differences in the effects of 
testosterone and its metabolites on vasopressin messenger RNA levels in the bed 
nucleus of the stria terminalis of rats. J Neurosci 14:1789-1794. 
De Wied D. 1965. The Influence of the Posterior and Intermediate Lobe of the Pituitary 
and Pituitary Peptides on the Maintenance of a Conditioned Avoidance Response 
in Rats. Int J Neuropharmacol 4:157-167. 
De Wied D. 1971. Long term effect of vasopressin on the maintenance of a conditioned 
avoidance response in rats. Nature 232:58-60. 
Delville Y, De Vries GJ, Schwartz WJ, Ferris CF. 1998. Flank-marking behavior and the 
neural distribution of vasopressin innervation in golden hamsters with 
suprachiasmatic lesions. Behav Neurosci 112:1486-1501. 
Demotes-Mainard J, Chauveau J, Rodriguez F, Vincent JD, Poulain DA. 1986. Septal 
release of vasopressin in response to osmotic, hypovolemic and electrical 
stimulation in rats. Brain Res 381:314-321. 
DeVries GJ, Buijs RM, Van Leeuwen FW, Caffe AR, Swaab DF. 1985. The 
vasopressinergic innervation of the brain in normal and castrated rats. J Comp 
Neurol 233:236-254. 
Dorsa DM, Majumdar LA, Petracca FM, Baskin DG, Cornett LE. 1983. Characterization 
and localization of 3H-arginine8-vasopressin binding to rat kidney and brain 
tissue. Peptides 4:699-706. 
Dubois-Dauphin M, Pevet P, Tribollet E, Dreifuss JJ. 1990. Vasopressin in the brain of 
the golden hamster: the distribution of vasopressin binding sites and of 
immunoreactivity to the vasopressin-related glycopeptide. J Comp Neurol 
300:535-548.
Dubois-Dauphin M, Tribollet E, Dreifuss JJ. 1989. Distribution of neurohypophysial 
peptides in the guinea pig brain. I. An immunocytochemical study of the 
vasopressin-related glycopeptide. Brain Res 496:45-65. 
Everts HG, De Ruiter AJ, Koolhaas JM. 1997. Differential lateral septal vasopressin in 
wild-type rats: correlation with aggression. Horm Behav 31:136-144. 
Everts HG, Koolhaas JM. 1997. Lateral septal vasopressin in rats: role in social and 
object recognition? Brain Res 760:1-7. 
Everts HG, Koolhaas JM. 1999. Differential modulation of lateral septal vasopressin 
receptor blockade in spatial learning, social recognition, and anxiety-related 
behaviors in rats. Behav Brain Res 99:7-16. 
209
Farini F. 1913. Diabete insipido ed opoteria. Gazz. Osped Clin 34. 
Ferguson D, Lin S, Sapolsky R. 2008. Viral vector-mediated blockade of the endocrine 
stress-response modulates non-spatial memory. Neurosci Lett 437:1-4. 
Ferris CF, Albers HE, Wesolowski SM, Goldman BD, Luman SE. 1984. Vasopressin 
injected into the hypothalamus triggers a stereotypic behavior in golden hamsters. 
Science 224:521-523. 
Ferris CF, Delville Y, Brewer JA, Mansour K, Yules B, Melloni RH, Jr. 1996. 
Vasopressin and developmental onset of flank marking behavior in golden 
hamsters. J Neurobiol 30:192-204. 
Ferris CF, Delville Y, Grzonka Z, Luber-Narod J, Insel TR. 1993. An iodinated 
vasopressin (V1) antagonist blocks flank marking and selectively labels neural 
binding sites in golden hamsters. Physiol Behav 54:737-747. 
Ferris CF, Meenan DM, Albers HE. 1986. Microinjection of kainic acid into the 
hypothalamus of golden hamsters prevents vasopressin-dependent flank-marking 
behavior. Neuroendocrinology 44:112-116. 
Fliers E, Guldenaar SE, van de Wal N, Swaab DF. 1986. Extrahypothalamic vasopressin 
and oxytocin in the human brain; presence of vasopressin cells in the bed nucleus 
of the stria terminalis. Brain Res 375:363-367. 
Franklin KBJ, Paxinos G. 2008. The mouse brain in stereotaxic coordinates. Amsterdam: 
Elsevier.
Gainer H, Sarne Y, Brownstein MJ. 1977. Neurophysin biosynthesis: conversion of a 
putative precursor during axonal transport. Science 195:1354-1356. 
Gatewood JD, Wills A, Shetty S, Xu J, Arnold AP, Burgoyne PS, Rissman EF. 2006. Sex 
chromosome complement and gonadal sex influence aggressive and parental 
behaviors in mice. J Neurosci 26:2335-2342. 
Hammock EA, Lim MM, Nair HP, Young LJ. 2005. Association of vasopressin 1a 
receptor levels with a regulatory microsatellite and behavior. Genes Brain Behav 
4:289-301.
Hammock EA, Young LJ. 2005. Microsatellite instability generates diversity in brain and 
sociobehavioral traits. Science 308:1630-1634. 
Han TM, De Vries GJ. 2003. Organizational effects of testosterone, estradiol, and 
dihydrotestosterone on vasopressin mRNA expression in the bed nucleus of the 
stria terminalis. J Neurobiol 54:502-510. 
210
Hikosaka O, Sesack SR, Lecourtier L, Shepard PD. 2008. Habenula: crossroad between 
the basal ganglia and the limbic system. J Neurosci 28:11825-11829. 
Hoorneman EM, Buijs RM. 1982. Vasopressin fiber pathways in the rat brain following 
suprachiasmatic nucleus lesioning. Brain Res 243:235-241. 
Insel TR, Wang ZX, Ferris CF. 1994. Patterns of brain vasopressin receptor distribution 
associated with social organization in microtine rodents. J Neurosci 14:5381-
5392.
Iqbal J, Jacobson CD. 1995. Ontogeny of arginine vasopressin-like immunoreactivity in 
the Brazilian opossum brain. Brain Res Dev Brain Res 89:11-32. 
Jenkins JS, Ang VT, Hawthorn J, Rossor MN, Iversen LL. 1984. Vasopressin, oxytocin 
and neurophysins in the human brain and spinal cord. Brain Res 291:111-117. 
Jin X, Shearman LP, Weaver DR, Zylka MJ, de Vries GJ, Reppert SM. 1999. A 
molecular mechanism regulating rhythmic output from the suprachiasmatic 
circadian clock. Cell 96:57-68. 
Kalsbeek A, Verhagen LA, Schalij I, Foppen E, Saboureau M, Bothorel B, Buijs RM, 
Pevet P. 2008. Opposite actions of hypothalamic vasopressin on circadian 
corticosterone rhythm in nocturnal versus diurnal species. Eur J Neurosci 27:818-
827.
Kaufer D, Ogle WO, Pincus ZS, Clark KL, Nicholas AC, Dinkel KM, Dumas TC, 
Ferguson D, Lee AL, Winters MA, Sapolsky RM. 2004. Restructuring the 
neuronal stress response with anti-glucocorticoid gene delivery. Nat Neurosci 
7:947-953.
Koolhaas JM, Van den Brink THC, Roozendaal B, Boorsma F. 1990. Medial amygdala 
and aggressive behavior: Interaction between testosterone and vasopressin. 
Agressive Behavior 16:223-229. 
Lakhdar-Ghazal N, Dubois-Dauphin M, Hermes ML, Buijs RM, Bengelloun WA, Pevet 
P. 1995. Vasopressin in the brain of a desert hibernator, the jerboa (Jaculus 
orientalis): presence of sexual dimorphism and seasonal variation. J Comp Neurol 
358:499-517.
Land H, Schutz G, Schmale H, Richter D. 1982. Nucleotide sequence of cloned cDNA 
encoding bovine arginine vasopressin-neurophysin II precursor. Nature 295:299-
303.
211
Landgraf R, Frank E, Aldag JM, Neumann ID, Sharer CA, Ren X, Terwilliger EF, Niwa 
M, Wigger A, Young LJ. 2003. Viral vector-mediated gene transfer of the vole 
V1a vasopressin receptor in the rat septum: improved social discrimination and 
active social behaviour. Eur J Neurosci 18:403-411. 
Landgraf R, Gerstberger R, Montkowski A, Probst JC, Wotjak CT, Holsboer F, 
Engelmann M. 1995. V1 vasopressin receptor antisense oligodeoxynucleotide into 
septum reduces vasopressin binding, social discrimination abilities, and anxiety-
related behavior in rats. J Neurosci 15:4250-4258. 
Landgraf R, Malkinson TJ, Veale WL, Lederis K, Pittman QJ. 1990. Vasopressin and 
oxytocin in rat brain in response to prostaglandin fever. Am J Physiol 259:R1056-
1062.
Lecourtier L, Kelly PH. 2007. A conductor hidden in the orchestra? Role of the habenular 
complex in monoamine transmission and cognition. Neurosci Biobehav Rev 
31:658-672.
Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein R. 2009. 
Association between arginine vasopressin 1a receptor (AVPR1a) promoter region 
polymorphisms and prepulse inhibition. Psychoneuroendocrinology 34:901-908. 
Li JD, Burton KJ, Zhang C, Hu SB, Zhou QY. 2009. Vasopressin receptor V1a regulates 
circadian rhythms of locomotor activity and expression of clock-controlled genes 
in the suprachiasmatic nuclei. Am J Physiol Regul Integr Comp Physiol 
296:R824-830.
Lim MM, Wang Z, Olazabal DE, Ren X, Terwilliger EF, Young LJ. 2004. Enhanced 
partner preference in a promiscuous species by manipulating the expression of a 
single gene. Nature 429:754-757. 
Lim MM, Young LJ. 2004. Vasopressin-dependent neural circuits underlying pair bond 
formation in the monogamous prairie vole. Neuroscience 125:35-45. 
Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ. 1992. 
Cloning and characterization of a vasopressin V2 receptor and possible link to 
nephrogenic diabetes insipidus. Nature 357:336-339. 
Mayes CR, Watts AG, McQueen JK, Fink G, Charlton HM. 1988. Gonadal steroids 
influence neurophysin II distribution in the forebrain of normal and mutant mice. 
Neuroscience 25:1013-1022. 
Michelsen KA, Schmitz C, Steinbusch HW. 2007. The dorsal raphe nucleus--from silver 
stainings to a role in depression. Brain Res Rev 55:329-342. 
212
Miller MA, DeVries GJ, al-Shamma HA, Dorsa DM. 1992. Decline of vasopressin 
immunoreactivity and mRNA levels in the bed nucleus of the stria terminalis 
following castration. J Neurosci 12:2881-2887. 
Miller MA, Ferris CF, Kolb PE. 1999. Absence of vasopressin expression by galanin 
neurons in the golden hamster: implications for species differences in 
extrahypothalamic vasopressin pathways. Brain Res Mol Brain Res 67:28-35. 
Miller MA, Kolb PE, Raskind MA. 1993. Extra-hypothalamic vasopressin neurons 
coexpress galanin messenger RNA as shown by double in situ hybridization 
histochemistry. J Comp Neurol 329:378-384. 
Miller MA, Vician L, Clifton DK, Dorsa DM. 1989. Sex differences in vasopressin 
neurons in the bed nucleus of the stria terminalis by in situ hybridization. Peptides 
10:615-619.
Mitchell AS, Browning PG, Baxter MG. 2007. Neurotoxic lesions of the medial 
mediodorsal nucleus of the thalamus disrupt reinforcer devaluation effects in 
rhesus monkeys. J Neurosci 27:11289-11295. 
Morel A, O'Carroll AM, Brownstein MJ, Lolait SJ. 1992. Molecular cloning and 
expression of a rat V1a arginine vasopressin receptor. Nature 356:523-526. 
Murphy D, Carter D. 1990. Vasopressin gene expression in the rodent hypothalamus: 
transcriptional and posttranscriptional responses to physiological stimulation. Mol 
Endocrinol 4:1051-1059. 
Naylor AM, Ruwe WD, Kohut AF, Veale WL. 1985. Perfusion of vasopressin within the 
ventral septum of the rabbit suppresses endotoxin fever. Brain Res Bull 15:209-
213.
Oliver G, Schafer EA. 1895. On the Physiological Action of Extracts of Pituitary Body 
and certain other Glandular Organs: Preliminary Communication. J Physiol 
18:277-279.
Ostrowski NL, Lolait SJ, Bradley DJ, O'Carroll AM, Brownstein MJ, Young WS, 3rd. 
1992. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic 
acids in rat liver, kidney, pituitary and brain. Endocrinology 131:533-535. 
Ostrowski NL, Lolait SJ, Young WS, 3rd. 1994. Cellular localization of vasopressin V1a 
receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain 
vasculature. Endocrinology 135:1511-1528. 
Ostrowski NL, Young WS, 3rd, Knepper MA, Lolait SJ. 1993. Expression of vasopressin 
V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of 
embryonic, developing, and adult rats. Endocrinology 133:1849-1859. 
213
Pitkow LJ, Sharer CA, Ren X, Insel TR, Terwilliger EF, Young LJ. 2001. Facilitation of 
affiliation and pair-bond formation by vasopressin receptor gene transfer into the 
ventral forebrain of a monogamous vole. J Neurosci 21:7392-7396. 
Pittman QJ, Franklin LG. 1985. Vasopressin antagonist in nucleus tractus solitarius/vagal 
area reduces pressor and tachycardia responses to paraventricular nucleus 
stimulation in rats. Neurosci Lett 56:155-160. 
Raggenbass M, Goumaz M, Sermasi E, Tribollet E, Dreifuss JJ. 1991. Vasopressin 
generates a persistent voltage-dependent sodium current in a mammalian 
motoneuron. J Neurosci 11:1609-1616. 
Raggenbass M, Tribollet E, Dubois-Dauphin M, Dreifuss JJ. 1989. Vasopressin receptors 
of the vasopressor (V1) type in the nucleus of the solitary tract of the rat mediate 
direct neuronal excitation. J Neurosci 9:3929-3936. 
Reisine TD, Soubrie P, Artaud F, Glowinski J. 1982. Involvement of lateral habenula-
dorsal raphe neurons in the differential regulation of striatal and nigral 
serotonergic transmission cats. J Neurosci 2:1062-1071. 
Risold PY, Swanson LW. 1997. Connections of the rat lateral septal complex. Brain Res 
Brain Res Rev 24:115-195. 
Rood BD, Murray EK, Laroche J, Yang MK, Blaustein JD, De Vries GJ. 2008. Absence 
of progestin receptors alters distribution of vasopressin fibers but not sexual 
differentiation of vasopressin system in mice. Neuroscience 154:911-921. 
Rosen GJ, De Vries GJ, Goldman SL, Goldman BD, Forger NG. 2007. Distribution of 
vasopressin in the brain of the eusocial naked mole-rat. J Comp Neurol 500:1093-
1105.
Rossor MN, Iversen LL, Hawthorn J, Ang VT, Jenkins JS. 1981. Extrahypothalamic 
vasopressin in human brain. Brain Res 214:349-355. 
Russell JT, Brownstein MJ, Gainer H. 1981. Time course of appearance and release of 
[35S]cysteine labelled neurophysins and peptides in the neurohypophysis. Brain 
Res 205:299-311. 
Saito M, Sugimoto T, Tahara A, Kawashima H. 1995. Molecular cloning and 
characterization of rat V1b vasopressin receptor: evidence for its expression in 
extra-pituitary tissues. Biochem Biophys Res Commun 212:751-757. 
Saper CB, Lu J, Chou TC, Gooley J. 2005. The hypothalamic integrator for circadian 
rhythms. Trends Neurosci 28:152-157. 
214
Saper CB, Sawchenko PE. 2003. Magic peptides, magic antibodies: guidelines for 
appropriate controls for immunohistochemistry. J Comp Neurol 465:161-163. 
Scharrer E. 1951. Neurosecretion X.  A relationship between the paraphysis and the 
paraventricular nucleus in the garter snake (thamnopsis sp.). Biol. Bull. 101:106-
113.
Shewey LM, Dorsa DM. 1988. V1-type vasopressin receptors in rat brain septum: 
binding characteristics and effects on inositol phospholipid metabolism. J 
Neurosci 8:1671-1677. 
Simerly RB. 2002. Wired for reproduction: organization and development of sexually 
dimorphic circuits in the mammalian forebrain. Annu Rev Neurosci 25:507-536. 
Sofroniew MV, Weindl A. 1978a. Extrahypothalamic neurophysin-containing perikarya, 
fiber pathways and fiber clusters in the rat brain. Endocrinology 102:334-337. 
Sofroniew MV, Weindl A. 1978b. Projections from the parvocellular vasopressin- and 
neurophysin-containing neurons of the suprachiasmatic nucleus. Am J Anat 
153:391-429.
Stephan FK, Zucker I. 1972. Circadian rhythms in drinking behavior and locomotor 
activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A 
69:1583-1586.
Stephens LR, Logan SD. 1986. Arginine-vasopressin stimulates inositol phospholipid 
metabolism in rat hippocampus. J Neurochem 46:649-651. 
Sutherland RJ. 1982. The dorsal diencephalic conduction system: a review of the 
anatomy and functions of the habenular complex. Neurosci Biobehav Rev 6:1-13. 
Swaab DF, Pool CW. 1975. Specificity of oxytocin and vasopressin 
immunofluorescence. J Endocrinol 66:263-272. 
Swanson LW. 1977. Immunohistochemical evidence for a neurophysin-containing 
autonomic pathway arising in the paraventricular nucleus of the hypothalamus. 
Brain Res 128:346-353. 
Swanson LW, Cowan WM. 1979. The connections of the septal region in the rat. J Comp 
Neurol 186:621-655. 
Thompson RR, George K, Walton JC, Orr SP, Benson J. 2006. Sex-specific influences of 
vasopressin on human social communication. Proc Natl Acad Sci U S A 
103:7889-7894.
215
Turner MR, Pallone TL. 1997. Vasopressin constricts outer medullary descending vasa 
recta isolated from rat kidneys. Am J Physiol 272:F147-151. 
Turner RA, Pierce JG, du VV. 1951. The purification and the amino acid content of 
vasopressin preparations. J Biol Chem 191:21-28. 
Van der Werf YD, Witter MP, Groenewegen HJ. 2002. The intralaminar and midline 
nuclei of the thalamus. Anatomical and functional evidence for participation in 
processes of arousal and awareness. Brain Res Brain Res Rev 39:107-140. 
van Leeuwen F, Caffe R. 1983. Vasopressin-immunoreactive cell bodies in the bed 
nucleus of the stria terminalis of the rat. Cell Tissue Res 228:525-534. 
Vandesande F, Dierickx K. 1975. Identification of the vasopressin producing and of the 
oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy 
system of the rat. Cell Tissue Res 164:153-162. 
Vandesande F, Dierickx K, DeMey J. 1975. Identification of the vasopressin-neurophysin
producing neurons of the rat suprachiasmatic nuclei. Cell Tissue Res 156:377-
380.
Veenema AH, Neumann ID. 2007. Neurobiological mechanisms of aggression and stress 
coping: a comparative study in mouse and rat selection lines. Brain Behav Evol 
70:274-285.
Veney SL, Rissman EF. 2000. Steroid implants in the medial preoptic area or 
ventromedial nucleus of the hypothalamus activate female sexual behaviour in the 
musk shrew. J Neuroendocrinol 12:1124-1132. 
Ventura MA, Rene P, de Keyzer Y, Bertagna X, Clauser E. 1999. Gene and cDNA 
cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor. 
J Mol Endocrinol 22:251-260. 
Walum H, Westberg L, Henningsson S, Neiderhiser JM, Reiss D, Igl W, Ganiban JM, 
Spotts EL, Pedersen NL, Eriksson E, Lichtenstein P. 2008. Genetic variation in 
the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding 
behavior in humans. Proc Natl Acad Sci U S A 105:14153-14156. 
Wang RY, Aghajanian GK. 1977. Physiological evidence for habenula as major link 
between forebrain and midbrain raphe. Science 197:89-91. 
Wang Z, Bullock NA, De Vries GJ. 1993. Sexual differentiation of vasopressin 
projections of the bed nucleus of the stria terminals and medial amygdaloid 
nucleus in rats. Endocrinology 132:2299-2306. 
216
217
Wang Z, De Vries GJ. 1995. Androgen and estrogen effects on vasopressin messenger 
RNA expression in the medial amygdaloid nucleus in male and female rats. J 
Neuroendocrinol 7:827-831. 
Wang Z, Ferris CF, De Vries GJ. 1994. Role of septal vasopressin innervation in paternal 
behavior in prairie voles (Microtus ochrogaster). Proc Natl Acad Sci U S A 
91:400-404.
Wang Z, Toloczko D, Young LJ, Moody K, Newman JD, Insel TR. 1997. Vasopressin in 
the forebrain of common marmosets (Callithrix jacchus): studies with in situ 
hybridization, immunocytochemistry and receptor autoradiography. Brain Res 
768:147-156.
Wang Z, Zhou L, Hulihan TJ, Insel TR. 1996. Immunoreactivity of central vasopressin 
and oxytocin pathways in microtine rodents: a quantitative comparative study. J 
Comp Neurol 366:726-737. 
Watts AG, Swanson LW. 1987. Efferent projections of the suprachiasmatic nucleus: II. 
Studies using retrograde transport of fluorescent dyes and simultaneous peptide 
immunohistochemistry in the rat. J Comp Neurol 258:230-252. 
Wersinger SR, Caldwell HK, Martinez L, Gold P, Hu SB, Young WS, 3rd. 2007. 
Vasopressin 1a receptor knockout mice have a subtle olfactory deficit but normal 
aggression. Genes Brain Behav 6:540-551. 
Yates FE, Russell SM, Dallman MF, Hodge GA, McCann SM, Dhariwal AP. 1971. 
Potentiation by vasopressin of corticotropin release induced by corticotropin-
releasing factor. Endocrinology 88:3-15. 
Young LJ, Nilsen R, Waymire KG, MacGregor GR, Insel TR. 1999. Increased affiliative 
response to vasopressin in mice expressing the V1a receptor from a monogamous 
vole. Nature 400:766-768. 
